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Effects of climate change on immunity could affect wildlife disease risk. Climate change 
is predicted to alter conditions in ephemeral ponds, which many amphibians threatened by the 
disease chytridiomycosis require for larval development. Environmental stressors like early pond 
drying and elevated temperature are known to accelerate larval development and metamorphosis 
in some amphibians, allowing them to escape harsh aquatic conditions faster. However, little is 
known about how these stressors may impact the development of immune defenses. In this 
dissertation, I investigated how pond drying and an increase in pond temperature impact the 
development of immune defenses and susceptibility to Batrachochytrium dendrobatidis (Bd), the 
fungus that causes chytridiomycosis, in North American leopard frogs. To better understand the 
dynamics and spread of Bd, I also conducted a field study comparing infection among amphibian 
communities that breed in permanent versus ephemeral ponds. Exposure to pond drying and 
elevated temperatures resulted in froglets that were smaller at metamorphosis. Both stressors also 
had direct and indirect carry-over effects on the post-metamorphic immune system. Frogs that 
developed under different drying and temperature treatments differed in many immune 
parameters. The innate and adaptive immune systems tended to respond differently, suggesting 
that both branches should be considered when evaluating the potential impacts of climate 
change. Upon exposure to Bd, pathogen load did not differ among frogs from different climate 
v 
treatments. However, mortality was greater in frogs that developed in faster drying and higher 
temperature treatments. This suggests that climate stressors experienced during early 
development can impact how tolerant hosts are to infection later in life. In my field study, I 
found a large amount of genetic variation in the Bd sampled from amphibian hosts. Bd 
prevalence and load were lower on hosts from ephemeral ponds than permanent ponds early in 
the breeding season. Interestingly, some ephemeral pond breeders emerged from terrestrial 
hibernation sites infected with Bd, suggesting that transmission from permanent ponds is not 
required to bring Bd to ephemeral ponds each year. My findings in this amphibian disease system 




Table of contents 
Preface ....................................................................................................................................... xxvi 
1.0 Effects of hydroperiod on the immune defenses and Bd susceptibly of northern 
leopard frog ............................................................................................................................ 1 
1.1 Introduction .................................................................................................................... 1 
1.2 Methods ........................................................................................................................... 9 
1.2.1 Egg collection ........................................................................................................9 
1.2.2 Mesocosm set up .................................................................................................10 
1.2.3 Experimental design ..........................................................................................11 
1.2.4 Bd exposure .........................................................................................................12 
1.2.5 Mucosome collection ..........................................................................................15 
1.2.6 Collection of peptides secreted onto the skin ...................................................15 
1.2.7 Quantification of total peptides ........................................................................16 
1.2.8 Mass spectrometry .............................................................................................17 
1.2.9 Bd growth assays ................................................................................................18 
1.2.10 Statistical analysis ............................................................................................21 
1.3 Results ............................................................................................................................ 25 
1.4 Discussion ...................................................................................................................... 40 
1.4.1 Simulated pond drying conditions did not induce developmental plasticity 40 
1.4.2 Effects of drying conditions on survival and growth ......................................41 
1.4.3 Effects of pond drying on development of immune defenses .........................42 
1.4.4 Lower survival after Bd exposure .....................................................................42 
vii 
1.4.5 Indirect effects of drying and Bd exposure ......................................................43 
1.4.6 Antimicrobial peptides after drying treatment and exposure to Bd .............44 
1.4.7 Mucosome after drying treatment and exposure to Bd ..................................46 
2.0 Impacts of elevated temperature and Bd exposure on immune function ........................ 48 
2.1 Introduction .................................................................................................................. 48 
2.2 Methods ......................................................................................................................... 54 
2.2.1 Temperature treatment design .........................................................................54 
2.2.2 Animals ...............................................................................................................59 
2.2.3 Statistical analyses for comparisons of larval survival, growth and 
development .......................................................................................................63 
2.2.4 Post-metamorphic treatments ...........................................................................64 
2.2.5 Immune assays of newly metamorphosed froglets ..........................................65 
2.2.6 Skin peptide collection and quantification .......................................................65 
2.2.7 Skin peptide analyses .........................................................................................68 
2.2.8 White blood cell counts ......................................................................................69 
2.2.9 White blood cell analyses ...................................................................................69 
2.2.10 Lymphocyte counts ..........................................................................................70 
2.2.11 Lymphocyte analyses .......................................................................................70 
2.2.12 T- and B-cell proliferation ...............................................................................71 
2.2.13 T- and B-cell proliferation analysis ................................................................71 
2.2.14 Bd exposure and subsequent immune measurements ..................................72 
2.2.15 Statistical analyses of infection and disease indicators .................................73 
2.2.16 Splenocyte counts .............................................................................................74 
viii 
2.2.17 Post-exposure splenocyte analysis ..................................................................75 
2.2.18 Mucosome collection ........................................................................................75 
2.2.19 Mucosome effects on Bd viability ...................................................................76 
2.3 Results ............................................................................................................................ 78 
2.3.1 Survival ...............................................................................................................78 
2.3.2 Larval period ......................................................................................................80 
2.3.3 Mass at metamorphosis .....................................................................................82 
2.3.4 Body size (SVL) ..................................................................................................83 
2.3.5 Total peptides in skin secretions .......................................................................84 
2.3.6 Secretion of antimicrobial peptides ..................................................................87 
2.3.7 White blood cell counts ......................................................................................94 
2.3.8 Thymocyte counts ..............................................................................................98 
2.3.9 Splenocyte counts .............................................................................................101 
2.3.10 T-lymphocyte proliferation ...........................................................................103 
2.3.11 B-lymphocyte proliferation ...........................................................................104 
2.3.12 Bd infections ....................................................................................................106 
2.3.13 Splenocyte counts after Bd exposure ............................................................113 
2.3.14 Inhibition of Bd growth by mucosome samples ...........................................115 
2.4 Discussion .................................................................................................................... 120 
3.0 Understanding the landscape-level movement of an emerging wildlife pathogen ........ 131 
3.1 Introduction ................................................................................................................ 131 
3.2 Methods ....................................................................................................................... 137 
3.2.1 Surveys at permanent and ephemeral ponds ................................................137 
ix 
3.2.2 Surveys at fenced ephemeral ponds ...............................................................139 
3.2.3 DNA extraction and qPCR protocol ...............................................................141 
3.2.4 Isopropanol precipitation of samples containing Bd DNA ...........................142 
3.2.5 Sequencing and cleaning .................................................................................142 
3.2.6 Statistical analysis ............................................................................................144 
3.3 Results .......................................................................................................................... 146 
3.3.1 Genetic variation in the fenced ponds ............................................................154 
3.4 Discussion .................................................................................................................... 159 
3.4.1 Bd prevalence and load in Pennsylvania ........................................................160 
3.4.2 Bd infections in ephemeral vs permanent ponds ...........................................160 
3.4.3 Genotyping Bd in and out of the ponds ..........................................................166 
4.0 Conclusion ........................................................................................................................... 169 
Appendix A ................................................................................................................................ 178 
Appendix B ................................................................................................................................ 195 
Appendix C ................................................................................................................................ 261 






List of tables 
Table 2.1  Modelled and measured water temperatures for each temperature treatment for 
each egg collection locality and month of the experiment. .......................................... 57 
Table 2.2  Sample sizes for each treatment group for each experiment and assay performed.
........................................................................................................................................... 61 
Table 2.3  AIC values for models compared for each immune variable. ............................... 90 
Table 2.4 Table showing the mean and log10 transformed mean of immune measures at one- 
and two-months post-metamorphosis in frogs reared in current and future 
temperature treatments. ................................................................................................. 97 
Table 2.5 AIC values for models compared for each immune variable after Bd exposure.
......................................................................................................................................... 117 
Table 2.6 Table showing the mean and log10 mean of splenocyte counts from exposed and 
sham exposed frogs from current and future temperature treatments. .................. 117 
Table 3.1 Field site names, locations, and pond types ........................................................... 137 
Table A.1 Output from a linear mixed-effect model examining the variation in larval period 
across drying treatments. ............................................................................................. 178 
Table A.2 Output from a generalized linear model (quasi-binomial link) examining the 
number of animals that survived through metamorphosis versus the number of 
animals that did not per mesocosm as a concatenated variable. .............................. 179 
xi 
Table A.3 Output from a Cox proportional hazards model examining survival across the 
three drying treatments from metamorphosis to 42 d post-metamorphosis, clustered 
by mesocosm. ................................................................................................................. 180 
Table A.4 Output from a linear model examining body mass at metamorphosis across the 
three drying treatments, clustered by mesocosm. ...................................................... 181 
Table A.5 Output from a linear model examining body length (SVL) at metamorphosis 
across the three drying treatments, clustered by mesocosm. .................................... 182 
Table A.6 Generalized linear mixed model with a binomial distribution of the probability of 
Bd infection across the three drying treatments. ....................................................... 183 
Table A.7 Linear mixed model of Bd infection load with drying treatment. ...................... 185 
Table A.8 Linear mixed model of body condition [measured as log (scaled mass index), or 
log SMI)]. ....................................................................................................................... 186 
Table A.9 Output from a Cox proportional hazards model examining survival after Bd 
exposure. ........................................................................................................................ 188 
Table A.10 Output from a linear model examining total mucosal peptides after Bd exposure 
across exposure groups and drying treatments.......................................................... 189 
Table A.11 Output from a linear model examining Bd inhibition by peptides after Bd 
exposure across the three drying treatments and two exposure groups. ................. 190 
Table A.12 General linear model for presence/absence of AMPs after Bd exposure across the 
three drying treatments. ............................................................................................... 191 
Table A.13 Output of a PERMANOVA for AMP presence/absence after Bd exposure. ... 192 
Table A.14 Output of a PERMANOVA for AMP relative intensities after Bd exposure .. 192 
xii 
Table A.15 Output of an ANOVA for Shannon diversity index comparing the AMP relative 
intensities between exposed and control frogs in the three drying treatments. ...... 192 
Table A.16 Similarity percentage (simper) analysis results based on the decomposition of the 
Bray-Curtis dissimilarity index based on presence/absence of AMPs. .................... 192 
Table A.17 Similarity percentage (simper) analysis results based on the decomposition of the 
Bray-Curtis dissimilarity index based on AMP relative intensities. ........................ 193 
Table A.18 Output from a linear model examining inhibition of Bd growth by mucosome 
samples in Bd-exposed and naïve (control) frogs. ...................................................... 193 
Table A.19 Output from a linear model examining the correlation between Bd load and 
inhibition of Bd growth by mucosome samples. ......................................................... 194 
 
Table B.1 Output from a Cox proportional hazards model examining survival after 
metamorphosis between the two temperature treatments for VT. .......................... 195 
Table B.2 Output from a Cox proportional hazards model examining survival after 
metamorphosis between the two temperature treatments for PA............................ 196 
Table B.3 Output from a Cox proportional hazards model examining survival after 
metamorphosis between the two temperature treatments for TN. .......................... 197 
Table B.4 Output from a Cox proportional hazards model examining survival after 
metamorphosis between the two temperature treatments for LA. .......................... 198 
Table B.5 Output from a Cox proportional hazards model examining time to metamorphosis 
between the two temperature treatments for VT....................................................... 199 
Table B.6 Output from a Cox proportional hazards model examining time to metamorphosis 
between the two temperature treatments for PA. ...................................................... 200 
xiii 
Table B.7 Output from a Cox proportional hazards model examining time to metamorphosis 
between the two temperature treatments for LA....................................................... 201 
Table B.8 Output from a linear model examining body mass at metamorphosis across the 
two temperatures in VT................................................................................................ 202 
Table B.9 Output from a linear model examining body mass at metamorphosis across the 
two temperatures in PA. ............................................................................................... 203 
Table B.10 Output from a linear model examining body mass at metamorphosis across the 
two temperatures in LA................................................................................................ 204 
Table B.11 Output from a linear model examining body length (mm) at metamorphosis 
across the two temperatures in VT.............................................................................. 205 
Table B.12 Output from a linear model examining body length (mm) at metamorphosis 
across the two temperatures in PA. ............................................................................. 206 
Table B.13 Output from a linear model examining body length (mm) at metamorphosis 
across the two temperatures in LA.............................................................................. 207 
Table B.14 Output from a linear model examining mucosal peptides at one month across the 
two temperatures in VT................................................................................................ 208 
Table B.15 Output from a linear model examining mucosal peptides at two months across 
the two temperatures in VT. ........................................................................................ 209 
Table B.16 Output from a linear model examining mucosal peptides at one month across the 
two temperatures in PA. ............................................................................................... 210 
Table B.17 Output from a linear model examining mucosal peptides at two months across 
the two temperatures in PA. ........................................................................................ 210 
xiv 
Table B.18 Output from a linear model examining mucosal peptides at one month across the 
two temperatures in LA................................................................................................ 211 
Table B.19 Output from a linear model examining mucosal peptides at two months across 
the two temperatures in LA. ........................................................................................ 212 
Table B.20 Output of a Permanova for AMPs presence/absence between temperature 
treatments in Vermont at 1 month. ............................................................................. 213 
Table B.21 Output of a Permanova for AMPs presence/absence between temperature 
treatments in Vermont at 2 months. ........................................................................... 213 
Table B.22 Output of a Permanova for AMPs presence/absence between temperature 
treatments in Pennsylvania at 1 month. ...................................................................... 213 
Table B.23 Output of a Permanova for AMPs presence/absence between temperature 
treatments in Pennsylvania at 2 months. .................................................................... 214 
Table B.24 Output of a Permanova for AMPs intensities between temperature treatments in 
Vermont at 1 month. ..................................................................................................... 214 
Table B.25 Output of a Permanova for AMPs intensities between temperature treatments in 
Vermont at 2 months. ................................................................................................... 214 
Table B.26 Output of a Permanova for AMPs intensities between temperature treatments in 
Pennsylvania at 1 month. ............................................................................................. 214 
Table B.27 Output of a Permanova for AMPs intensities between temperature treatments in 
Pennsylvania at 2 month. ............................................................................................. 215 
Table B.28 Output of a Permanova for AMPs presence/absence between temperature 
treatments with seven known peptides for Vermont at 1 month.............................. 215 
xv 
Table B.29 Output of a Permanova for AMPs presence/absence between temperature 
treatments with seven known peptides in Vermont at 2 months. ............................. 215 
Table B.30 Output of a Permanova for AMPs intensities between temperature treatments 
with seven known peptides for Vermont at 1 month. ................................................ 215 
Table B.31 Output of a Permanova for AMPs intensities between temperature treatments 
with seven known peptides in Vermont at 2 months. ................................................ 216 
Table B.32 Output of a generalized linear model with a Poisson distribution for VT at 1 
month. ............................................................................................................................ 216 
Table B.33 Output of a generalized linear model with a Poisson distribution for VT at 2 
months. ........................................................................................................................... 216 
Table B.34 Output of a generalized linear model with a Poisson distribution for PA at 1 
month. ............................................................................................................................ 216 
Table B.35 Output of a generalized linear model with a Poisson distribution for PA at 2 
months ............................................................................................................................ 216 
Table B.36 Output of a generalized linear model with a Poisson distribution for LA at 1 
month. ............................................................................................................................ 217 
Table B.37 Output of a generalized linear model with a Poisson distribution for LA at 2 
months. ........................................................................................................................... 217 
Table B.38 Output from a linear model examining total white blood cell counts at 1 month 
across the two temperatures in VT.............................................................................. 218 
Table B.39 Output from a linear model examining total white blood cell counts at 2 months 
across the two temperatures in VT.............................................................................. 219 
xvi 
Table B.40 Output from a linear model examining total white blood cell counts at 1 month 
across the two temperatures in PA. ............................................................................. 220 
Table B.41 Output from a linear model examining total white blood cell counts at 2 months 
across the two temperatures in PA. ............................................................................. 221 
Table B.42 Output from a linear model examining total white blood cell counts at 1 month 
across the two temperatures in LA.............................................................................. 222 
Table B.43 Output from a linear model examining total white blood cell counts cells/ml at 2 
months across the two temperatures in LA. ............................................................... 223 
Table B.44 Output from a linear model examining log Thymocyte counts cells/g at 1 month 
across the two temperatures in VT.............................................................................. 224 
Table B.45 Output from a linear model examining log Thymocyte counts cells/g at 2 months 
across the two temperatures in VT.............................................................................. 225 
Table B.46 Output from a linear model examining log Thymocyte counts cells/g at 1 month 
across the two temperatures in PA. ............................................................................. 226 
Table B.47 Output from a linear model examining log Thymocyte counts cells/g at 2 months 
across the two temperatures in PA. ............................................................................. 227 
Table B.48 Output from a linear model examining log Thymocyte counts cells/g at 1 month 
across the two temperatures in LA.............................................................................. 228 
Table B.49 Output from a linear model examining log Thymocyte counts cells/g at 2 months 
across the two temperatures in LA.............................................................................. 229 
Table B.50 Output from a linear model examining log Splenocyte count (cells/g) at 1 month 
across the two temperatures in VT.............................................................................. 230 
xvii 
Table B.51 Output from a linear model examining log Splenocyte count (cells/g) at 2 months 
across the two temperatures in VT.............................................................................. 231 
Table B.52 Output from a linear model examining log Splenocyte count (cells/g) at 1 month 
across the two temperatures in PA. ............................................................................. 232 
Table B.53 Output from a linear model examining log Splenocyte count (cells/g) at 2 months 
across the two temperatures in PA. ............................................................................. 233 
Table B.54 Output from a linear model examining log Splenocyte count (cells/g) at 1 month 
across the two temperatures in LA.............................................................................. 234 
Table B.55 Output from a linear model examining log Splenocyte count (cells/g) at 2 months 
across the two temperatures in LA.............................................................................. 235 
Table B.56 Output from a linear model examining log T lymphocyte proliferation proportion 
at 1 month across the two temperatures in VT. ......................................................... 236 
Table B.57 Output from a linear model examining log T lymphocyte proliferation proportion 
at 1 month across the two temperatures in PA. ......................................................... 237 
Table B.58 Output from a linear model examining log T lymphocyte proliferation proportion 
at 1 month across the two temperatures in LA. ......................................................... 238 
Table B.59 Output from a linear model examining log B lymphocyte proliferation proportion 
at 2 months across the two temperatures in VT......................................................... 239 
Table B.60 Output from a linear model examining log B lymphocyte proliferation proportion 
at 2 months across the two temperatures in PA. ........................................................ 240 
Table B.61 Output from a linear model examining log B lymphocyte proliferation proportion 
at 2 months across the two temperatures in LA......................................................... 241 
xviii 
Table B.62 Linear mixed model of Bd infection load with temperature treatment, time post 
exposure as fixed effects and their interaction for LA. ............................................. 242 
Table B.63 Generalized linear mixed model with a binomial distribution of the probability 
of Bd infection across the two temperatures by week in LA..................................... 243 
Table B.64 Linear mixed model of Bd infection load with temperature treatment, days post 
exposure as fixed effects and their interaction for PA............................................... 244 
Table B. 65 Generalized linear mixed model with a binomial distribution of the probability 
of Bd infection across the two temperatures by week in PA. .................................... 245 
Table B.66 Linear mixed model of Bd infection load with temperature treatment, days post 
exposure as fixed effects and their interaction for VT. ............................................. 246 
Table B.67 Generalized linear mixed model with a binomial distribution of the probability 
of Bd infection across the two temperatures by week in VT..................................... 247 
Table B.68 Linear mixed model of Body condition (measured as log (scaled mass index), or 
log SMI) in VT and the interaction between Bd exposure and time of exposure. .. 248 
Table B.69 Linear mixed model of Body condition (measured as log (scaled mass index), or 
log SMI) in PA and the interaction between Bd exposure and time of exposure.... 249 
Table B.70 Linear mixed model of Body condition (measured as log (scaled mass index), or 
log SMI) in LA and the interaction between Bd exposure and time of exposure. .. 250 
Table B.71 Output from a Cox proportional hazards model examining survival across the 
two temperatures after Bd exposure in VT. ............................................................... 251 
Table B.72 Output from a Cox proportional hazards model examining survival across the 
two temperatures after Bd exposure in PA. ............................................................... 251 
xix 
Table B.73 Output from a Cox proportional hazards model examining survival across the 
two temperatures after Bd exposure in LA. ............................................................... 251 
Table B.74 Output from a linear model examining log Splenocyte count (cells/g) after 
exposure across the two temperatures in VT. ............................................................ 252 
Table B.75 Output from a linear model examining log Splenocyte count (cells/g) after 
exposure across the two temperatures in PA. ............................................................ 253 
Table B.76 Output from a linear model examining log Splenocyte count (cells/g) after 
exposure across the two temperatures in LA. ............................................................ 254 
Table B.77 Output from a linear model examining total mucosal peptides after Bd exposure 
across exposure groups for VT .................................................................................... 256 
Table B.78 Output from a linear model examining total mucosal peptides after Bd exposure 
across exposure groups for PA. ................................................................................... 257 
Table B.79 Output from a linear model examining total mucosal peptides after Bd exposure 
across exposure groups for LA. ................................................................................... 258 
Table C.1 Output from a generalized linear mixed model with a binomial distribution of the 
probability of Bd infection (yes/no) with pond type (ephemeral vs. permanent), pH 
and animal body temperature as factors. ................................................................... 261 
Table C.2 Output from a linear mixed model of Bd load with pond type (ephemeral vs. 
permanent), pH and animal body temperature as factors. ....................................... 262 
Table C.3 Output from a linear mixed model of Bd load on infected animals across the two 
hibernation types (permanent pond vs. terrestrial) in the two fenced ponds.......... 263 
xx 
Table C.4 Output from a generalized linear mixed model with a binomial distribution of the 
probability of Bd infection (yes/no) across the two hibernation types in the two ponds.
......................................................................................................................................... 264 
Table C.5 Output from a linear mixed model comparing Bd infection load on leopard frogs 
(Rana pipiens) that metamorphosed in the Sanctuary Lake pond to all other 
amphibians captured leaving the pond. ...................................................................... 265 
Table C.6 Output from a generalized linear mixed model with a binomial distribution 
comparing the probability of Bd infection on leopard frogs (Rana pipiens) that 
metamorphosed in the Sanctuary Lake pond to all other amphibians captured leaving 
the pond.......................................................................................................................... 266 
Table C.7 Output from a linear mixed model comparing Bd infection load on the spotted 
salamanders (Ambystoma maculatum) that metamorphosed in the Wood Lab pond 
to all other amphibians captured leaving the pond. .................................................. 267 
Table C.8 Generalized linear mixed model comparing the probability of Bd infection for the 
spotted salamanders (Ambystoma maculatum) that metamorphosed in the Wood Lab 
pond to all other amphibians captured leaving the pond. ......................................... 268 
Table C.9 Output from a linear mixed model comparing Bd infection load on the wood frogs 
(Rana sylvatica) that metamorphosed in the Wood Lab pond to all other amphibians 
captured leaving the pond. ........................................................................................... 269 
Table C.10 Output from a generalized linear mixed model with a binomial distribution of 
the probability comparing Bd infection on the wood frogs (Rana sylvatica) that 
metamorphosed in the Wood Lab pond to all other amphibians captured leaving the 
pond. ............................................................................................................................... 270 
xxi 
List of figures 
Figure 1.1 Water height in the mesocosms over the course of the experiment. .................... 11 
Figure 1.2 Comparisons of leopard frog survival and development across drying treatments.
........................................................................................................................................... 28 
Figure 1.3 Relationship between the probability of becoming infected with Bd after exposure 
and post-metamorphic growth rate (g/day) in the three drying treatments. ............ 29 
Figure 1.4 Relationship between the probability of becoming infected with Bd after exposure 
and time since first exposure in the three drying treatments. .................................... 30 
Figure 1.5 Relationship between the probability of becoming infected with Bd after exposure 
and mass at metamorphosis (g) for frogs reared in the three drying treatments. .... 31 
Figure 1.6 Relationship between body mass just prior to the first exposure and Bd infection 
load in Bd-exposed animals from the three drying treatments. ................................. 32 
Figure 1.7 Relationship between days since first Bd exposure and Bd infection load in the 
three drying treatments. ................................................................................................. 32 
Figure 1.8 Relationship between body condition (measured as scaled mass index, or SMI) 
and days since first Bd exposure in frogs from control (sham infected) and Bd-exposed 
treatment groups. ............................................................................................................ 33 
Figure 1.9 Survival curves for control (sham infected) and Bd-exposed frogs reared under 
the different drying treatments...................................................................................... 34 
Figure 1.10 Non-multidimensional scaling (NMDS) plot of Bray–Curtis distances based on 
presence/absence of AMPs detected by MALDI in control (sham exposed) and Bd-
exposed frogs. .................................................................................................................. 36 
xxii 
Figure 1.11 Boxplots showing counts of AMPs secreted by control (sham exposed) and Bd-
exposed animals after the Bd-exposure experiment. ................................................... 37 
Figure 1.12 Non-multidimensional scaling (NMDS) plot based on Bray–Curtis distances on 
relative intensities of antimicrobial peptides (AMPs) detected by MALDI in control 
(sham exposed) and Bd-exposed frogs. ......................................................................... 38 
Figure 1.13 Boxplots of Shannon index of diversity showing differences in AMP communities 
secreted by control (sham-exposed) and Bd-exposed frogs from the exposure 
experiment. ...................................................................................................................... 38 
Figure 1.14 Scatterplot showing the percent inhibition of Bd growth by mucosome samples 
versus log-transformed mass of frogs at metamorphosis. ........................................... 40 
Figure 2.1 Map showing the four different locations where the egg masses were collected for 
the experiment (stars) and the ranges of R. pipiens (green shading) and R. 
sphenocephala (orange shading). ................................................................................... 60 
Figure 2.2 Experimental design indicating when each experiment took place. .................... 63 
Figure 2.3 Larval survival curves. ............................................................................................. 79 
Figure 2.4 The proportion of individuals that successfully metamorphosed (tail fully 
absorbed, Gosner stage 46) from each temperature treatment, from the Vermont and 
Pennsylvania R. pipiens and the Louisiana R. sphenocephala populations. ............. 81 
Figure 2.5 Box plots showing mass at metamorphosis (g). ...................................................... 82 
Figure 2.6 Box plots showing snout-vent length (SVL) at metamorphosis for frogs from 
current and future treatments. ...................................................................................... 83 
Figure 2.7 Box plots showing total peptides secreted (in μg per g body weight, or μg/gbw) for 
R. pipiens from Vermont. ............................................................................................... 86 
xxiii 
Figure 2.8 Scatter plot and lines of best fit for the relationships between the number of 
antimicrobial peptides (AMPs) detected and time to metamorphosis (days)  for R. 
pipiens from Vermont reared in current and future temperature treatments. ........ 88 
Figure 2.9 Non-multidimensional scaling (NMDS) plot of Bray-Curtis distances between 
AMP communities from R. pipiens from Pennsylvania at two months post-
metamorphosis. ............................................................................................................... 93 
Figure 2.10 Scatter plot and lines of best fit for the relationships between log-transformed 
white blood cell counts (cells/ml). .................................................................................. 96 
Figure 2.11 Scatter plot and lines of best fit for the relationships between log-transformed 
thymocyte counts (cells /g)............................................................................................ 100 
Figure 2.12 Scatter plots and lines of best fit for the relationships between log-transformed 
splenocyte counts (cells/g)............................................................................................. 102 
Figure 2.13 Scatter plot and lines of best fit for the relationships between log-transformed T-
lymphocyte proliferationat one-month post-metamorphosis.................................... 104 
Figure 2.14 Scatter plot and lines of best fit for the relationships between log-transformed B-
lymphocyte proliferation at two months post-metamorphosis. ................................ 106 
Figure 2.15 Survival curves for R. pipiens from Vermont that were exposed to Bd. ......... 107 
Figure 2.16 Scatter plot and lines of best fit for the relationship between Bd infection load, 
in log (DNA copies + 1), and since first exposure for Bd-exposed R. pipiens from 
Pennsylvania that were reared in current and future temperature treatments. .... 109 
Figure 2.17 Relationship between the mean proportion of frogs infected with Bd, as 
determined by qPCR, and time since first exposure for Bd-exposed R. pipiens from 
Pennsylvania reared in current and future temperature treatments. ..................... 110 
xxiv 
Figure 2.18 Scatter plot and lines of best fit for the relationship between body condition, 
measured as scaled mass index, and time since first exposure for Bd-exposed R. 
pipiens from Pennsylvania reared under current and future temperature treatments.
......................................................................................................................................... 110 
Figure 2.19 Relationship between the mean proportion of frogs infected with Bd, as 
determined by qPCR, and time since first exposure for Bd-exposed R. sphenocephala 
from Louisiana reared in current and future temperature treatments. .................. 112 
Figure 2.20 Scatter plot and lines of best fit for the relationship between body condition, 
measured as scaled mass index, and time since exposure for Bd-exposed R. 
sphenocephala from Louisiana reared in current and future temperature treatments.
......................................................................................................................................... 112 
Figure 2.21 Box plots showing the relationship between log-transformed splenocyte counts 
(cells/gbw)for R. pipiens from Vermont and Pennsylvania, and R. sphenocephala 
from Louisiana at one week after the last exposure to Bd. ....................................... 114 
Figure 2.22 Scatter plots and lines of best fit for the relationship between log-transformed 
splenocyte counts (cells/gbw). ...................................................................................... 115 
Figure 2.23 Boxplots showing the relationship between inhibition (%) of Bd growth by 
mucosome....................................................................................................................... 119 
Figure 3.1 Relationship between the proportion of sampled animals that tested positive for 
Bd (via skin swab) and body temperature for amphibians sampled from ephemeral 
and permanent ponds. .................................................................................................. 147 
Figure 3.2  Relationship between amphibian body temperature and Bd infection load in 
ephemeral and permanent ponds. ............................................................................... 148 
xxv 
Figure 3.3 Relationship between time in Julian days for frogs collected from ephemeral and 
permanent ponds. .......................................................................................................... 149 
Figure 3.4 Box plots showing the relationship between Bd infection load, in log (DNA copies 
+ 1), for animals entering the two fenced ponds and the hibernation typefor their
species (permanent pond vs. terrestrial). .................................................................... 151 
Figure 3.5 Proportion of individuals infected with Bd, upon arrival to (but before entering) 
the fenced ephemeral ponds, by hibernation type. .................................................... 151 
Figure 3.6 Proportion of individuals infected comparing spotted salamander (Ambystoma 
maculatum) metamorphs to all other animals leaving the Wood Lab pond. .......... 153 
Figure 3.7 Box plots showing the relationship between Bd infection load, in log (DNA copies 
+ 1), for leopard frog (Rana sylvatica) metamorphs and for all other animals captured
leaving the Sanctuary Lake. ......................................................................................... 153 
Figure 3.8 Proportion of individuals infected comparing wood frog (Rana sylvatica) 
metamorphs to all other animals leaving the Sanctuary Lake pond........................ 154 
Figure 3.9 Scatter plot of PC1 versus PC2 showing variance among Bd haplotypes from the 
two fenced ponds. .......................................................................................................... 155 
Figure 3.10 Scatterplot of PC1 versus PC2 showing variance among Bd haplotypes from 
animals entering (outside) vs. leaving (inside) the fenced ponds. ............................. 155 
Figure 3.11 Scatterplot of PC1 versus PC2 showing variance among Bd haplotypes from 
different amphibian species in the two fenced ponds. ............................................... 156 
Figure 3.12 Scatterplot of PC1 versus PC2 showing variance among Bd haplotypes from 
animals collected in the spring vs. summer from the fenced ponds. ........................ 156 
Figure 3.13 Phylogeny of Bd haplotypes inferred from ASTRAL and RAxML analyses. 158 
Figure B.1 Distance between each pond where the egg masses were collected.....................260
xxvi 
Preface 
First and foremost, I would like to thank my advisor and mentor, Dr. Cori Richards-
Zawacki, for taking me into her lab two times. Thank you for your continuous support of my 
Ph.D., for your patience, motivation, and all your knowledge. Your guidance helped me during 
my research and writing of this thesis. I would also like to thank you for your friendship during 
these eight years. You have not only made me a better scientist, but also made me a kinder and 
more open human being.  
To my committee members, Dr. Anne Carlson, Dr. Jon Boyle, Dr Kevin Kohl and Dr 
Louise Rollins Smith, thank you for the guidance and advice during all the years of my 
dissertation.     To Dr. Michel Ohmer, thank you for guiding me in R, for always answering the 
hard questions patiently, and for all the collaboration in the three chapters of my dissertation. 
Also, thank you for your great friendship. 
To Dr. Tali Hammond, thank you for teaching me R and for all your friendship and fun 
moments in the field and lab. 
To Dr. Laura Brannelly and Dr. Karie Altman, thank you for all the help in the field and 
for the collaboration in the SERDP project. 
To my field and lab assistants, thank you for all the late hours in the field and for taking 
care of all the tadpoles inside the chambers. 
To all the collaborators in the SERDP project, thank you for helping me in the immune 
assays and analyzing the data that was outside my knowledge in the project. 
 
xxvii 
Thank you to my advisor, the University of Pittsburgh, SERDP, the Pymatuning Lab of 
Ecology, and Senescyt for funding my research. 
To Chris Davis, Jessica Barabas and Nick Mihailoff, thank you for all the help during my 
long stay over four summers at PLE. 
To all the current and previous members of the RZ lab, thank you for your support and 
friendship. 
To my parents, thank you for always supporting my choice of research and for helping 
me by calling me online every day. 
To my fiancé, thank you for supporting me in the long-distance relationship and for 
calling me every day. 
1 
1.0 Effects of hydroperiod on the immune defenses and Bd susceptibly of northern leopard 
frog 
The part up until the Bd infection experiment occurred has already been published in Brannelly, 
L. A., Ohmer, M. E., Saenz, V., & Richards‐Zawacki, C. L. (2019). Effects of hydroperiod on 
growth, development, survival and immune defences in a temperate amphibian. Functional 
Ecology, 33(10), 1952-1961 
1.1 Introduction 
Climate change is predicted to alter air and water temperatures, precipitation, and 
humidity (Easterling et al. 2000). The global mean air temperature is projected to increase by 
0.3C to 0.7C between 2016 and 2035 (IPCC 2014). In general, precipitation is predicted to 
decrease in the middle latitudes and subtropical dry regions (IPCC 2014). With these predicted 
changes will come increased rates of evapotranspiration (water lost to the atmosphere from land 
surfaces and via transpiration from plants), meaning that human activities like agriculture will 
require increasing volumes of freshwater to maintain the same area of cultivated land (Peterson 
and Keller 1990). This, coupled with increased rates of evaporation, suggests that dramatic 
changes are in store for North American freshwater ecosystems. More streams may become 
ephemeral or remain dry for longer periods (Schindler et al. 1996), and water availability in 
ponds is predicted to decrease as well (Peterson and Keller 1990, Wilk and Hughes 2002). 
Organisms that depend on these small bodies of freshwater to complete their life cycles will be 
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negatively impacted by these changes (Deutsch et al. 2008, IPCC 2014). In addition to its direct 
negative effects, climate change may impact the susceptibility of animals to disease outbreaks. 
The potential for this sort of interaction, however, remains poorly understood. 
Climate change is likely to influence the dynamics of many infectious disease systems. 
The consistent and expected pattern of seasonal outbreaks exhibited by many exclusively human 
pathogens provides a clear example of how climate can impact host-pathogen systems. Influenza 
and Pneumococcus infections are most prevalent in winter, measles cases usually peak in the 
spring, and risk of contracting polio is greatest in the Summer (Dowell 2001). Explanations for 
these phenomena have been attributed to three interrelated seasonal drivers: (1) pathogen 
appearance and disappearance, (2) environmental changes, and (3) host behavior changes 
(Dowell 2001). For aquatic vertebrates, the same factors may drive seasonal patterns of 
infectious disease. Many parasites, viruses and bacteria that infect these hosts are known to have 
an optimal temperature for growth and reproduction (McArthur 2006). Changes in precipitation 
can also modify the balance between hosts and their parasites, leading to outbreaks (Adlard et al. 
2015).  
Climate change has the potential to push hosts and/or pathogens outside of their optimal 
thermal conditions. One way that organisms can rapidly adapt to such changes is through 
phenotypic plasticity. Phenotypic plasticity is the ability of an organism to produce different 
phenotypes in response to stimuli or inputs from the environment (Pigliucci et al. 2006). 
Changes in developmental timing (e.g., a shorter generation time; Altizer et al. 2013) are a 
common form of phenotypic plasticity that hosts and pathogens exhibit in response to climate 
stressors. For example, warmer temperatures generally accelerate development (but they can also 
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reduce life span; Harvell et al. 2002). The problem for hosts is that their pathogens may adapt 
more quickly than they do (Raffel et al. 2013).  
While studies aimed at understanding the impact of climate change on disease risk 
remain few, several illustrate why this is an important topic. For example, elevated water 
temperatures increase the virulence of the pathogen Vibrio coralliilyticus (Burge et al. 2014) and 
also reduce the fitness of its coral host, Pocillopora damicornis, such that the coral is not able to 
effectively resist infection (Ben-Haim et al. 2003). This host-pathogen interaction provides a 
useful case study of increased virulence in the face of warming ocean temperatures driven by 
anthropogenic climate change. Effects of climate change have also been documented in 
freshwater and terrestrial host-pathogen systems. For example, in birds, there is evidence that 
disease and climate change may be interacting to affect species distributions. The avian malaria 
parasite (Plasmodium relictum), which was introduced into Hawaii, caused marked declines in 
endemic forest birds. Malaria’s impact is most intense in mid-elevation forests where conditions 
that support the mosquito that vectors this disease and endemic birds have the greatest overlap 
(Liao et al. 2017). Malaria currently poses the least risk to birds at high elevations where 
mosquito populations and disease transmission are limited by cool temperatures. Models predict 
that with climate change, the mosquito vector will expand its range upward in elevation reducing 
or eliminating the high elevation refuge some endemic bird species depend on for their survival 
(Liao et al. 2017). And finally, in Pacific chorus frogs (Pseudacris regilla), infection with a 
pathogenic trematode parasite (Ribeiroia ondatrae) appears to hinder the tadpole’s ability to 
speed metamorphosis and escape a drying pond. Tadpoles experiencing accelerated pond drying 
were twice as likely to metamorphose early if they were not infected with the parasite 
(Koprivnikar et al. 2014).  
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Amphibians are an ideal taxon for studies that aim to understand the potential impact of 
climate change on disease dynamics in freshwater ecosystems. Many amphibians require aquatic 
habitats to reproduce and complete larval development. They are also a group known to exhibit 
plasticity in developmental timing in response to conditions in the aquatic environment. This 
type of plasticity has been documented in at least 20 species representing 12 amphibian genera 
(Ruthsatz et al. 2018). For example, accelerated metamorphosis has been documented in wood 
frog (Rana sylvatica) and Western spadefoot toad (Scaphiopus hammondii) tadpoles exposed to 
simulated pond drying. In both species, larvae that develop under simulated drying not only have 
shorter larval periods but are also smaller in size at metamorphosis than animals from control 
(non-drying) treatments (Denver et al. 1998, Gervasi and Foufopoulos 2008). Tradeoffs like 
these, between growth and development, have been observed in many amphibian species (Edge 
et al. 2016, Tejedo et al. 2010). Faster development is clearly beneficial for larvae seeking to 
escape from desiccation (or predation, or competition) that might occur before they are equipped 
to survive on land. However, beginning the next life stage a smaller size may represent an 
important fitness tradeoff.  
It is well-established that the environment that is experienced early in life can affect the 
expression of traits in later life stages and different habitats (O’Connor et al. 2014, Moore and 
Martin 2019). Little is known about how the developmental plasticity an animal exhibits in 
response to climate early on may affect its ability to withstand threats later in life. Given the 
threat that diseases pose to wildlife, one of the ways we can assess the effects of developing 
under stressful conditions is by measuring immune function. A good example of such a study 
comes from tree swallows (Tachycineta bicolor). Nestlings that were incubated as eggs in 
experimentally cooled nests had lower body mass and reduced constitutive innate immunity, as 
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reflected in a reduced ability of B-cells to kill a strain of E. coli (Ardia et al. 2010). Only a few 
studies have examined the effects of accelerated development on amphibian immune function, 
and these suggest that individuals with accelerated development in response to a stressor tend to 
invest less in costly immune defenses, and hence be more prone to infections (Gervasi & 
Foufopoulos 2008, Johnson et al. 2012, Brannelly et al. 2019). For example, juvenile wood frogs 
that were exposed to simulated pond drying as larvae have weaker cellular immune responses to 
the T-cell mitogen phytohemagglutinin (PHA) and lower leukocyte numbers in the blood than 
animals that developed under non-drying conditions (Gervasi and Foufopoulos 2008). How 
common this sort of trade-off between development and immune function is, and its potential 
impact on disease dynamics, remains poorly understood.   
Infectious disease threatens amphibian diversity. In particular, chytridiomycosis, the 
disease caused by the chytrid fungus Batrachochytrium dendrobatidis (Bd), has been linked to 
amphibian declines worldwide (Berger et al. 1998; Scheele et al. 2019). The effects of Bd on its 
hosts differs among species and populations (Schloegel et al. 2006). For example, some species 
like Rana catesbeiana (American bullfrog) and Xenopus laevis (African clawed frog) appear to 
tolerate infection well. They carry and spread Bd rarely suffer mortality when infected or even 
develop clinical signs of chytridiomycosis (Daszak et al. 2004). In other amphibians infected 
with Bd, the intensity of infection (i.e., pathogen load) can increase exponentially, causing a 
breakdown in proper cutaneous functioning that leads to mortality (Voyles et al. 2009). There is 
evidence that Bd evades some amphibian immune defenses. For example, it has been shown that 
Bd can inhibit the proliferation, and induce apoptosis of, amphibian lymphocytes, limiting the 
potential for an adaptive immune response (Fites et al. 2013). However, there is evidence for 
adaptation of amphibian hosts to this pathogen as well. For example, some species that 
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experienced Bd-associated population declines during an epizootic were found, decades later, to 
be surviving and even rebounding despite the continued presence and virulence of the Bd 
pathogen (Knapp et al. 2016, Voyles et al. 2018). Evidence suggests that adaptations in innate 
immune defenses of amphibian hosts are playing a role in this recovery (Voyles et al. 2018). 
Elements of the adaptive and innate immune responses, as well as cutaneous microbial 
communities, appear to contribute to the amphibian response to Bd (reviewed in Rollins-Smith 
and Woodhams 2012). Cutaneous antimicrobial peptides (AMPs) are an essential component of 
an amphibian’s innate immunity to Bd (Rollins-Smith 2009). AMPs are natural cationic 
amphipathic helical peptides that are secreted by granular glands at the surface of the skin 
(Rollins-Smith 2009). Amphibian AMPs are active against Gram positive and Gram negative 
bacteria, fungi, protozoa, and viruses (Narayana and Chen 2015). Members of four families of 
AMPs (ranatuerin, temporin, brevinin and esculetin) have been shown to inhibit Bd growth in 
vitro (Rollins-Smith et al. 2006, Rollins-Smith and Conlon 2005, Rollins-Smith 2009).  
Besides AMPs, other components of the mucosal layer on the amphibian skin also appear to kill 
Bd. Collectively, the AMPs and other defenses found in skin mucus have been termed the 
mucosome (Woodhams et al. 2014). The mucosome contains secondary metabolites, AMPs, 
lysozymes, mucosal antibodies, and alkaloids (Woodhams et al. 2014). In one study, in which 
four host species were raised from field collected eggs in outdoor mesocosms through 
metamorphosis then exposed to Bd, a greater capacity of the mucosome to inhibit Bd growth was 
found to be correlated with a lower Bd load (Woodhams et al. 2014). An amphibian’s skin also 
harbors symbiotic resident microbes which constitute a line of defense that is not directly host-
produced but interacts with the innate immune system (Harris et al. 2009). Amphibians also have 
a complex adaptive immunity, with similar immune cell types and functions (including 
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lymphocytes, neutrophils, monocytes, basophils, and eosinophils) to mammals (Hadji-Azimi et 
al. 1987). The extent of the adaptive immune system’s involvement in defense against Bd 
remains unclear, though Ramsey et al. (2010) found that some frogs (Xenopus laevis) possess 
antibodies that bind to Bd and inhibit infection. Clearly, amphibians have a suite of potential 
defenses against Bd that could be contributing to the endemic coexistence of these hosts with the 
Bd pathogen. 
In general, low temperatures favor Bd over its amphibian hosts because Bd is cold-
tolerant (growing from ~4 – 25 °C; Woodhams et al. 2008, Voyles et al. 2012), and amphibian 
immune defenses are often sluggish at low temperatures (Robak et al. 2019). In nature, declines 
due to Bd have been largely limited to areas with at least seasonally cool climates, including 
temperate and mid- to high-elevation areas of the tropics (Berger et al. 2004, Kriger et al. 2007). 
Given this, an increase in mean environmental temperatures, as is predicted with global climate 
change, may be favorable to amphibians, decreasing the likelihood of Bd outbreaks and declines 
(Stevenson et al. 2013). However, an increase in temperature variability, as is also predicted 
under global climate change, could impair amphibian defenses and increase the risk of Bd 
epidemics, the pathophysiology of Bd, or both (Rohr and Raffel 2010, Raffel et al. 2011, Raffel 
et al. 2013). The mechanisms linking climate variation to the occurrence and severity of 
chytridiomycosis outbreaks remain unclear. Recently metamorphosed frogs are usually more 
vulnerable than older frogs to chytridiomycosis, in part because their immune systems are often 
immature (Rachowicz & Vredenburg, 2004). More rapid development in nutrient limited 
conditions, as may occur more frequently in a warmer and less predictable climate, may result in 
metamorphs with underdeveloped AMP repertoires (Holden et al. 2015) and fewer lymphocytes 
(Rollins-Smith, 1988). Additional studies are needed to understand how plasticity in 
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developmental timing, in response to climate change affects immune development. Here, I 
examine specifically how the climate change stressor of pond drying, alone, and in combination 
with Bd exposure, affect the development and the immune system of one North American 
amphibian host, the Northern leopard frog (Rana pipiens).  
Rana pipiens has a broad distribution in Eastern North America and relies on flooded 
grasslands and permanent ponds to breed (Noland and Ultsh 1981). In northwest Pennsylvania, 
where my study was conducted, R. pipiens had the highest springtime Bd load of any amphibian 
species surveyed (Richards-Zawacki, unpublished data). The aim of this study was to determine 
whether developing in a stressful larval environment impacts the availability of key immune 
defenses against Bd post-metamorphosis. My focal climate stressor was hydroperiod, the length 
of time an ephemeral wetland holds water (Babbitt, 2005), as this is predicted to decrease with 
climate change. I hypothesized that if Northern leopard frogs exhibit developmental plasticity, 
those that develop in fast-drying ponds will have shorter larval periods, will be smaller at 
metamorphosis, and will have higher mortality than frogs that develop in slower-drying and non-
drying ponds. I also hypothesized that frogs that develop under drying conditions would exhibit 
carry over effects that increase their susceptibility to Bd infections and chytridiomycosis. 
Specifically, I predicted that Bd infection would have the greatest negative impacts on survival 
and body condition in frogs that developed as larvae under drying conditions. I also predicted 
that both Bd exposure and development under drying conditions would lead to decreases in the 
immune function of juvenile frogs.  
To test these predictions, I conducted a mesocosm experiment in which I allowed R. 
pipiens to develop as larvae under three drying treatments (fast, moderate, and no drying). I first 
tested for direct effects of pond drying on development up to and right after metamorphosis. 
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Then, beginning when the frogs were five weeks post-metamorphosis, I conducted a 12- week 
Bd exposure experiment during which I measured Bd load, probability of infection, and survival 
among frogs from the three larval drying treatments. This allowed me to test for direct effects of 
pond drying on susceptibility to Bd. However, I also tested for indirect effects of post-
metamorphic growth rate and mass on the outcomes of Bd exposure. After the exposure 
experiment, I compared the total number of antimicrobial peptides (AMPs), their diversity, and 
the ability of mucosome to inhibit Bd growth among frogs from the three drying and two 
exposure (Bd and sham) treatments. These results of this study will help us better understand the 
effects of drying, an important climate change stressor for freshwater species, on immune 
function before and after exposure to a pathogen.  
1.2 Methods 
1.2.1 Egg collection 
In early April 2016, I collected four Rana pipiens egg masses from wetlands near 
Linesville, PA for study at the Donald S. Wood Field Lab at the Pymatuning Lab of Ecology's 
(PLE) in Crawford County, PA. I reared each egg mass in a separate green plastic kiddie pool 
(89 cm x 89 cm x 15 cm) containing 150 L aged well water until embryos reached the free-
swimming stage (stage 25 of Gosner 1960, 18-20 days from egg mass collection). I used DNA 
sequencing to verify that the collected egg masses were from R. pipiens (as opposed to R. 
sylvatica, which often breeds concurrently and has similar-looking egg masses). To do this, I 
sacrificed one egg per clutch, placing it in 95% ethanol at -20ºC prior to DNA extraction. I 
10 
extracted genomic DNA from each egg using the Qiagen DNeasy Blood and Tissue kit following 
the protocol for animal tissue extraction and amplified a portion of the 16s rDNA gene using 
16Spip-L forward and 16Saa reverse primers (Hillis and Wilcox 2005) and reaction condidtions 
described in Brannelly et al. (2019). The PCR products were then Sanger sequenced and a 
BLAST search in Genbank (Benson et al. 2013) was used to confirm that the sequences from our 
eggs were a match for R. pipiens. 
1.2.2 Mesocosm set up 
The experiment took place in twenty-one 770 L cattle tanks (1.6 m diameter, 0.6 m 
height), which I cleaned with 13% bleach, rinsed twice, and left outside to dry for five days prior 
to use. I added 600 L (a 41 cm depth) of well water, 200 g of dry leaf litter, and 15 g of rabbit 
chow to each cattle tank to provide the initial food and substrate for periphyton growth and 
covered the tanks with black 50% shade cloth (Turner and Chislock, 2007). Six days after adding 
the leaf litter and rabbit chow, I added 0.5 L of water collected from a local pond to provide a 
source of algae and zooplankton. Before seeding the mesocosms I tested our pond water samples 
for Bd using an environmental DNA protocol (Lacoursière-Roussel et al. 2016). I filtered 1 liter 
of water and extracted genomic DNA from the filter following the “animal tissue” protocol and 
the Qiagen DNeasy Blood and Tissue Kit. I used a quantitative polymerase chain reaction 
(qPCR) assay (Boyle et al. 2004) to ensure that no Bd DNA was detected in the filtered sample. 
One day after adding the pond water, and when the larvae were free swimming (Gosner stage 25, 
Gosner 1960), I added 40 R. pipiens tadpoles (10 from each of the four egg masses) to each cattle 
tank. I added 5 g of rabbit chow to each cattle tank 75 days after the tadpoles were added to 
ensure they had sufficient food.  
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1.2.3 Experimental design 
Our experiment included three treatments: fast, medium, and no drying (control) regimes, 
each with seven replicates (840 total tadpoles). To simulate drying, I removed water from 
mesocosms in our fast and medium drying treatments. In the control treatment, mesocosm water 
levels were allowed to fluctuate naturally in response to local precipitation and evaporation. I 
removed 43.6 L (3 cm) of water from fast-drying mesocosms and 29.1 L (2 cm) of water from 
our medium-drying mesocosms every five days (Figure 1.1) using dedicated 10L buckets, each 
fit with a screen mesh top to prevent the accidental removal tadpoles and large organic material. 
 
 
Figure 1.1 Water height in the mesocosms over the course of the experiment. 
Each point represents the average of the seven mesocosms in that treatment on a specific day, the lines represent 




Water in no-drying (control) mesocosms was disturbed using a bucket on the same day as 
the other mesocosms but no water was taken from it unless the level was higher than 50 cm. In 
this case, I removed water until the depth reached 50 cm. This resulted in drying to 10 cm depth 
(150 L) by 50 and 75 days after the start of the experiment in the fast- and medium-drying 
mesocosms, respectively. After this point, water was added to or removed from fast- and 
medium-drying mesocosms every five days to maintain a 10 cm depth. I chose these drying 
regimes based on the knowledge that Rana pipiens takes from 60 – 90 days to develop from a 
free-swimming tadpole through metamorphosis (Kendell, 2002).  
I checked the mesocosms daily and removed individuals when their forelimbs emerged 
(Gosner stage 42), placing them individually into 2.12 L Ziploc plastic containers with 1.5 cm of 
filtered well water. I tilted one end of these containers to allow the froglets access to a dry habitat 
and provided each with an inverted plastic cup with a hole cut in one side, which was used as a 
hide. Water was changed twice per week and animals were fed crickets two or three times a 
week (5-10 crickets per frog per feeding). Following completion of metamorphosis (Gosner 
stage 46), I measured the frogs (mass and snout-vent length, hereafter SVL) using a 0.01 g scale 
and a dial caliper. I assigned them to immune assay treatments (details below) using a 
randomized block design, to make sure I had similar animal numbers for each experimental 
condition. 
1.2.4 Bd exposure 
I exposed a subset (N = 120) of the newly metamorphosed R. pipiens from our 
mesocosms (N = 40 fast-drying, N = 41 medium-drying, N = 39 no-drying treatment) to 
zoospores of Bd every two weeks for 12 weeks (Table 1.1). To prepare the inocula, I used a 
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culture of the “Rio Maria” isolate of Bd, isolated from a Pristimantis cruentus frog from Panama 
by Jamie Voyles in 2012, which had been passaged 14 times prior to this experiment. I used two-
week-old liquid TGhL broth (16 g tryptone, 4 g gelatin hydrolysate, 2 g lactose, 1000 ml distilled 
water; Longcore et al. 1999; Boyle et al. 2003) cultures to grow Bd on agar plates. The inverted 
plates grew for one week before I flooded them with DI water to collect zoospores for 
inoculation. Frogs were exposed to Bd for the first time ~ 5-6 weeks after metamorphosis. I 
exposed them to differing quantities of Bd zoospores ranging from 500,000-5,000,000 per 
inoculation (Table 1.1). For the first one and last three inoculations the frogs were exposed to Bd 
by individual baths in 60 ml containers containing 5 ml of a zoospore solution in DI for eight 
hours. For the second and third inoculations the frogs were again inoculated using 5 ml of DI 
water containing Bd zoospores, but these times the inoculum was put directly on each frog’s skin 
and was allowed to run off its back and into its enclosure (a 2.12 L Ziplock container which 
contained 400 ml of water) before the animal was returned to this enclosure. The enclosures were 
cleaned two days after each exposure. Another subset of frogs (N = 40 fast-drying, N = 41 
medium-drying, N = 38 no-drying treatment) of the same age were sham-exposed and served as 
a control group. I exposed these control frogs following the protocol and schedule described 
above but made our sham inoculum by flooding blank (no Bd) agar plates with of DI water.   
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2 500,000 5 cup 
4 5,000,000 400 tank 
6 5,000,000 400 tank 
8 250,000 5 cup 
10 250,000 5 cup 
12 250,000 5 cup 
 
I swabbed, measured, and weighed the frogs seven days after each inoculation using a 
0.01 g scale and a dial caliper. I checked the frogs daily for clinical signs of chytridiomycosis 
(Berger et al. 1999) and I measured mass, snout-vent length and infection intensity every two 
weeks. To estimate infection intensity, I swabbed each frog five times on each of the dorsal 
surface, ventral surface, each side of the body and each limb, making sure to rotate the swab 
while taking the samples. DNA was extracted from each swab using the “animal tissue” protocol 
and the Qiagen Dneasy Extraction Kit with a final elution volume of 200 µl. I then ran a qPCR 
assay (Boyle et al. 2004) using a QuantStudio™ 3 Real Time PCR system. I used 25 µl reactions 
containing 12.5 µl of 2x SensiFast probe Lo-Rox Mix, PCR primers at a concentration of 900 
nM, the MGB probe at 240 nM, 400 ng/µl BSA, 3 µl water per well and 5 µl of template DNA 
(diluted 1:10 in DI water). The negative controls had the same master mix but with water added 
instead of a DNA template. The default QuantStudio amplification (V.1.4) software conditions 
(2 min at 50°C and 10 min at 95°C, followed by 50 cycles of 15 s at 95°C and 1 min at 60°C) 
were used to amplify a portion of the ITS-3 and 5.8S rDNA genes (Boyle et al. 2004; Hyatt et al. 
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2007). Each swab sample was run once and each qPCR run contained a positive and negative 
control, and a series of plasmid dilution standards (Pisces Molecular, CO).  
1.2.5 Mucosome collection 
I collected skin mucus from a subset of Bd-exposed and sham-exposed frogs from each 
drying treatment after the Bd exposure experiment to test for differences in the ability of the 
“mucosome” (Woodhams et al. 2014), which includes secondary metabolites, AMPs, lysozymes, 
mucosal antibodies, and alkaloids, to inhibit Bd growth in vitro. To collect the mucosome, each 
frog was rinsed in 10 ml of molecular grade water for one hour in a 50 ml conical tube. The frog 
was then returned to its enclosure and the rinse water was immediately passed through a 0.22 μm 
filter to remove live bacterial cells. The filtered samples were then stored at -20 °C prior to 
growth challenge assays (described below). The mucosome collection occurred after 14 weeks of 
exposure (or sham exposure) to Bd zoospores, when the frogs were 19 – 20 weeks post-
metamorphosis. I collected mucus from sham-exposed frogs from fast- (N = 8), medium- (N = 
10), and no-drying treatments (N = 7), and Bd-exposed frogs from fast- (N = 7), medium- (N = 
9), and no-drying (N = 9) treatments.  
1.2.6 Collection of peptides secreted onto the skin 
One hour after sampling their mucosomes, I collected skin secretions from the same 
subset of Bd-exposed and sham-exposed frogs as described above in order to compare the AMPs 
they produced.  I collected the secretions using a modification of the protocol outlined in Rollins-
Smith et al. (2002). I began by weighing each frog and then giving an injection (in the dorsal-
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plicae) of norepinephrine (40 nmol/g body weight in 0.01 ml/g body weight), a hormone that 
stimulates the secretion of skin peptides (Ramsey et al. 2010). After injection, I placed frogs 
individually in 50 ml conical tubes containing 15 ml high performance liquid chromatography 
(HPLC) grade water for 15 minutes to collect secretions. After returning the frogs to their 
enclosures, I acidified the water in the 50 ml conicals with HCl (Sigma) to a final concentration 
of 1 % HCl to inactivate endogenous peptidases that might also have been secreted. These 
peptide samples were stored at -20°C and shipped frozen to Vanderbilt University for enrichment 
and mass-spectrometry.  
At Vanderbilt University, my collaborators in the Rollins-Smith lab activated the C18 
Sep Pak cartridges (Waters Corp, Milford, MA) with 10 ml of 100% HPLC grade methanol then 
washed them with 10 ml of Buffer A (0.1% triflouroacetic acid in HPLC grade water). Next, 
they passed the thawed skin secretion samples over the activated Sep Pak cartridges then washed 
the Sep Paks again with Buffer A. They then eluted the Sep Paks in 11 ml of Buffer B (0.1% 
triflouroacetic acid, 70% acetonitrile, 29.9% HPLC water). One ml of the eluted material was 
removed to quantify total peptides in the skin secretion (see below) and the remaining volume 
(10 ml) they then spun under vacuum until dry in preparation for mass spectrometry (see below). 
1.2.7 Quantification of total peptides 
Peptides were quantified, by my collaborators in the Rollins-Smith lab at Vanderbilt 
University, in a 1 ml sample of skin secretion using a Micro BCA™ Protein Assay Kit (Pierce 
Biotechnology, Rockford, IL). The protocol for this followed Rollins-Smith et al. (2002) but 
used bradykinin instead of BCA (bovine serum albumin) as a standard as it is more similar in 
size to the peptides I was hoping to detect. A standard curve was run at the following bradykinin 
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concentrations: 200 μg/ml, 40 μg/ml, 20 μg/ml, 10 μg/ml, 5 μg/ml, 2.5 μg/ml, 1.0 μg/ml, 0.5 
μg/ml. Using a 96 well microtiter plate, they added 100 μl of the peptide or standard sample to 
100 μg of the working reagent. All standards and samples were run in triplicate. The working 
reagent is supplied with the kit and was diluted according to the manufacturer’s instructions. The 
plate was incubated at 37 °C for 2 hours. They then measured absorbance at 570 nm on a Biotek 
Elx808 spectrophotometer using Gen5 2.01 software for analysis. 
1.2.8 Mass spectrometry 
Peptides were examined by mass spectrometry by my collaborators in the Rollins-Smith 
lab at Vanderbilt University. They first resuspended the dried peptide samples to a concentration 
of 1 mg/ml in HPLC water then spotted them onto a Matrix Assisted Laser Desorption/Ionization 
(MALDI) plate at a 1:1 ratio with matrix [10 mg/ml α-cyano-4-hydroxycinnamic acid (Sigma, 
St. Louis, MO), 60% acetonitrile, 39.6% HPLC-grade water, and 0.4% trifluoroacetic acid 
(v/v/v)]. An Ultraflex III time-of-flight mass spectrometer (Bruker Daltonics, Billerica, MA) was 
used and calibrated using the following standards (Sigma, St. Louis, MO): bradykinin fragment 
1-7 (m/z 757.3997), human angiotensin II (m/z 1046.5423), P14R synthetic peptide (m/z 
1533.8582), adrenocorticotropic hormone fragment 18-39 (m/z 2464.1989), and bovine oxidized 
insulin chain B (m/z 3494.6513). For each standard and peptide sample, 250 laser shots were 
collected (following Woodhams et al. 2006). They analyzed the spectra with Data Explorer v4.4 
software (Applied Biosystems, Foster City, CA). The nineteen most common AMPs in R. 
pipiens skin secretions have been previously described (Tennessen et al. 2009). I used the 
Tennessen et al. (2009) peptide list and their reported peptide centroid masses to determine the 
presence/absence and relative intensities of these common AMPs in our samples. I created a data 
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matrix that listed the relative intensity for each peptide detected. I used zeros to denote non-
detection of peptides and removed rows/columns with (a) individual (frog) samples for which no 
or only one peptide was detected and (b) peptides that were only detected in one frog. I did this 
because rows or columns with only one non-zero cell are uninformative for the multivariate 
analyses I used.  
1.2.9 Bd growth assays 
To test for differences in the abilities of the skin secretions of frogs from our drying and 
Bd-exposure treatments to inhibit the growth of Bd, I used in vitro growth (for AMP enriched 
samples, following Bell et al. 2013) and viability (for whole mucosome samples, (Woodhams et 
al. 2014) assays. To begin each assay, I harvested Bd zoospores by filtering the Bd grown in 
TGhL broth through a cone shaped filter funnel (8 mL, 10 μm pore size, Chemrus Inc.). This 
removes the larger sporangia but allows the smaller zoospores to pass through. I then diluted the 
filtered broth solution to our desired concentration and added a standard volume of this zoospore 
solution to wells of a 96 well optical plate (Costar, 3799). Skin secretion samples (either whole 
mucosome or AMP enriched) were then added to these wells in triplicate, as described below. 
Each plate contained samples from all treatment groups and samples were randomly ordered in 
96 well plates. Each plate also contained replicated positive (containing no skin secretion 
sample) and negative (containing heat-killed Bd: a Bd zoospore solution heated to 60 – 80 ºC for 
10 – 30 min) control wells. Plates were incubated at 21 °C and growth or viability of Bd was 
compared among wells using a plate reader. 
To assess the inhibition of Bd growth by AMPs, I quantified the concentration of a five-
day old culture of Bd isolate “Rio Maria” (passage 22) using a hemocytometer and diluted a 
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sample to a concentration of 555,555 zoospores/ml. I put 90 µl of this zoospore solution into 
each sample well for a starting concentration of ~50,000 zoospores/well. I diluted the 
concentration of our peptide samples (originally at 1 mg/ml in HPLC water) to 0.5 mg/ml using 
HPLC water and added 10 µl of each diluted sample to three replicate wells containing 90 µl of 
the zoospore solution to reach a final volume of 100 µl and peptide concentration of 50 µg/ml. 
Each plate contained three positive control and four negative control wells. The positive control 
wells contained 90 µl of Bd solution + 10 µl of HPLC water. The negative control wells 
contained 90 µl of heat killed Bd plus 10 µl of HPLC water. The perimeter wells of the plate 
were designated as blanks and contained 10 µl HPLC water and 90 µl of broth. The optical 
density of each well at 490 nm was measured immediately after the plate set-up was complete 
(day 0) and at day 3, 5 and 7 using an Epoch™ Biotek spectrophotometer. For each sampling 
day, I first calculated the mean of the daily absorbance values for all replicates of each type of 
control and experimental sample. Then, to remove baseline absorbance, I subtracted the mean 
negative control value on each day from each of the mean sample and positive control values on 
that day, to obtain corrected absorbance values. Optical density (OD) readings were transformed 
using equation: ln(OD/(1-OD)) (Becker et al. 2015). A linear regression was then used to 
estimate the growth rate of Bd in the presence of each peptide sample, using only the linear part 
of the growth curve. To calculate Bd inhibition, an average slope was calculated for each set of 
triplicate samples. I then divided this by the average growth rate of the positive control and 
subtracted from 1 to yield positive values representing proportional growth above that of the 
positive control and negative values that represent proportional growth inhibition.  
To assess the effect of whole mucosome on zoospore viability I used an assay that 
quantifies cell proliferation by ATP detection. To begin, I lyophilized each mucosome sample 
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until completely dry and resuspended it in 1 ml of sterile molecular grade water. I quantified the 
concentration of a 4-day old culture of Bd isolate “Rio Maria” (passage 32) using a 
hemocytometer and diluted a sample to a concentration of 106 zoospores/ml. Each sample was 
run in triplicate wells containing Bd plus media and in duplicate wells containing sterile media to 
facilitate background correction (due the potential for ATP presence in water and media). For 
each sample, 25 μl of Bd solution (or sterile medium) and 25 μl of the mucosome sample were 
added to each well. Each plate contained 6 positive control wells (25 μl of Bd solution + 25 μl of 
sterile MilliQ water) and 6 negative control wells (25 μl of heat killed Bd + 25 μl of sterile 
MilliQ water). Triplicate nutrient background wells (to account for ATP in the water and media) 
were also included on each plate by adding 25 μl of media and 25 μl of sterile MilliQ water to 
each well. After setup was complete, I incubated each plate for 1 hour at 21 ºC, then in a dark 
room, I added 50 μl of Cell Titer Glo Reagent (Promega) to each well to make a 1:1 solution and 
covered the plate with a foil sealing film. I placed the plates on a shaker for 3 minutes at 200 rpm 
and then removed the plates and incubated them at 21 ºC for 15 min to lyse the cells and release 
ATP. Plates were then read using a luminescent channel of a POLARstar Omega microplate 
reader. To calculate percent zoospore viability, I first subtracted the average media control 
(media + MilliQ) luminescent reading value from each positive and negative control, and from 
each of the triplicate samples. I then averaged the background luminescent reading (containing 
media + mucosome) for each sample and subtracted this value from each sample replicate that 
contained mucosome and Bd. I averaged the replicates for the negative control wells, and 
subtracted this value from each of the other wells (mucosome and positive controls) to remove 
the ATP value of dead Bd. Finally, I averaged the resulting values for the positive control 
replicates and divided the background-corrected sample well values by the average positive 
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control value to get a proportional cell viability. These proportional cell viability values were 
then averaged for each sample prior to statistical analysis. 
1.2.10 Statistical analysis 
All statistical analyses were performed using R Studio 2017 (RStudio Team 2017) and R 
version 1.1.383 (R Core Team 2017). Additional details for analyses of tadpole metamorphosis 
time, survival and size at metamorphosis are described in Brannelly et al. (2019). Tables 
describing the statistical models and their outputs can be found in Appendix A (Tables A1-A19). 
Larval period – To compare larval period, here defined as the time between when tadpoles were 
placed in mesocosms and when tail absorption (Gosner stage 46) occurred, across drying 
treatments I used a linear mixed-effects model (LMM) with larval period as the dependent 
variable, drying treatment as the fixed effect and mesocosm as the random effect (package: 
‘nlme’, function: ‘lme’: Pinheiro et al. 2017). 
Survival – In order to compare whether survival to metamorphosis differed between 
drying treatments, I concatenated two numbers per mesocosm; 1) the number of animals that 
successfully completed metamorphosis and 2) the number of animals remaining as tadpoles in 
each mesocosm on day 120. I compared survival across drying treatments using a generalized 
linear mixed model (GLME) with a binomial error structure (package: ‘lme4’, function: ‘glmer’). 
I also tested for differences in survival from metamorphosis until day 42 post-metamorphosis, 
when animals began entering immune assay treatments. To do this, I used the Cox proportional 
hazards model (package: ‘survival’, function: ‘coxph’), with drying treatment, body size (SVL, 
mm) and their interaction as factors, clustered by mesocosm. 
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Size at metamorphosis – In order to compare size at metamorphosis between drying 
treatments, I compared SVL and mass (log-transformed) at metamorphosis across the three 
drying treatments using a linear mixed model (LMM) with drying treatment and larval period as 
interactive fixed effects and mesocosm as a random effect.  
Infection and disease indicators- To examine the relationship between growth rate and 
infection probability, I calculated growth in mass (g/day) using mass before each exposure minus 
mass previous to each exposure divided by the age in days at the second time point. I centered or 
scaled days post exposure, mass at metamorphosis and growth in mass by using (package: ‘stats’, 
function: ‘scale’). I then ran a generalized linear mixed model (package: ‘lme4’, function: 
‘glmer’) with binomial distribution. The response variable was infection probability, the 
interaction between drying treatment and days post exposure was the independent variable, the 
covariates were mass at metamorphosis and growth in mass, and the random effect was frog ID. 
To measure infection load, quantified as the log number of zoospores detected on each swab, I 
ran a linear mixed model (package: ‘lme4’, function: ‘lmer’) (LMM) with infection load as the 
dependent variable and drying treatment was the independent variable. The covariates used were 
mass at metamorphosis and growth in mass. I also included the interaction between treatment 
and days post exposure, and the random effect was frog ID. To compare survival between naïve 
and exposed frogs after exposure I used a Cox proportional hazards model (package: ‘survival’, 
function: ‘coxph’), in exposed and naïve frogs. I included mesocosm as a cluster effect and the 
time-dependent covariate developmental time in the model, which was time transformed using 
the tt function (package: coxph). To compare survival between all combinations of drying 
treatments and exposure group, I used the same cox regression but included an interaction term 
(Drying treatment * Exposure group). To compare scaled mass index (a measure of body 
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condition) among temperature treatments I used the R package “23mart”, following Peig and 
Green (2009). The Peig and Green (2009) method accounts for the covariation between body 
size and body mass by calculating a score that standardizes body mass at a fixed value of a linear 
body measurement based on the scaling relationship between mass and length (Kelly et al. 
2014). I used the animal’s mass just before the first exposure as a reference for the slope. I ran a 
linear mixed effect model (package nlme, lme function). Log-transformed SMI was the 
dependent variable and the three-way interaction between drying treatment, Bd exposure group, 
and days post exposure were the independent variables. The random effects were mesocosm and 
frog ID. I tested for differences in mass and SVL across groups using the same linear mixed 
effect model structure, but the dependent variables were log mass and log SVL, respectively. 
Total mucosal peptides – The total concentration of skin peptides recovered after Sep-Pak 
separation was determined by Micro BCA protein Assay Kit. To test for a difference in peptide 
concentrations among frogs from different drying treatments and between sham- and Bd-exposed 
frogs, I used a linear model (LM), function: ‘lm’ with BCA as the dependent variable and 
exposure group, drying group and their interaction as main effects.  
Peptide growth challenge assay – To test for a difference in Bd growth inhibition by 
AMPs collected from sham- and Bd-exposed frogs and frogs from the three drying treatments I 
also ran a linear model (LM) with exposure and drying treatments and their interaction as main 
effects and Bd growth as the dependent variable with time to metamorphosis as a covariate.  
Antimicrobial peptide compositions – To test for differences in the composition of 
previously described skin antimicrobial peptide samples among Bd exposure groups and drying 
regimes, I used a non-metric multidimensional scaling (NMDS) ordination to compare the Bray–
Curtis distance (a metric of difference in relative abundance) among samples, using the 
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“metaMDS” command (Vegan package in R). I then used the “Adonis” function in the Vegan 
package (Oksanen et al. 2013) to carry out a permutation-based multivariate analysis of variance 
(PERMANOVA) in R (R-Core-Team 2013). PERMANOVA tests were run using the Bray–
Curtis distance comparisons of peptide relative abundances among samples, using 9,999 
permutations. When the PERMANOVA suggested differences between treatment groups, I then 
used SIMPER (Similarity Percentage) to determine which peptides are primarily responsible for 
those observed differences (Clarke 1993). In this case, I used SIMPER to assess differences 
between Bd-exposed and sham-exposed and frogs in both the presence/absence and relative 
intensity of secreted peptides. In order to know the difference between peptide counts, I counted 
the number of known antimicrobial skin peptides of R. pipiens per frog and compared these 
counts among treatment groups. I did a generalized linear model (GLM) with exposure, drying 
treatments and their interaction as main effects and peptide counts as the dependent variable with 
a quasi-Poisson distribution. To ask which treatment had greater peptide diversity I calculated 
the Shannon index between naïve and exposed frogs using the relative peptide intensity.  I did an 
ANOVA with the diversity index as the dependent variable Shannon diversity is a measure of 
biodiversity which accounts for richness and evenness (Shannon, 1948).    
Mucosome Bd inhibition assay – To test for a difference in Bd viability when exposed to 
mucosome samples collected from sham- and Bd-exposed frogs and frogs from our three drying 
treatments I ran a linear mixed model (LMM). I subtracted viability from 100 to calculate 
inhibition. Bd inhibition was the dependent variable, exposure the independent variable, log mass 
at metamorphosis was a covariate and mesocosms ID were the random effects. To see if there 
was correlation between higher loads and better Bd inhibition I ran an LMM with Bd inhibition 
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as the dependent variable Bd load in the last week of exposure was the independent variable 
mesocosms ID was the random effect. 
1.3 Results 
Tables describing all statistical models and their outputs for this chapter can be found in 
Appendix A (Tables A1-A19). 
Differences in water height levels – There were significant differences between drying 
treatments in the water heights in the mesocosms, including between medium and fast drying 
treatments (LMM: χ2  ≤ 15833, p  ≤  0.001), suggesting that our manipulations were successful in 
creating different drying environments among the three treatments. 
Larval period – Larval period ranged from 62 to 127 d, with a mean and standard deviation 
of 85.58 ± 16.27 d. (Figure 1.2A). There was no significant difference in larval period among 
drying treatments (LMM: χ2 = 0.650, p = 0.722).  
Survival - The proportion of animals that successfully metamorphosed per mesocosm did 
not differ significantly across drying treatments (GLME: χ2 = 0.388, p = 0.824, Figure 1.2A). 
However, survival from metamorphosis until day 42 post-metamorphosis did differ among 
treatments (: χ2 = 6.042, p = 0.049; Figure 1.2B). Survival was higher in the no drying treatment 
(mean, 95% CI = 0.952, 0.914 – 0.974; COXPH: β = -0.803, p = 0.018) (Figure 1.2B) than in the 
fast drying treatment but there was no difference in survival between the moderate (mean, 95% 
CI = 0.890, 0.855 – 0.933) and fast drying treatments (0.890, 0.856 – 0.936; COXPH: β = -0.107, 
p = 0.685). Body size (SVL, in mm) was also a significant predictor of survival probability after 
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metamorphosis (COXPH: χ2 = 5.856, β = -0.247, p = 0.016), with larger frogs being more likely 
to survive than smaller frogs. 
Body size – Neither body mass (in g; LMM= χ22 = 1.571, p = 0.455) nor body size (SVL in 
mm; LMM: χ2 = 5.477, p = 0.064) at metamorphosis differed significantly among drying 
treatments. However, the animals in the fast and medium drying treatments were, on average, 
17.08% smaller in mass (mean ± SD = 0.73 ± 0.17 g) than animals in the no drying treatment 
(0.86 ± 0.21 g) and slope of the regression for fast vs. no drying treatment was significantly 
different (LMM no drying: β = -0.048 p = 0.374). Likewise, animals in the fast and medium 
drying treatments were, on average, 4.94% smaller in SVL (mean ± SD = 21.71 ± 1.69 mm) at 
metamorphosis than animals in the no drying treatment (22.78 ± 1.75 mm) and the comparison 
between fast and no drying treatment was again significant (LMM: β = -0.043, p = 0.034). There 
were significant interactions between larval period and drying treatment on the mass (LMM: χ2 = 
10.774, p = 0.005) and SVL (LMM: χ22 = 15.163, p = 0.001) at metamorphosis such that both 
measures of size increased with larval period more rapidly in the no drying treatment (mass 













Figure 1.2 Comparisons of leopard frog survival and development across drying treatments. 
A) The proportion of individuals (that entered the mesocosms on day 0) that successfully metamorphosed (i.e., 
survived to tail-absorption, Gosner stage 46) by day and drying treatment. The shortest time to tail-absorption was 
62 days after tadpoles were placed in the mesocosms. B) Size-adjusted (using gg-adjusted curves, taking into 
account animal size at metamorphosis and clustered by mesocosm) survival rate from metamorphosis until day 42 
after metamorphosis in the three drying treatments. C) Un-adjusted survival curve (using ggsurvplot). D) Mass (g) 
of each frog at tail-absorption from the three drying treatments. Shaded areas are 95% confidence intervals. E) Body 
size, measured as SVL (mm) of each frog at tail-absorption from the three drying treatments. In D) and E), each 
point represents an individual, and the lines represent the linear relationships between the y-variable and larval 
period (time from start of experiment to tail-absorption) for each drying treatment. Shaded areas are 95% confidence 
intervals. 
 
Infection and disease indicators – I hypothesized that frogs that developed under drying 
conditions would exhibit carry-over effects that increase their susceptibility to Bd infections and 
chytridiomycosis. However, for frogs exposed to Bd in our exposure experiment, I did not find a 
significant main effect of drying treatment on whether the animal became infected (infection 
probability, GLME: χ2 = 4.708, p = 0.095). However, post-metamorphic growth rate (GLME: χ2 
= 4.191, β = 0.301, p = 0.041, Figure 1.3), the interaction between time since first exposure and 
drying treatment (GLME: χ2 = 7.889, p = 0.019) were significant predictors of probability of 
infection for Bd-exposed frogs; frogs that grew faster after metamorphosis, from all drying 
treatments, were more likely to become infected upon exposure and as the experiment 
progressed, frogs from the no drying treatment were less likely to be infected while frogs from 
the moderate drying treatment were more likely to become infected (β = 0.589, p = 0.006, Figure 
1.4). While the interaction between drying treatment and mass at metamorphosis was not a 
significant predictor across all drying treatments (GLME: χ2 = 4.807, p = 0.090), there was 
significant positive relationship between mass at metamorphosis and infection for frogs from the 
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fast drying treatment (GLME: β = 0.490, p = 0.040, Figure 1.5); frogs with greater mass at 
metamorphosis were more likely to become infected after exposure to Bd if they were reared in 
the fast drying treatment, but in the no drying treatment frogs with greater mass at 
metamorphosis had lower probability of getting infected.  The main effects of time post 
exposure, mass at metamorphosis, and the interactions between drying treatment and mass at 




Figure 1.3 Relationship between the probability of becoming infected with Bd after exposure and post-metamorphic 
growth rate (g/day) in the three drying treatments. 




Figure 1.4 Relationship between the probability of becoming infected with Bd after exposure and time since first 
exposure in the three drying treatments. 
The lines represent the logistic regressions between infection probability and days since first Bd exposure and the 




Figure 1.5 Relationship between the probability of becoming infected with Bd after exposure and mass at 
metamorphosis (g) for frogs reared in the three drying treatments. 
The lines represent the logistic regressions between infection probability and growth rate. The shaded areas are 95% 
confidence intervals. 
I did not find a significant effect of drying treatment on Bd load after exposure doing a 
linear mixed model (LMM: χ2 = 1.465, p = 0.481). However, Bd load was significantly correlated 
with time since first exposure (LME: χ2 = 4.771, p = 0.031) and body mass just prior to the first 
exposure (LMM: χ2 = 9.870, p = 0.002). Animals with lower mass tended to develop greater 
infection loads (β = 0.242, Figure 1.6). There was also a significant interaction between drying 
treatment and days since first Bd exposure (LMM: χ22 = 6.949, p = 0.031) on infection load such 
that Bd load decreased faster in frogs reared in the drying treatments than in frogs from the no 
drying treatment (Figure 1.7). There was not a significant main effect of growth rate on Bd load 
(LMM: χ2 = 0.512, p = 0.223). 
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Figure 1.6 Relationship between body mass just prior to the first exposure and Bd infection load in Bd-exposed 
animals from the three drying treatments. 
The lines represent the linear regression, and the shaded areas are 95% confidence intervals. The larger the marker 
size the larger the mass 
 
Figure 1.7 Relationship between days since first Bd exposure and Bd infection load in the three drying treatments. 
The lines represent the smoothed quadratic model fit between days post exposure and Bd load and the shaded areas 
are 95% confidence intervals. 
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When I considered body condition (measured as scaled mass index, or SMI) over the 
course of the exposure experiment, I did not find significant main effects of drying treatment or 
exposure group (Bd vs. sham). The interactions between these two factors, the interaction 
between drying treatment and time since first exposure, and the three-way interaction between 
exposure group, drying treatment, and time since first exposure were also not significant (LMM: 
all χ2 ≤ 4.0851, p ≥ 0.077). However, time since first exposure had a significant main effect on 
body condition (LMM: χ2 = 8.763, p = 0.003) and there was a significant interaction between 
exposure group and days post exposure (LME: χ2 = 37.562, p < 0.001) such that sham infected 
(control) frogs gained body condition over the course of the experiment while Bd-exposed frogs 
declined in body condition (Figure 1.8).  
 
 
Figure 1.8 Relationship between body condition (measured as scaled mass index, or SMI) and days since first Bd 
exposure in frogs from control (sham infected) and Bd-exposed treatment groups. 
Thick lines represent linear regressions and thin lines show changes in SMI over time for individual frogs. 
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When considering survival to three months post-exposure as the dependent variable, I 
found a significant interaction between drying treatment and exposure group (COXPH: χ25 = 
11.061, p = 0.050). The Bd-exposed frogs in the fast-drying treatment (COXPH: β = 1.803, z = 
2.475, p = 0.013) and in the moderate drying treatment (COXPH: β = 1.572, z = 2.061, p = 
0.040) had a lower survival probability than the Bd-exposed frogs in the no drying control 
(Figure 1.9). There was no significant difference in survival among control (sham exposed) frogs 
reared in the different drying treatments (COXPH: β = ≤ 0.676, z ≤ 1.650, p ≥ 0.318). 
 
A                                                                           B 
 
Figure 1.9 Survival curves for control (sham infected) and Bd-exposed frogs reared under the different drying 
treatments. 
A) Adjusted survival curves (using gg-adjusted curves, taking into account animal size at metamorphosis and 
clustered by mesocosm). B) Un-adjusted survival curves (using ggsurvplot). 
 
Total mucosal peptides - There was no significant main effect of drying treatment (LM: 
F2,52 = 2.225, p = 0.118) or exposure group (LM: F1,52 = 0.691, p = 0.410) on the total quantity of 

































exposure group on peptide quantity (LM: F1,52 = 1.721, p = 0.189). The mean mass of mucosal 
peptides secreted by all Bd exposed frogs was 107.021 µg/gbw (range: 15.161 to 284.243 
µg/gbw) and for sham-exposed frogs, the mean was 121.936 µg/gbw (range: 10.939 to 286.585 
µg/gbw). 
Bd growth challenge assay with mucosal peptides - Across all drying treatments and 
exposure groups there were some AMP samples that enhanced (positive growth index values) 
and others that inhibited (negative growth index values) growth of Bd. There was no significant 
difference in Bd growth in the presence of AMP samples collected from frogs in the different 
drying treatments (LM: F2,42 = 0.258, p = 0.773) or from Bd- and sham-exposed frogs (LM: F1,42 
= 0.258, p = 0.721). Nor was there a significant interaction between drying treatment and 
exposure group on Bd growth in the presence of mucosal peptides (LM: F2,42 = 0.046, p = 0.830).  
The mean of Bd growth inhibition index after Bd exposure was 0.003 (range: -2.928 to 0.978).  
AMP composition – After the exposure experiment (18 weeks post-metamorphosis), frogs 
were found to have secreted 18 of the 19 previously described peptides for R. pipiens (Tennessen 
et al., 2009), the majority of which were from the family of Brevinins. The PERMANOVA 
considering antimicrobial peptide presence/absence only showed differences between the AMP 
communities in secretions collected from Bd-exposed and naïve (sham exposed) frogs (Bray–
Curtis distance: F1,48 = 14.087, R2 = 0.228 p < 0.001, Figure 1.10) with the naïve frogs secreting 
a greater number of AMPs than the exposed frogs (GLM: χ2 = 6.326, p = 0.021, Figure 1.11). 
However, I did not find a significant difference in AMP communities in the secretions collected 
from frogs that developed in the different drying treatments (Bray–Curtis distance: F2,48 = 0.972, 
R2 = 0.032, p = 0.426).  
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Figure 1.10 Non-multidimensional scaling (NMDS) plot of Bray–Curtis distances based on presence/absence of 
AMPs detected by MALDI in control (sham exposed) and Bd-exposed frogs. 





Figure 1.11 Boxplots showing counts of AMPs secreted by control (sham exposed) and Bd-exposed animals after the 
Bd-exposure experiment. 
The middle line corresponds to the median. The lower and upper hinges correspond to the first and third quartiles 
(the 25th and 75th percentiles). The upper whisker extends from the hinge to the largest value no further than 1.5 
times the inter-quartile range. 
 
I did the same analysis but with relative peptide intensities instead of just 
presence/absence for each peptide and found similar results. The PERMANOVA comparing 
relative peptide intensities showed that Bd- and sham-exposed frogs had different peptide 
communities (Bray–Curtis distance: F1,43 = 7.160, R2 = 0.134, p < 0.001, Figure 1.12). However, 
I did not find a significant difference between drying treatments (Bray–Curtis distance: F2,43 = 
0.709, R2 = 0.026, p = 0.629). The Shannon index indicated that the sham-exposed frogs have a 
greater diversity of AMP community than the Bd-exposed frogs (ANOVA: F1,43 = 14.935, p < 
0.001) (Fig 1-13).  
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Figure 1.12 Non-multidimensional scaling (NMDS) plot based on Bray–Curtis distances on relative intensities of 
antimicrobial peptides (AMPs) detected by MALDI in control (sham exposed) and Bd-exposed frogs. 
Blue dots represent the peptides present in control frogs and yellow dots represent the peptides in the Bd-exposed 
frogs. The ellipses are 95% confidence intervals. 
 
 
Figure 1.13 Boxplots of Shannon index of diversity showing differences in AMP communities secreted by control 
(sham-exposed) and Bd-exposed frogs from the exposure experiment. 
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Each point represents one individual. The middle line corresponds to the median. The lower and upper hinges 
correspond to the first and third quartiles (the 25th and 75th percentiles). The upper whisker extends from the 
hinge to the largest value no further than 1.5 times the inter-quartile range. 
 
Using a SIMPER analysis, I assessed which peptides were primarily responsible for the 
observed differences between Bd- and sham-exposed frogs. For the presence/absence analysis, 
six peptides drove the differences between naïve and exposed frogs (brevinin 1Pa, brevinin 1Pb, 
brevinin 1Pc, brevinin 1Pd, brevinin 1Pe, brevinin 1Pla). For the peptide intensity analysis, three 
peptides were found to be driving the difference (brevinin 1Pg, brevinin 1Pk, brevinin 1Pe). 
Bd growth challenge assay with mucosome – After the exposure experiment, the ability of 
mucosome samples to inhibit the growth of Bd did not differ among Bd-exposed and sham 
exposed frogs or between the frogs in the three drying treatments and the interaction between 
exposure group and drying treatment was also non-significant (LME all: χ2 ≤ 1.969, p ≥ 0.374). 
However, there was significant effect of mass at metamorphosis on Bd growth inhibition (LME: 
χ2= 7.146, p = 0.013, Figure 1.14). The frogs that metamorphosed at a smaller size had 
mucosome that was less effective at inhibiting Bd growth. Contrary to what I expected, I didn’t 





Figure 1.14 Scatterplot showing the percent inhibition of Bd growth by mucosome samples versus log-transformed 
mass of frogs at metamorphosis. 
Each point represents one individual, and the linear relationship between mucosome inhibition and log (mass) 
metamorphosis is represented with the line and 95% confidence interval (shaded area). 
1.4 Discussion 
1.4.1 Simulated pond drying conditions did not induce developmental plasticity 
Most amphibian species rely on humid to aquatic environments for reproduction and 
are more active during wet periods. To cope with the unpredictable availability of such 
conditions, many amphibians exhibit developmental plasticity. For example, many anurans that 
develop as larvae in ephemeral water bodies and can accelerate metamorphosis to escape a 
drying pond (Denver et al.1998, Loman and Claesson, 2003). The endocrine stress axis 
modulates the timing of metamorphosis in amphibians in response to pond desiccation and other 
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environmental cues such as predators, and food resources (Kikuyama et al. 1993, Crespi and 
Warne, 2013). Specifically, the developmental response to environmental stimuli in amphibians 
is regulated by the hypothalamus–pituitary–interrenal (HPI) axis and is driven by plasma 
corticosterone levels. However, not all amphibians that develop in unpredictable aquatic habitats 
show plasticity in development in response to drying (Amburgey et al. 2012). Here I found that, 
contrary to my predictions, the larval period of northern leopard frog (Rana pipiens), a species 
that often breeds in the calm water of lakes, ponds, canals, and streams (Stebbins 2003), did not 
respond to drying by accelerating development to shorten the aquatic larval period. The animals 
in my drying treatments did, however, experience other physiological and immunological costs 
of developing in a drying habitat. 
1.4.2 Effects of drying conditions on survival and growth 
The animals that experienced the fast and medium drying treatments during their larval 
period had lower survival to, and size at metamorphosis. Reduced survival to metamorphosis is a 
clear indication of a fitness cost of developing in a drying pond. However, small size at 
metamorphosis may also be detrimental as for many anurans, larger juveniles have greater 
survival in the terrestrial habitat and grow to be larger adults whereas smaller juveniles take 
longer to reach sexual maturity and lay smaller egg masses (Berven, 1990, Rowe and Ludwig 
1991, Reques and Tejedo 1997, Cabrera‐Guzmán et al. 2013). Anurans that are larger at 
metamorphosis can also exhibit greater resistance to parasites (Rohr et al. 2009) and can build up 
larger energy stores before hibernation (Reading and Clarke 1999). There are numerous anuran 
species in which size at metamorphosis, through one or more of the mechanisms listed above, 
has been shown to affect fitness later in life (e.g., Hyla pseudopuma, Crump, 1989; Spea 
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intermontana, Pseudacris regilla, and Rana aurora, O’Regan et al. 2013). Taken together, this 
strongly suggests that even though I did not see a plastic response to drying in terms of 
developmental timing in R. pipiens, there were costs associated with developing in our drying 
mesocosms.  
1.4.3 Effects of pond drying on development of immune defenses 
While changes in developmental timing and growth due to the stress of a drying pond 
have been well studied in anurans, the potential impacts of drying on other aspects of physiology 
has received less attention. In particular, the impact that developing in a drying pond may have 
on immune development has received little attention even though infectious disease (namely 
chytridiomycosis caused by Bd) ranks among the top threats to amphibian populations globally 
(Scheele et al. 2019). One study by Gomez-Mestre et al. (2013) showed that accelerated 
development in response to pond desiccation in the Andean frog Pristimantis curtipes resulted in 
smaller juveniles with proportionately shorter limbs, and an increase in activity of the antioxidant 
enzymes catalase, superoxide dismutase, and gluthathione peroxidase. However, more studies 
that investigate the impacts of drying on immune function and disease are needed to understand 
the potential threat that climate change induced shifts in the availability of aquatic breeding and 
developmental poses for amphibians.  
1.4.4 Lower survival after Bd exposure 
Regardless of in which drying treatments they developed in as larvae, the juvenile 
leopard frogs in this study appeared to be somewhat resistant to Bd infection. Despite being 
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exposed multiple times, I rarely saw clinical signs of chytridiomycosis, I only detected Bd 
infections in ~ 50% of animals at any given time point in our experiment, and infection loads 
decreased over time in animals from all three drying treatments. However, survival was lower in 
the frogs exposed to Bd than in the sham-exposed control frogs, and Bd-exposed frogs lost body 
condition over the course of the study while the body condition of sham-exposed frogs increased, 
suggesting that even in animals that are able to resist infections and do not show signs of disease 
there can be costs associated with fighting infection.  
1.4.5 Indirect effects of drying and Bd exposure 
The Bd-exposed frogs that experienced fast drying during development had the lowest 
survival and developed the largest difference in body condition (as compared with sham-exposed 
controls) over the course of the exposure experiment. These results suggest that developing in a 
drying pond has indirect effects on susceptibility to Bd that act through differences in size and 
growth rate after metamorphosis, rather than through differences in developmental timing as I 
had predicted. A similar outcome was observed in tadpoles of the gray treefrog (Hyla 
versicolor), which co-occur in temporary and permanent ponds with a snail (Pseudosuccinea 
columella) that is frequently infected with trematodes (Telorchis sp.) whose cercariae can infect 
H. versicolor tadpoles. When these tadpoles were exposed to the infected snails in drying ponds 
their survivorship decreased by 30%, and mass at metamorphosis was reduced by 40% as 
compared with permanent ponds (Kiesecker and Skelly 2001). While developing in a drying 
environment did not appear to directly affect infection loads or the probability that a Bd-exposed 
frog would become infected in this study, body mass at metamorphosis, which was affected by 
my drying treatment, was a significant predictor of the infection load a Bd-exposed frog would 
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develop, with animals that were larger at metamorphosis having lower infection loads. 
Furthermore, individuals that experienced a faster growth rate post-metamorphosis, as many 
frogs from our drying treatments did, had a greater probability of developing a Bd infection after 
exposure. This may have resulted from undersized froglets preferentially investing more energy 
into growth and less into their immune defenses. Also, despite drying treatment not having direct 
effects on the probability or load of infection, frogs that developed in our drying treatments 
before being exposed to Bd had significantly lower survival.  
1.4.6 Antimicrobial peptides after drying treatment and exposure to Bd 
I hypothesized that, due to stress and/or the need to accelerate growth and 
metamorphosis, animals that developed as larvae in our drying treatments would secrete lower 
quantities of peptides and a less diverse cocktail of AMPs than frogs from our no drying 
treatment. This hypothesis is also consistent with previous work suggesting an evolutionary 
trade-off between larval period and AMP production in anurans, with species with longer larval 
periods having more secreting quantities of AMPs (Woodhams et al. 2016). Thus, I predicted I 
may see a similar effect within species, with individuals that experienced longer larval periods 
secreting more AMPs after metamorphosis. However, in the juvenile leopard frogs in this study, 
I found no evidence for an effect of exposure to drying during development on the quantity of 
peptides secreted, the identities or relative intensities of AMPs, or the ability of secreted peptides 
to inhibit Bd growth.  Perhaps because the tadpoles developed at a similar rate across the drying 
treatments they also developed their peptide repertoires on a similar schedule. Or, since I 
collected peptides 19 weeks post-metamorphosis, it is also possible that frogs that initially had 
less-developed peptides had already ‘caught up’ with their peers by that point in development. 
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AMPs appear to be an important part of the defense against Bd. For example, frogs from 
populations that are recovering from Bd epizootics in Panama were found to have mucosal 
peptides than were more effective against Bd than did animals from those same populations prior 
to the pathogen’s arrival (Voyles et al. 2018). In Southern leopard frogs (R. sphenocephala), 
Robak et al. (2019) also showed that AMPs are renewed more slowly by Bd-infected animals 
(than by sham-exposed animals). Hence, I hypothesized that the frogs exposed to Bd in this study 
would secrete different quantities and/or communities of peptides than sham-exposed frogs and 
that these differences would be related to the peptides’ abilities to inhibit Bd growth. Twenty 
AMPs have been identified in R. pipiens: 15 from the brevinin family, four from ranateurin 
family, and one each in the esculetin and temporin families (Tennessen et al. 2009). Of these 20 
peptides, brevinines are the most common peptides expressed, and they have been shown to 
inhibit Bd growth (Tennessen et al. 2009). I also found that the brevinins are the most common 
peptides expressed in my study population of R. pipiens from Pennsylvania. The peptides that 
were most abundant in both Bd-exposed and Bd-naïve frogs were brevinins Pk, Pg and Pe. These 
peptides do inhibit Bd growth when purified, but not to the extent that other brevinin peptides 
have been shown to (Rollins-Smith et al. 2002). In this study, on average, the purified peptides 
from neither sham-exposed nor Bd-exposed frogs were able to inhibit Bd growth in vitro. After 
the end of our exposure experiment, the Bd-exposed frogs in our study secreted similar quantities 
of total peptides to the sham exposed frogs. However, the Bd-exposed frogs secreted lower 
quantities of antimicrobial peptides, and fewer peptide types than Bd-naive frogs. This suggests 
that either the Bd-exposed frogs were using up more of their store of AMPs (but somehow not 
depleting total peptide stores) to fight Bd infection, Bd exposure impacted the production of 
AMPs, or both.  In a previous experiment with R. sphenocephala, a sister species to R. pipiens, 
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Bd infection was shown impaired the capacity of juvenile frogs to produce and secrete AMPs 
(Robak et al. 2019). Given that I found fewer AMPs but not smaller overall quantities of 
hydrophobic peptides secreted by Bd-exposed R. pipiens, specific inhibition of AMP production 
by Bd infection seems the most likely explanation for the pattern I saw as well. However, in the 
field, in the lowland population of Australian frog Litoria genimaculata, heavier Bd infections 
were correlated with lower intensities of total AMPs (Woodhams et al. 2010).  
1.4.7 Mucosome after drying treatment and exposure to Bd 
While I did not see effects of my drying treatments on AMP secretion, the effects of 
developing in a drying pond appear to have impacted the juvenile leopard frogs’ skin mucus in 
other ways. It has been shown previously that mucosome’s function against Bd is predictive of 
infection risk in natural amphibian populations and of survival in laboratory exposure 
experiments (Woodhams et al. 2014). In my experiment, the mucosome of frogs that were larger 
in mass at metamorphosis, which was more often the case when they developed in our no drying 
treatment, was more effective at inhibiting Bd growth in vitro. In Xenopus, it has been shown 
that the size of the granular glands in the skin, which hold and secrete AMPs, increase as the 
animal grows (Flucher et al. 1986). Larger leopard frogs in our study may have larger granular 
glands that can hold more AMPs. If so, this may have resulted in more concentrated mucosome 
samples coming from these larger frogs, which could explain the relationship I found between 
body mass and Bd-growth inhibition by mucosome. In nature, larger frogs that can secrete more 
mucus containing AMPs may also be able to fight Bd better, but the relationship between body 
size and mucosome efficacy against Bd has not yet been studied in vivo. In our experiment, 
neither being previously exposed to Bd nor experiencing drying during development reduced the 
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ability of the mucosome to inhibit Bd growth. Antifungal function is often primarily attributed to 
innate defenses like AMPs, but to understand this result it will likely be necessary to quantify 
other components of the mucus, including microbial products, some of which have been shown 
to have antifungal properties (Woodhams et al. 2020).  
Taken together, my results suggest that the combined threats of drought and infectious 
disease across life stages may interact to put amphibians at a greater risk of mortality than would 
be expected from one of these threats alone. This work demonstrates that developing under the 
stress of a drying pond can have complex effects on amphibians. Although development in 
drying conditions impacted some fitness-related traits (e.g., size at metamorphosis), it did not 
seem to have effects on the timing of metamorphosis or the development of immune defenses 
directly. Instead, drying indirectly impacted susceptibility to Bd via impacts on size at 
metamorphosis and juvenile growth rate. Smaller sizes at metamorphosis, and larger (likely 
compensatory) growth rates in juvenile frogs appear to result in lower mucosal defenses and 
greater susceptibility to Bd. The amphibian immune system is complex (Rollins-Smith, 1998; 
Rollins-Smith & Woodhams, 2012) and the impacts of stressors on some elements of the 
immune system might be more pronounced than others. I have shown that the environmental 
stress of a reduced hydroperiod during development can impact post-metamorphic size, growth 
rate, and survival. These carry over effects of a stressful larval environment impacted the 
immune function and disease susceptibility of frogs post-metamorphosis, demonstrating that the 
effects of these combined stressors, even if not experienced at the same time, may be detrimental 
to wildlife populations. 
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2.0 Impacts of elevated temperature and Bd exposure on immune function 
2.1 Introduction 
A clearer understanding of how climate affects host-pathogen interactions is needed to 
predict and mitigate the effects of wildlife diseases. Ecoimmunology is a field that examines how 
host immune systems and pathogens interact in different environments (Demas and Nelson, 
2012). An important component of this is understanding how environmental change may 
influence disease susceptibility (Downs and Stewart, 2014). For ectotherm hosts, the effects of 
temperature on immunity, and the ability to regulate immune activity in conjunction with other 
physiological demands, could play important roles in shaping disease risk. For example, 
exposing the blue mussel, Mytilus edulis, to elevated temperatures and cadmium had a 
significant negative effect on hemocyte (phagocytic cells in invertebrates) counts and no effects 
on lysozymes (cells that disrupt the bacterial cell membranes) at 5, 10 and 20 °C (Beaudry et al. 
2016). In the tortoise Gopherus polyphemus, the heterophil (a leukocyte) to lymphocyte ratio in 
the blood was found to be significantly reduced as a result of rapid warming in winter. This 
created a lag in immunity, which may make the species more susceptible to infectious diseases 
(Goessling et al. 2017). These examples illustrate that climate change can affect the immune 
system and how well a host can defeat a pathogen. 
As infectious diseases emerge with increasing frequency and impact wildlife populations, 
it becomes increasingly critical to understand the links between environment, host-pathogen 
biology, and disease dynamics (Raffel et al. 2013). Fungal pathogens, like the ones linked to 
white nose syndrome in bats (Foley et al. 2011), colony collapse disorder in bees (Bromenshenk 
49 
et al. 2010), and chytridiomycosis in amphibians (Berger et al. 1998), have driven recent wildlife 
declines and appear to be particularly sensitive to changes in climate (Fisher and Garner 2020). 
For example, for white nose syndrome in bats, replication of the causal fungus (Geomyces 
destructans) and transmission among hosts peak in early winter when the temperatures are cooler 
and bats begin hibernating (Langwig et al. 2015). By contrast, the rabies virus, generally pauses 
transmission and/or decelerates disease progression while bats are hibernating (Streicker et al. 
2012). Similarly, chytridiomycosis in amphibians, caused by the fungal pathogen 
Batrachochytrium dendrobatidis (Bd), has caused mass mortality events on several continents, 
and differences in Bd infection load and prevalence within and among host species have been 
attributed to environmental conditions (Phillott et al. 2013, Simpkins et al. 2017, Cohen et al. 
2019). Temperature, in particular, is an important factor in the distribution of Bd (Kriger et al. 
2007, Xie et al. 2016) and its impacts on hosts (Robak and Richards-Zawacki 2019, Sonn et al. 
2019). These examples clearly illustrate how interactions between climate, host, and pathogen 
seem to be driving the emergence and spread of infectious fungal diseases. 
The interaction between Bd and its amphibian hosts provides a good study system for 
understanding how climate change may impact host-pathogen interactions. As a moderate carbon 
fuel emission scenario (RCP4.5), climatologists project a rise in mean air temperature from 1990 
to 2100 of 1.1°C to 2.6°C (IPCC 2014, Houghton et al. 2007) along with shifts in water 
temperature, precipitation, and humidity (Zhang et al. 2017). While climate change impacts 
diverse taxonomic groups, amphibians are particularly at risk of adverse effects because their 
body temperatures are modulated by environmental temperatures (Angilletta and Angilletta 
2009) and because susceptibility to Bd also appears to be temperature dependent (Sonn et al. 
2017, 2019, 2020). Temperature is known to affect the amphibian immune response to Bd 
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(Robak et al. 2018, 2019), suggesting that the rapid fluctuations and extreme conditions that are 
projected to result from human-induced climate change may impact the ability of these hosts to 
effectively defend themselves from Bd and other pathogens (Rohr et al. 2013).  
Amphibians have many forms of defense against pathogens, including both adaptive and 
innate immune responses and cutaneous microbial communities. The innate immune response is 
activated as soon as a pathogen is detected and players in this response include antimicrobial 
peptides (AMPs), the complement pathway, and non-specific leukocytes (Carey et al. 1999). In 
amphibians, antimicrobial peptides are an important component of the innate immune response. 
These host-produced peptides are secreted from granular glands in the skin into the mucus layer 
that surrounds the body from granular glands in the skin and represent the first line of defense 
against pathogens (Rollins-Smith 2009). They can kill a variety of microorganisms, including 
bacteria, yeast, and fungi (Nicolas and Mor, 1995). The ‘mucosome’, a term used to holistically 
describe the contents of amphibian skin mucus (Woodhams 2014), contains AMPs, lysozymes 
and other small organic molecules, such as alkaloids, which may also play a role in defense 
(Rollins-Smith, 2020). The adaptive immune response requires time to be activated following the 
body’s detection of a pathogen. Amphibian immune systems have T- and B-lymphocytes 
(Baldwin and Cohen, 1981) that have cell surface receptors that recognize and bind to certain 
pathogens and regulate antibody production. Amphibians also have two important lymphoid 
organs: the thymus and the spleen. The thymus is the site of T cell development (Jurd, 1994) 
while the spleen is in charge of antigen processing and development of immune T and B cell 
responses (Kanakambika and Muthukkaruppan, 1972) and production of some new blood cells 
(Zapata et al. 1981). Thus, amphibians have a suite of defenses against pathogens, though our 
understanding of how they may be impacted by climate change remains poor. 
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Physiological processes are governed by temperature in ectotherms, and accordingly, 
many aspects of the immune system of amphibians are also known to exhibit temperature 
dependence (Rollins-Smith and Woodhams 2012). Some studies have shown detrimental effects 
of sudden increases or decreases in temperature on the amphibian immune system. Lymphocytes, 
eosinophils, complement proteins, and antibodies generally remain at low levels when 
environmental temperatures are low and take a while to recover after temperatures are increased. 
For example, in northern leopard frogs (Rana pipiens), the serum complement activity took 7-9 
days to recover following an increase in air temperature from 5 to 22ºC degrees (Maniero and 
Carey, 1997). Another study showed that immunoglobulin Y (IgY) antibodies recovered from 
southern leopard frogs (Rana sphenocephala) that had previously been exposed to the Bd 
pathogen at 14ºC had greater binding activity to that pathogen at 14ºC than at 26ºC (Robak 
2016). Few studies have examined the role of increased environmental temperature on innate 
defenses. However, one study found that southern leopard frogs held at 26°C produced more 
AMPs than frogs at 14°C after peptide secretion (Robak et al. 2019).  
Stressors experienced early in development, such as harsh environmental conditions or 
poor nutrition, can have impacts on the health and fitness of individuals much later in life. 
Extreme temperatures, like those predicted to occur more frequently under global climate 
change, are known to have effects on developmental timing that carry over to affect fitness later 
in life (Groner et al. 2013, Martin et al. 2010). For example, in the relict leopard frog (Rana 
onca), time to metamorphosis was faster for tadpoles reared at 25°C (their optimal temperature) 
than for tadpoles reared at 20 or 30°C (Goldstein et al. 2017, Ruthsatz et al. 2018). Usually, 
ectotherms that develop as larvae in warmer temperatures develop faster, but at the cost of a 
smaller body size at metamorphosis (Harkey and Semlitsch 1988). These differences can be 
52 
important because in many species of amphibians, both size and age at metamorphosis directly 
affect factors like survival rate, reproductive output, and dispersal ability later in life (Riha and 
Berven 1991, Freitas et al. 2017, Brannelly et al. 2019). The development of immune defenses 
is also energetically costly and an organism that experiences stress during development might 
not have the resources it needs to devote to this, leaving it susceptible to infection (Schmid-
Hempel 2005). Lower immune function as a result of developmental stress could be particularly 
detrimental to species threatened by infectious disease, like amphibians. Here I test the 
hypothesis that elevated temperatures, when experienced during the larval period, affect 
amphibian development, immunity, and susceptibility to the fungal pathogen Bd. 
Researchers disagree as to whether climate change will ease or worsen the impact of Bd 
on amphibian populations. Some have hypothesized that climate change will worsen Bd’s 
effects, based on the idea that increasing variability of temperatures and precipitation may 
change the host-pathogen dynamics (Yeh et al. 2009). Others have predicted the opposite, that 
climate change will lessen the impact of Bd on its hosts given that Bd is a cold-adapted fungus 
and warmer temperatures are associated with faster amphibian immune responses (Rohr and 
Raffel 2010). To test the hypothesis that elevated environmental temperatures during the larval 
period negatively affect the ability of newly-metamorphosed froglets (the life stage most 
susceptible to chytridiomycosis; Rollins-Smith 1998) to defend themselves against the Bd 
fungus, I experimentally raised larvae from two populations of each of two species (northern 
leopard frog Rana pipiens and southern leopard frog Rana sphenocephala) under either their 
current or simulated future local pond temperatures. I then tested whether exposure to warmer 
temperatures during development, as predicted under global climate change, impacts later-life 
fitness and the development of the amphibian immune system.  
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I tested for direct effects of temperature treatment on growth and development to 
metamorphosis in all frogs. Then, I tested for direct and indirect effects of temperature on 
different measures of the innate immune system in the same subset of frogs (including both 
temperature treatments) at one- and two-months post-metamorphosis. Another subset of frogs 
from both temperature treatments was used for measurements of the adaptive immune system at 
one and two months post-metamorphosis. Finally, when another subset of frogs reached one to 
two weeks post-metamorphosis, I exposed them to Bd. I measured Bd load and probability of 
becoming infect during the eight weeks that followed. After infection, I compared splenocyte 
counts and the mucosome’s ability to inhibit Bd among frogs from both temperature treatments 
and both (Bd and sham) exposure groups (Figure 2.2). I predicted that frogs that developed under 
future (warmer) climate conditions would have lower survival, a smaller size at metamorphosis, 
reduced immune function, and greater susceptibility to Bd relative to those developing under 
current (cooler) climate conditions. The results of this study bring us closer to understanding 
how climate change will impact amphibian populations, particularly those that are threatened 
with emerging pathogens such as Bd. Given the potential impact of climate change on disease 
dynamics, studies of this nature may be critical in developing strategies to promote the long-term 
health of threatened wildlife. 
54 
2.2 Methods 
2.2.1 Temperature treatment design 
To design current and future temperature regimes for each leopard frog population, I used 
the microclimate model of the Niche MapperLLC package (Kearney and Porter, 2017) to model 
water temperatures in the ponds where the egg masses were collected, including both daily and 
monthly variation, across the time period when leopard frogs would be undergoing embryonic 
and larval development. The Niche Mapper model uses meteorological variables, soil properties 
and terrain characteristics to predict the local microclimate (Kearney et al. 2014). To model 
water temperature in Niche Mapper, I started by collecting air temperature information for the 
current climate and a predicted future climate scenario from each egg collection site. For current 
climate, I used 30-year-average air temperatures for the years 1960-1990 from WorldClim (Fick 
and Hijmans 2005, 30 s or ~ 1 km2 resolution). For future climate, I used air temperatures 
averages for the years 2061-2080. These were downscaled IPCC5 data, also at 30 s resolution, 
that were calibrated using the WorldClim 1.4 database. Specifically, I used the HadGEM2-ES 
global climate model (Collins et al. 2011) from IPCC5 with representative concentration 
pathway 60 (an intermediate gas emission scenario). Under this model, global temperatures are 
predicted to increase by an average of 1 to 2.5 °C between 2010 and 2070 (Collins et al. 2013).  
For each egg collection site, I set the properties of the substrate (thermal conductivity, density, 
and specific heat) to the values for fresh water at each month’s average air temperature using the 
online applications Presto (v. 0.255, https://prestodb.io) and Niche Mapper (http://niche-
mapper.com/). I set the percent of the substrate that acts like a free water surface to 100 % since I 
was modelling water temperature, and I set the substrate reflectivity to 12 %, which is the 
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average reflectivity of fresh water at an incident angle of 25 ° (Kirk, 1984). I used the monthly 
average minimum and maximum relative humidity and wind speed values recorded in 2017 at 
the nearest weather station (Figure B1, Appendix B) for both current and future climate models. 
The distances between the ponds where eggs were collected, and these weather stations are 
provided in Figure B1, Appendix B. The end result of our model was an average predicted 24 h 
temperature profile for each pond for each month under both current and predicted future climate 
scenarios. 
I programmed environmental chambers (Conviron, model BDR16 and A1000 accurate to 
± 0.5 °C) hour by hour so that the air temperature inside would fluctuate to match our predicted 
water temperature values for one egg collection site and temperature treatment (current vs. 
future). In each chamber, the temperature program was set to cycle from the average daily high-
water temperature (which occurred at 18:00) to the average daily low water temperature (which 
occurred at 8:00) for a given month and back again within a 24 h period. Lights inside the 
chamber provided a photoperiod of 12 hours of light (600 - 1800 h) and 12 hours of dark. 
Throughout the experiment I had two temperature data-loggers inside each environmental 
chamber, one measuring water temperature in a volume of water equivalent to that in the 
tadpoles’ enclosures (HOBO pendant temp/alarm one channel data loggers UA-001-08, accurate 
to ± 0.53 °C, Onset Computer Corporation, Bourne, MA). Another logger was suspended in the 
chamber to measure air temperature (HOBO Pro v2 Temperature/Relative Humidity U23-002 
accurate to ± 0.21 °C, Onset Computer Corporation, Bourne, MA). The differences between 
measured air and water temperatures throughout the experiment can be found in (Table 2.1).  
Following the predictions from our model, the difference in water temperature programs 
between current and future climate chambers (measured using data loggers) differed by egg 
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collection site. The minimum difference between the two treatments at any given time was 1.14 
°C and the maximum was 4.29 °C. Under this model, the average temperature difference for all 
sites was 2.277 °C. The same temperature regime was applied each day for one month before 
switching to the temperature regime representative of the next month. The only exceptions to this 
occurred for the larvae from our Vermont and Pennsylvania collection sites, where the 
temperatures in both current and future climate treatments were maintained at modeled August 
pond temperatures for longer than one month (174 days for PA and 200 for VT).  For these 
populations, the August temperatures were used until the end of the experiment because the 
larvae were developing so slowly, even at warm August temperatures, that I worried dropping 
temperatures to mimic September and later fall conditions would prohibit animals from 
metamorphosing at all. 
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LA Future February 8.89 10.96 - - - - - 
LA Future March 12.5 15.21 - - - - - 
LA Future April 16.64 19.68 - - - - - 
LA Future May 21.74 24.96 0.55408 0.1287262 0.0252638 0.802 0.458 
LA Future June 25.18 27.9 0.97327 0.1041491 0.0175301 0.522 1.022 
LA Future July 26.1 29.33 1.36907 0.0263625 0.001533 1.27 1.652 
LA Future August 27.06 29.49 - - - - - 
LA Current February 6.77 8.67 - - - - - 
LA Current March 10.34 12.81 - - - - - 
LA Current April 13.79 16.55 - - - - - 
LA Current May 18 20.86 - - - - - 
LA Current June 21.87 24.34 - - - - - 
LA Current July 22.62 25.46 - - - - - 
LA Current August 23.03 25.19 - - - - - 
TN Future March 4.92 8.01 - - - - - 
TN Future April 9.81 12.12 - - - - - 
TN Future May 15.51 18.64 0.33675 0.1487597 0.0345975 0.595 0.323 
TN Future June 20.55 23.26 0.74783 0.1131538 0.0216457 0.831 1.363 
TN Future July 23.48 25.96 0.32476 0.0437979 0.0077416 -0.248 2.865 
TN Future August 23.49 25.99 0.12417 0.109788 0.0216637 0.023 2.017 









Table 2.1 (continued) 
TN Current April 8.47 11.93 - - - - - 
TN Current May 13.58 16.47 0.59639 -0.0721425 -0.021617 0.519 0.466 
TN Current June 18.44 20.81 0.26844 0.1002015 0.0215999 0.431 0.229 
TN Current July 20.58 23.34 0.62573 0.0474237 0.0077818 0.24 1.763 
TN Current August 19.92 22.41 0.75778 0.0434347 0.0065228 1.169 2.445 
VT Future May 12.05 15.49 - - - - - 
VT Future June 17.16 19.53 -0.41004 -0.0926854 -0.0199463 -0.229 0.2 
VT Future July 20.57 23.99 0.19983 -0.1708824 -0.0369414 -0.168 1.873 
VT Future August 19.1 22.76 -0.95001 -0.0188113 0.0009103 -1.398 -1.038 
VT Current May 9.06 12.64 - - - - - 
VT Current June 13.61 17.03 -0.40727 0.1426242 0.0341224 2.794 -0.06 
VT Current July 17.16 19.53 0.47656 0.5869134 0.1271003 2.809 -1.059 
VT Current August 18.16 15.77 -0.34603 0.0439915 0.0150092 -0.3 -1.607 
PA Current June 10.23 12.28 -13.92542 -0.6266126 -0.1679171 -15.08 -13.02 
PA Current July 15.33 17.21 -0.58618 -0.0046647 0.001604 -1.18 -0.633 
PA Current August 17.67 19.77 -1.11211 -0.5658614 -0.122357 -5.824 0.279 
PA Current September 16.7 18.49 -0.71055 -0.0991379 -0.0201326 -1.356 -0.43 
PA Future June 12.64 14.59 0.71465 0.0294448 0.0110203 -0.298 -0.538 
PA Future July 17.76 19.62 0.50577 0.0074583 -0.0001616 0.562 2.234 
PA Future August 20.66 22.74 0.52222 -0.098195 -0.0233177 0.068 1.504 
PA Future September 20.31 22.21 0.4649 -0.2590353 -0.0632313 -0.382 3.065 
The absolute value mean (Mean diff.), standard error (SE), standard deviation (SD), maximum (Max Diff.) and minimum (Min Diff.) temperature differences 
between modeled water temperatures and water temperatures measured from within each environmental chamber are provided for each chamber and month 
where iButton temperature sensors were used to measure temperatures within the chamber
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2.2.2 Animals  
To begin this experiment, I collected naturally deposited egg masses from two 
populations of northern leopard frogs (Rana pipiens) and two populations of southern leopard 
frogs (R. sphenocephala) during the 2018 breeding season. The locations of these populations 
were chosen to represent different latitudes within each species’ range (Figure 2.1). For R. 
pipiens, I collected egg masses on April 25th from near the Pymatuning Lab of Ecology in 
northwest Pennsylvania (PA: 41.672 °N, 80.513 °W) and on May 1st from just north of 
Burlington, Vermont (VT: 44.494 °N, 73.243 °W). For R. sphenocephala, the egg masses were 
collected on February 18th from Arnold Air Force Base in central Tennessee (TN: 35.450 °N, 
86.070 °W) and on January 14th from Fort Polk Wildlife Management Area in central Louisiana 
(LA: 31.127 °N, 93.014 °W). The eggs from each location came from two different clutches and 
were shipped to the University of Pittsburgh (Pittsburgh, Pennsylvania, USA) in plastic 
containers or Ziplock bags. I held each egg mass at room temperature (measured as mean 18.3 
and range 16 - 20 °C) in a separate 11 L (36.8 cm L x 22.2 W x 24.8 H) plastic tank filled with 7 
L aged tap water until larvae hatched and reached the free-swimming stage (stage 21 of Gosner, 




Figure 2.1 Map showing the four different locations where the egg masses were collected for the experiment (stars) 
and the ranges of R. pipiens (green shading) and R. sphenocephala (orange shading). 
From north to south: Vermont R. pipiens, Pennsylvania R. pipiens, Tennessee R. sphenocephala, Louisiana R. 
sphenocephala. Blue shading indicates water areas, gray lines are U.S. state boundaries and black lines are U.S. and 
Canadian national boundaries. Species ranges are from the IUCN Red List of Threatened Species, Version 2020-3, 
https://www.iucnredlist.org, Downloaded on 24 February 2020. 
 
When they reached the free-swimming stage (stage 25 of Gosner 1960), I moved the 
tadpoles to individual housing in 1 L plastic cups filled with 0.9 L aged tap water. Half of all 
tadpoles from each population were then assigned haphazardly to a “current” temperature 
treatment and the remaining tadpoles to a “future” temperature treatment. The plastic cups, each 
containing 1 tadpole, were then placed in an environmental chamber where the air temperature 
was gradually shifted (by 1 °C every 3 h) from room temperature to the maximum daily 
temperature of the tadpole’s assigned population-specific current or future temperature regime 
(described above). Tadpoles remained in these environmental chambers until metamorphosis 
(Gosner stage 45). At the point when tadpoles entered their temperature treatments there were N 
= 135 - 190 tadpoles per treatment group (see Table 2.2 for details). 
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Table 2.2  Sample sizes for each treatment group for each experiment and assay performed. 
 Louisiana Pennsylvania Vermont 
Temperature treatments Current Future Current Future Current Future 
Temperature groups  135 145 190 184 152 148 
Metamorphosis time  153-241 127-169 206-262 145-207 182-321 141-259 
Immune Assays of Newly-metamorphosed Froglets 
Skin peptide collection (1 mo.) 11 9 7 11 5 7 
Skin peptide collection (2 mo.) 12 5 7 11 5 7 
AMPS (1 mo.) - - 3 4 5 3 
AMPS (2 mo.) - - 4 6 5 3 
Thymocytes 19 21 16 24 11 15 
Splenocytes       
B-cell proliferation 9 10 10 12 5 9 
T-cell proliferation 7 6 6 12 5 6 
White blood cell counts 17 15 10 24 9 13 
Exposure Experiment and Subsequent Immune Assays 
(Bd) or sham (S) exposure Bd S Bd S Bd S Bd S Bd S Bd S 
Exposure groups 16 16 16 16 15 15 15 15 10 8 15 8 
Splenocyte counts 9 12 13 9 13 14 11 14 7 7 14 7 




From the time they reached the free-swimming stage until metamorphosis was complete, 
each tadpole was fed ad libidum with TetraMin Complete Diet Tropical Tablets (Tetra, 
Germany) dissolved in tap water three times a week. I did full water changes once a week and 
one half of the water was changed two more times each week such that the water was at least 
partially changed approximately every other day. I monitored survival and tadpole development 
daily, and when the forelimbs emerged (Gosner stage 42), each animal was moved to an 
individual 2.12 L (9.32 x 30.48 x 22 cm) rectangular plastic container filled to a depth of 1 cm 
with aged tap water. These containers were placed back into the same environmental chamber so 
that they continued to experience the same temperature treatment as they had previously. I tilted 
one end of each container to create a dry side to the habitat and provided a small plastic dome as 
a hide. At completion of metamorphosis (Gosner stage 45), I calculated larval period as the time 
between when tadpoles were placed in the chambers (Gosner stage 21) and when tail absorption 
occurred (Gosner stage 45) and recorded each animal’s mass (using a scale accurate to 0.01 g), 
and snout-vent length (SVL, using dial caliper). At metamorphosis, frogs were removed from the 
environmental chambers and most were housed at room temperature. A subset of frogs were 
housed at 16 °C after metamorphosis and prior to Bd exposure (see Figure 2.2). After 
metamorphosis, water was changed twice per week and frogs were fed 5 - 10 crickets (3 – 4 mm 
in size) ad libidum three times a week.  
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Figure 2.2 Experimental design indicating when each experiment took place. 
In orange I show the temperatures at which the experiment took place and in blue the age of the frogs: A. Bd 
exposure experiment, which began at one week post-metamorphosis; B. Immune experiments that took place at four 
weeks post-metamorphosis; C. Immune experiments, which took place at four or eight weeks post-metamorphosis 
using a separate set of frogs than in B and D; D. Immune experiments that took place eight weeks post-
metamorphosis using a separate set of frogs than in B and C. 
2.2.3 Statistical analyses for comparisons of larval survival, growth and development 
All statistical analyses were performed using R Studio 2019 (RStudio Team 2019) and R 
version 1.1.383 (R Core Team 2019). For each analysis, I used a separate statistical model for 
animals from each locality to compare survival, growth and development between animals that 
developed under current vs. future temperature scenarios. Statistical model results tables can be 
found in Appendix B (Tables B1-B79) 
I compared tadpole survival, from the day animals were placed into their temperature 
regimes to the point of metamorphosis, among temperature groups using a Cox proportional 
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hazards model (package: ‘survival’, function: ‘coxph’), with days surviving as the dependent 
variable and temperature treatment as a factor. To compare larval period between temperature 
treatments I used a Cox proportional hazards model (package: ‘survival’, function: ‘coxph’), with 
larval period as the dependent variable and temperature treatment as a factor.  
To compare body size (SVL) and mass at metamorphosis among temperature treatments I 
ran separate linear models (package ‘nlme’, function ‘lm’). If needed to meet the assumption of 
normality, I ran the models with either mass, or mass and SVL log transformed. I used mass and 
SVL as the dependent variables and temperature treatment (current vs. future) as a factor in each 
model.  
2.2.4 Post-metamorphic treatments 
After metamorphosis, I haphazardly assigned frogs to one of three treatment groups such 
that each group contained an approximately equal number of animals from each locality and 
temperature treatment group and also contained animals that spanned the range of developmental 
timing (i.e., time to metamorphosis) I observed in this study (Table 2.2, Figure 2.2). Using two 
of these groups, I conducted a variety of immune assays on Bd-naïve (never exposed or sham-
exposed to Bd) juveniles, to assess the impact of exposure to current and simulated future 
temperatures on immune development, at one- and two-months post-metamorphosis. These two 
groups were shipped to Vanderbilt University, where the assays took place, when the frogs were 
one to three weeks post-metamorphosis. Using the third group of frogs, I ran a Bd exposure 
experiment (which began when the frogs were one to two weeks post-metamorphosis) and 
subsequently performed another set of immune assays to assess the combined impacts of 
developmental temperatures and Bd (vs. sham) exposure on immune development. At the end of 
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the experiment, all frogs were euthanized by bath in 1 % buffered tricaine methanosulfonate 
(MS-222, Sigma-Adrich, St Louis, Missouri, USA). 
2.2.5 Immune assays of newly metamorphosed froglets 
Statistical analyses for the immune assays described below often involved comparisons 
between models containing different sets of main effects. All models included temperature 
treatment (current vs. future) as a main effect. I also ran models that included the additional 
effects of mass at metamorphosis, growth rate (calculated as mass at one or two months old 
minus mass at metamorphosis divided by the number of days between the two time points), time 
to metamorphosis, and interactions between these variables and temperature on the dependent 
variables. The model with the lowest Akaike information criterion (AIC, an estimator of 
prediction error) is reported in the results. When the difference in AIC between two models was 
≤ 2, I reported results from the simpler of the two models. 
2.2.6 Skin peptide collection and quantification 
The skin peptide sample collection was done at Vanderbilt University. Samples were 
collected from 5 - 12 animals (Table 2.2) per treatment at both one month and two months post-
metamorphosis. Each frog was injected (in the dorsal lymph sac region) with norepinephrine 
(NE) bitartrate dissolved in amphibian phosphate buffered saline (APBS; 6.6 g of NaCl, 1.15 g 
of Na2HPO4, and 0.2 g of KH2PO4/liter of distilled water). For the one-month group, the frogs 
were injected with 10 nmol per gram body weight (gbw) NE and for the two months group, 20 
nmol/gbw NE was used. After injection, the frogs were individually placed into 50 ml conical 
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tubes containing 10 ml HPLC grade water for 15 min to collect secretions before returning the 
frogs to their enclosures. Because froglets were quite small, the conical tubes allowed for 
movement and breathing air but also ensured that the water level covered the dorsum. After 
returning the frogs to their enclosures, the water was acidified in the 50 ml conical tubes with 
Trifluoracetic acid (TFA, added to achieve a 1% concentration). These samples were then stored 
at -80 °C prior to analysis. 
The C18 Sep Pak cartridges were activated (Waters Corp, Milford, MA) with 10 ml of 
100 % HPLC grade methanol, then washed them with 10 ml of Buffer A (0.1 % triflouroacetic 
acid in HPLC grade water) to prepare them. The skin secretion samples were dried under 
vacuum at 70 °C as they thawed (following Rollins-Smith et al. 2002). Next, the thawed skin 
secretion samples were passed over the activated Sep Paks, then washed the Sep Paks again with 
Buffer A. Then they were eluted in 11 ml of Buffer B (0.1 % triflouroacetic acid, 70 % 
acetonitrile, 29.9 % HPLC water). This resulted in concentrated skin secretion samples enriched 
for hydrophobic peptides. One ml of the eluted material was then used to quantify total peptides 
in the skin secretion and the remaining volume (10 ml) was sedimented under vacuum until dry 
in preparation for mass spectrometry (see below). 
To quantify the total mass of peptides in a 1 ml sample of skin secretion, the Micro 
BCA™ Protein Assay Kit (Pierce Biotechnology, Rockford, IL) was used. The protocol in 
Rollins-Smith et al. (2002) was used with six bradykinin standards instead of BCA (bovine 
serum albumin) standards as bradykinin is more similar in size to the peptides I was measuring 
than BCA. A standard curve was run at the following concentrations: 200 µg/ml, 40 µg/ml, 20 
µg/ml, 10 µg/ml, 5 µg/ml, 2.5 µg/ml, 1.0 µg/ml, and 0.5 µg/ml bradykinin. Using a 96-well 
microtiter plate, 100 µl of the peptide or standard sample was added to 100 µl of the working 
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reagent (supplied with the kit and diluted according to the manufacturer’s instructions). All 
standards and samples were run in triplicate. Plates were incubated at 37 °C for 2 h, and 
absorbance was measured at 570 nm on a BioTek Elx808 spectrophotometer, using Gen5 2.01 
software for analysis.     
Mass spectrometry was used to identify, and obtain an approximate quantification of, 
antimicrobial peptides (AMPs) from the skin secretion samples. The dried peptide samples were 
resuspended at a concentration of 1 mg/ml in HPLC water and spotted them onto a Matrix 
Assisted Laser Desorption/Ionization (MALDI) plate at a 1:1 ratio with matrix [10 mg/ml α-
cyano-4-hydroxycinnamic acid (Sigma, St. Louis, MO), 60 % acetonitrile, 39.6 % HPLC-grade 
water, and 0.4 % trifluoroacetic acid (v/v/v)]. An Ultraflex III time-of-flight mass spectrometer 
(Bruker Daltonics, Billerica, MA) was used and calibrated using the following standards (Sigma, 
St. Louis, MO): bradykinin fragment 1-7 (m/z 757.3997), human angiotensin II (m/z 1046.5423), 
P14R synthetic peptide (m/z 1533.8582), adrenocorticotropic hormone fragment 18-39 (m/z 
2464.1989), and bovine oxidized insulin chain B (m/z 3494.6513). For each standard and peptide 
sample, 250 laser shots were collected (following Woodhams et al. 2006). Spectra were analyzed 
with Data Explorer v4.4 software (Applied Biosystems, Foster City, CA). The 19 most common 
AMPs in R. pipiens and closely related species secretions have been previously described 
(Tennessen et al. 2009), although only 7 were previously reported for R. pipiens in Vermont. For 
R. sphenocephala, there have only been 4 peptides described (Holden et al. 2015; Colon et al. 
2003). I used the Tennessen et al. (2009) and the Holden et al. (2015) peptide list and their 
reported peptide centroid masses to determine the presence/absence and relative intensities of 
these common AMPs. As a more conservative approach, I also analyzed the data using only the 
AMPs previously described for R. pipiens from Vermont to compare more specifically 
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differences in peptides from the Vermont and Pennsylvania R. pipiens in this study as the AMPs 
in R. pipiens from Pennsylvania have not been described. In data matrices representing relative 
intensities of AMPs I used zeros to denote non-detection of individual peptides. 
2.2.7 Skin peptide analyses 
To test for differences in the total secreted peptides, corrected for body weight (μg/gbw), 
among animals from different temperature treatments, I log transformed these values, as 
measured from frogs at one month and two months post-metamorphosis to meet the assumption 
of normality. I then ran separate linear models (package ‘nlme’, function ‘lm’), with peptide 
concentration as the response variable, for frogs at one- and two-months post-metamorphosis.  
To test for differences in the composition and intensities of skin peptide samples 
collected from frogs that developed as larvae in the different temperature treatments, I used a 
non-metric multidimensional scaling (NMDS) ordination to compare the Bray-Curtis distance (a 
metric of compositional dissimilarity) among samples, using the ‘metaMDS’ command (‘Vegan’ 
package). I then used the ‘Adonis’ function in the Vegan package (Oksanen et al. 2013) to carry 
out a permutation-based multivariate analysis of variance (PERMANOVA). PERMANOVA 
tests were run using the Bray-Curtis distance comparisons of peptide presence/absence and 
peptide relative abundances among temperature treatments for frogs from each locality, using 
9,999 permutations. The dependent variable for these models was either peptide 
presence/absence or the intensity of the mass signal for each peptide, and temperature treatment 
was the main effect. I did not run models containing other main effects or interaction terms 
because sample sizes were small.  
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To compare the total number of antimicrobial peptide species detected among frogs 
raised under different temperature treatments, I used a generalized linear model (Package MASS, 
function glm) with a Poisson distribution. The total number of peptide species was the dependent 
variable and temperature treatment was the main effect. Again, due to small sample sizes, 
models containing other main and interaction effects were not run. 
2.2.8 White blood cell counts 
The animals were euthanized at Vanderbilt University, after weighing and measuring 
them, with an overdose of 1% buffered tricaine methanosulfonate (MS-222). A cardiac puncture 
was used on euthanized frogs to collect blood samples in capillary tubes. This was done before 
dissecting the spleen and thymus. The white blood cells were stained with Trypan Blue (Sigma, 
T-6146), which permitted counting of only live cells. Splenocytes, thymocytes (see below) and 
white blood cells were counted from one group of animals at one-month post-metamorphosis and 
another set of animals at two months post-metamorphosis (11 - 24 animals per group, see Table 
2.2). White blood cells were counted in whole blood diluted 50-fold with APBS, using a 
hemocytometer to estimate cells/ml. They divided the total white blood cell counts by the total 
animal body weight to estimate white blood cell concentrations as cells/ml. 
2.2.9 White blood cell analyses 
To compare the white blood cell concentrations among frogs from different temperature 
treatments I ran a linear model (package ‘nlme’, function ‘lm’) with white blood cell 
concentration as the response variable.  
70 
2.2.10 Lymphocyte counts 
Splenocytes and thymocytes were counted at Vanderbilt University to compare 
lymphocyte activity among frogs from the current and future temperature treatments. The same 
two sets of animals were used, at one month and two months post-metamorphosis, that were used 
for the white blood cell counts described above (see Table 2.2). Spleens and thymuses were 
dissected and placed individually on autoclaved depression slides in 200 μl of complete L-15 
medium (L-15 medium supplemented with 100 I.U./mL penicillin, 100 μg/mL streptomycin, 1% 
Tetracycline, 12.5 mM sodium bicarbonate, 50 μM 2-mercaptoethanol, 2 mM L-glutamine, and 
1% heat inactivated fetal calf serum). Spleens and thymuses were disassociated separately using 
forceps and counted live (Trypan blue stained) lymphocytes using a hemocytometer. 
Lymphocytes were counted using the total sample volumes (whole organs). When only one 
thymus was found, (this happened for two animals from Pennsylvania and two from Louisiana), 
the number of cells found in the one thymus was multiplied by two for comparison with samples 
in which cells in both thymuses were counted. After counting, splenocytes were cultured to 
measure activity (see below).  
2.2.11 Lymphocyte analyses 
To compare thymocyte and splenocyte cell counts among frogs from the two temperature 
treatments, I log transformed the counts to meet the assumption of normality and ran linear 
models (package nlme, function lm). For both thymocytes and splenocytes, I used log 
transformed cell count as the response variable. Splenocyte counts were divided by animal body 
weight (gbw) for analysis. 
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2.2.12 T- and B-cell proliferation 
To compare lymphocyte proliferation among frogs from the two temperature treatments, 
splenocyte proliferation was measured in response to a T-cell mitogen (Phytohemagglutinin, or 
PHA at 2 μg/ml) and a B-cell mitogen (heat-killed E. coli at 107/ml) using splenocyte samples 
collected from 5 - 12 animals per treatment at one month (T-cells) or two months (B-cells) post-
metamorphosis (Table 2.2). Splenocytes were measured at a concentration of 10,000 cells/well in 
L-15 medium in the presence of one of these two mitogens at 26 °C in 5 % CO2, 95 % air in a 
laminar flow hood. When it was not possible to obtain 10,000 splenocytes from a single animal 
(Louisiana samples: 27/40, Pennsylvania samples: 4/40, Vermont samples: 2/26 individuals), the 
sample was divided among two wells to compare proliferation in one well containing the 
mitogen to the background proliferation in the well containing splenocytes and L-15 medium 
only. T-cell and B-cell assays were cultured for 3 and 5 d, respectively, and pulsed with 0.5 μCi 
3H-thymidine (5 μCi/mL, specific activity 2 Ci/mmole) (Perkin Elmer, Waltham, MA, USA) 24 
h before harvesting cells. Proliferation was measured by a scintillation counter (Beckman LS 
6500) to quantify the uptake of 3H-thymidine and recorded as counts per minute (CPM). 
Response was calculated as the average CPM in wells with PHA or E. coli, divided by the 
average CPM in wells with splenocytes only (no mitogen).  
2.2.13 T- and B-cell proliferation analysis 
For comparisons of T- and B-cell proliferation among frogs from different temperature 
treatments, I log transformed CPM ratios (mitogen present / mitogen absent) to achieve 
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normality, then ran linear models (package nlme, function lm) with log (CPM ratio) as the 
response variable. 
2.2.14 Bd exposure and subsequent immune measurements 
The group of 56 frogs (10 – 16 animals per temperature treatment, see Table 2.2) that I 
exposed to Bd was housed at 16 °C from metamorphosis until the end of the experiment. Fifteen 
to twenty days after metamorphosis, I haphazardly chose approximately half of these animals to 
expose to Bd and the remainder were sham-exposed (see Table 2.2). To prepare the Bd inoculate, 
I used one-week-old cultures of the “Section Line” isolate of Bd (passage # 12) grown in liquid 
TGhL broth (16 g tryptone, 4 g gelatin hydrolysate, 2 g lactose, 1000 ml distilled water; 
Longcore et al. 1999) to seed Bd growth on agar plates. The plates were inverted and incubated 
at 21 °C for one week before I flooded them with DI water to collect zoospores for inoculation. I 
exposed each frog individually to the same quantity of Bd zoospores (106 per inoculation) every 
two weeks for a period of 8 weeks (i.e., 4 inoculations). Animals were inoculated individually in 
100 mL plastic containers containing 40 mL of inoculum for 24 h before being returned to their 
Ziplock containers. I sham-exposed control frogs following the same schedule and protocol but 
using inoculum I created by flooding blank (no Bd) agar plates with DI water. 
Prior to each inoculation and at the end of the experiment (on days 0, 14, 28, 42 and 56), 
I measured each animal’s SVL and mass and collected a skin swab to test for Bd. To estimate 
infection load, I swabbed (using a Medical Wire and Equipment #MW113 swab) each frog five 
times on each of the dorsal surface, ventral surface, each side of the body and each limb, making 
sure to rotate the swab while taking the samples. The swabs were stored at -20 °C prior to DNA 
extraction.  
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To quantify Bd DNA from swab samples, I extracted genomic DNA from each swab 
using the “animal tissue” protocol and the Qiagen DNeasy Extraction Kit with a final elution 
volume of 200 µl. I then ran a qPCR assay (Boyle et al. 2004) using a QuantStudio™ 3 Real 
Time PCR system. I used 25 µl reactions containing 12.5 µl of 2x SensiFast probe Lo-Rox 
Master Mix (Bioline, London UK), PCR primers at a concentration of 900 nM, the MGB probe 
at 240 nM, 400 ng/µl BSA, 3 µl water, and 5 µl of template DNA. Positive (known to contain Bd 
DNA) and negative (same master mix but with molecular grade water added instead of DNA 
template) amplification controls and a 6-fold dilution series of plasmid-based standards (Pisces 
Molecular, CO) were included on each qPCR reaction plate. I used the default QuantStudio 
software (V.1.4) conditions for amplification (2 min at 50 °C and 10 min at 95 °C, followed by 
50 cycles of 15 s at 95 °C and 1 min at 60 °C). I report infection load in terms of Bd DNA copies 
(= plasmid equivalents). To estimate the Bd load on a swab, I multiplied the number of DNA 
copies detected in the qPCR reaction by 40 (since I used 1/40th of the DNA extracted from the 
swab in each reaction).  
2.2.15 Statistical analyses of infection and disease indicators 
To test for differences in Bd infection load across temperature treatments, I built 
generalized linear mixed models (function ‘glmer’) using Template Model Builder (package 
‘glmmTMB’). The response variable in each analysis was the log-transformed Bd load (Bd DNA 
copies +1) detected on each skin swab sample and the fixed effects were temperature treatment 
and the interaction between temperature treatment and time since first exposure. Individual frog 
ID was included as random effect in each model. I used a Gaussian (function ‘gaussian’) 
distribution because the data was normally distributed. I also tested for differences in the 
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probability of infection among temperature treatments by coding individuals as positive/negative 
for Bd for a given sampling period based on whether (or not) Bd DNA was detected on their 
swab sample using qPCR. For this analysis, I used generalized linear mixed models (package 
‘lme4’) with a binomial (function ‘glmer’) distribution, temperature treatment and the interaction 
between temperature treatment and time since first exposure were included as fixed effects and 
individual frog ID was included as a random effect.  
I compared body condition between sham- and Bd-exposed and animals that developed as 
larvae under different temperature treatments using scaled mass index as the dependent variable. 
I calculated scaled mass index using the ‘smatr’ package, which tests for a common slope 
amongst several allometric lines and used the animal’s mass just before the first exposure as a 
reference for the slope. To compare scaled mass index among Bd-exposed frogs from the two 
larval temperature treatments I used linear mixed models (‘nlme’ package function ‘lme’) with 
temperature treatment, time since first exposure, and their interaction as fixed effects. Individual 
frog ID was included as a random effect.  
To compare survival among Bd-exposed frogs and among temperature treatment groups, 
I used a Cox proportional hazards model (‘survival’ package, ‘coxph’ function), with days 
surviving as the dependent variable and larval temperature treatment as the only factor. 
2.2.16 Splenocyte counts 
At the end of the exposure experiment (56 days after initial exposure, when the frogs 
were two and a half months post-metamorphosis), I weighed the frogs and euthanized them by 
bath in 1% buffered tricaine methanosulfonate (MS-222, Sigma-Adrich, St Louis, MO, USA) I 
then dissected spleens from 7 - 14 frogs per treatment group (Table 2.2) and placed the spleens 
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individually on autoclaved depression slides in 20 μl sterile amphibian phosphate buffered saline 
(APBS; 100 mL PBS with 25 mL water). I used a slightly different procedure for breaking open 
the spleen and counting the splenocytes than described above for newly metamorphosed frogs. 
This time, I disassociated the spleens using 25-gauge needles and added 20 μl of Trypan blue 
stain (Sigma/Alrich, St. Louis, MO, USA) to each sample. I then used a hemocytometer to 
estimate live cell densities. I counted cells using the hemocytometer, counting cells in two to 
three 10 μl volumes and averaging those values. Following the hemocytometer’s instructions, I 
divided that count by the number of grid squares from which I counted cells and multiplied by 
10,000 to convert the volume to ml. I then divided by frog mass to yield the number of spleen 
cells per ml per gram body weight (cells/gbw).  
2.2.17 Post-exposure splenocyte analysis  
To test for differences in splenocyte concentrations between frogs from the two exposure 
and two temperature treatment groups, I log transformed the cell counts (cells/ml/gbw) to meet 
the normality assumption. To compare these counts between temperature treatments, I ran a 
linear model (package ‘nlme’, function ‘lm’) with log splenocyte cells/ml/gbw as the response 
variable. 
2.2.18 Mucosome collection 
I collected skin mucus from the Bd-exposed and sham-exposed frogs (Table 2.2) from 
each temperature treatment after two weeks of Bd (or sham) exposure to test for differences in 
the ability of the “mucosome” to kill Bd in vitro (Woodhams et al. 2014). The mucosome 
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includes secondary metabolites, AMPs, lysozymes, mucosal antibodies, and alkaloids. To collect 
the mucosome, each frog was rinsed in 10 ml of molecular grade water for 1 h in a 50 ml conical 
tube. The frog was then returned to its enclosure and the rinse water was immediately passed 
through a 0.22 μm filter to remove live bacterial cells. The filtered samples were then stored at -
20 °C prior to growth challenge assays (described below). 
2.2.19 Mucosome effects on Bd viability 
To assess the effect of whole mucosome on Bd zoospore viability, cell proliferation was 
quantified by ATP detection by the Woodhams Lab at the University of Massachusetts, Boston. 
To begin, each mucosome sample was lyophilized until completely dry and resuspended in 1 ml 
of sterile molecular grade water. The concentration of a 4-day old culture of the “Section Line” 
Bd isolate (passage #15) was quantified using a hemocytometer and diluted to a concentration of 
106 zoospores/ml. This process generally followed the mucosome viability assay setup of 
Woodhams et al. (2014), but the assay was slightly modified so that the CellTiter-Glo 2.0 
(Promega) kit could be used to measure zoospore viability.  
Each sample was run in five wells: 3 (triplicate) wells containing Bd plus media (1% 
tryptone) and 2 (duplicate) wells containing sterile media only. The duplicate media only wells 
were included to facilitate background correction, due to the potential for ATP presence in the 
mucosome. For each sample, 25 μl of Bd solution (or sterile medium alone) and 25 μl of the 
mucosome sample were added to each well. Each plate contained 6 positive control wells 
(containing 25 μl of Bd solution plus 25 μl of sterile MilliQ water, and 6 negative control wells 
(containing 25 μl of heat killed Bd plus 25 μl of sterile MilliQ water) for zoospore viability. 
Three nutrient background wells (to account for the potential presence of ATP in the water and 
77 
media) were also included on each plate. These contained 25 μl of media plus 25 μl of sterile 
MilliQ water.  
After setup was complete, each plate was incubated for 1 h at 21 ºC, then in a dark room, 
50 μl of CellTiter-Glo 2.0 Reagent was added to each well to make a 1:1 solution, and the plate 
was covered with a foil sealing film. The plates were then placed on a shaker for 3 min at 200 
rpm, then removed and incubated at 21 ºC for 15 min to lyse the cells and release ATP. Plates 
were then read using a luminescent channel of a POLARstar Omega microplate reader. To 
calculate percent zoospore viability, the average media control (media plus MilliQ water) 
luminescent reading value was subtracted from each positive and negative zoospore viability 
control. The background luminescent readings (duplicate wells containing media plus 
mucosome) were averaged for each sample and this value was subtracted from each of the 
triplicate sample replicates that contained mucosome and Bd. The readings were averaged for 
replicates of negative Bd viability control wells, and this value was subtracted from each of the 
other wells (mucosome and positive control wells) to remove the ATP value of dead Bd. Finally, 
the resulting values were averaged for the positive control replicates the background-corrected 
sample well values were divided by the average positive control value to get a proportional cell 
viability. These triplicate proportional cell viability values were then averaged for each sample 
prior to statistical analysis.  
To test for a difference in the viability of Bd zoospores following exposure to mucosome 
from frogs that developed under current and future temperature treatments, and among exposure 
groups, I log transformed the proportional cell viability values to meet the normality assumption. 
To compare these values among Bd- and sham-exposed frogs from the two temperature 
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treatments, I ran linear models (package ‘nlme’, function ‘lm’) with log (proportion viable cells) 
as the response variable. 
2.3 Results 
2.3.1 Survival  
In each population and temperature treatment, fewer than half of all tadpoles survived to 
metamorphosis. Survival to metamorphosis was observed in 34/152 (22 %) current temperature 
and 53/148 (35.82 %) future temperature treatment R. pipiens tadpoles from Vermont and in 
57/190 (30 %) current temperature and 78/184 (42 %) future temperature treatment R. pipiens 
tadpoles from Pennsylvania. For R. sphenocephala, tadpoles from Tennessee experienced 0 % 
(0/190 animals) survival in both temperature treatments whereas 73/135 (42 %) current and 
44/145 (33 %) future temperature animals from Louisiana survived to metamorphosis. I saw 
differences among populations and species in terms of which temperature treatment experienced 
greater survival. For R. pipiens, survival to metamorphosis did not differ significantly between 
temperature groups for animals from Vermont (COXPH: χ21 = 0.4633, p = 0.496; Figure 2.3A), 
but animals from Pennsylvania had significantly greater survival in the future temperature 
treatment (COXPH: χ21 = 6.0257, p = 0.014; Figure 2.3B). None of the R. sphenocephala 
animals from Tennessee survived to metamorphosis, but tadpoles in future temperature treatment 
survived longer (COXPH: χ21 = 53.789, p < 0.001; Figure 2.3C). Only for the R. sphenocephala 
from Louisiana was survival to metamorphosis reduced in the future temperature treatment 




Figure 2.3 Larval survival curves. 
A.) Vermont R. pipiens (COXPH: p = 0.496), B.) Pennsylvania R. pipiens (COXPH: p = 0.014), C.) Tennessee R. 
sphenocephala (COXPH: p < 0.001), and D.) Louisiana R. sphenocephala (COXPH: p < 0.001). Day zero is the day 







































































































2.3.2 Larval period  
Larval periods for animals from Vermont, Pennsylvania and Louisiana populations were 
shorter in the future temperature treatment than in the current temperature treatment (COXPH: 
χ21 ≥ 38.752, p < 0.001; Figure 2.4). The shortest larval periods we observed for Vermont, 
Pennsylvania and Louisiana were similar across species and populations (range: 127 – 153 d) for 
animals from the future temperature treatments whereas the longest larval periods (range 241 – 
321 d) for animals from the current temperature treatments differed more dramatically, with 




Figure 2.4 The proportion of individuals that successfully metamorphosed (tail fully absorbed, Gosner stage 46) 
from each temperature treatment, from the Vermont and Pennsylvania R. pipiens and the Louisiana R. 
sphenocephala populations. 
For R. pipiens from Vermont, larval period ranged from 141 – 321 d (current temperature mean: 248 d, range 182 to 
321 d; future temperature mean: 190 d, range 141 – 259 d; COXPH: p < 0.001).  For R. pipiens from Pennsylvania, 
larval period ranged from 145 – 262 d (current temperature mean: 230 d, range 206 - 262 d; future temperature 
mean: 164 d, range 145 – 207 d; COXPH: p < 0.001). For R. sphenocephala from Louisiana, larval period ranged 
from 153 – 241 d (current temperature mean: 184 d, range 153 – 241 d; future temperature mean 144 d, range 127 - 























































































2.3.3 Mass at metamorphosis 
Regardless of population of origin, R. pipiens that developed in the future temperature 
treatment had lower mass at metamorphosis than animals that developed in the current 
temperature treatment (LM: Vermont F1,84 = 62.778, p < 0.001; Pennsylvania F1,133 = 134.39, p < 
0.001; Figure 2.5). However, for R. sphenocephala from Louisiana there was not a significant 
difference in mass between metamorphs from the current and future temperature treatments (LM: 
F1,97 = 0.396 p = 0.531).  
 
 
Figure 2.5 Box plots showing mass at metamorphosis (g). 
For frogs reared in current and future temperature treatments from Vermont (VT), Pennsylvania (PA), and Louisiana 
(LA). For Vermont R. pipiens: current temperature treatment, mean = 2.35 g, range = 1.04 to 3.23 g; future 
temperature treatment mean = 1.32 g, range = 0.84 to 2.45 g.  For R. pipiens from Pennsylvania, current temperature 
treatment mean = 2.50 g, range = 1.79 to 3.20 g; future temperature mass mean = 1.79 g, range = 1.18 to 2.61 g. For 
R. sphenocephala from Louisiana, current temperature treatment mean = 0.84 g, range = 0.40 to 1.26 g; future 
temperature mean = 0.87 g, range = 0.49 – 1.98 g. The middle line corresponds to the median. The lower and upper 
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hinges correspond to the first and third quartiles (the 25th and 75th percentiles). The upper whisker extends from 
the hinge to the largest value no further than 1.5 times the inter-quartile range. 
2.3.4 Body size (SVL) 
For all three populations that survived to metamorphosis, animals from the future 
temperature treatment were smaller in size at metamorphosis, as determined by SVL, than 
animals from the current temperature treatment (ANOVAs: Vermont R. pipiens: F1,85 = 83.469, p 
< 0.001; Pennsylvania R. pipiens: F1,133 = 187.83, p < 0.001; Louisiana R. sphenocephala: F1,97 = 
4.602 p = 0.034; Figure 2.6).  
 
 
Figure 2.6 Box plots showing snout-vent length (SVL) at metamorphosis for frogs from current and future 
treatments. 
For Vermont R. pipiens from the current temperature treatment mean = 28.4 mm, range = 22.4 to 32.8 mm; future 
temperature treatment mean = 23.519 mm, range = 19.5-29.2 mm. For R. pipiens from Pennsylvania, current 
temperature treatment mean = 29.8 mm, range = 25.6 to 33.9 mm; future temperature treatment mean = 25.6 mm, 
range = 19.5 to 29.2 mm). For R. sphenocephala from Louisiana, current temperature treatment mean = 21.3 mm, 
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range = 17.6-24.1 mm; future temperature treatment mean = 20.7 mm, range = 19.5 – 29.2 mm. The middle line 
corresponds to the median. The lower and upper hinges correspond to the first and third quartiles (the 25th and 
75th percentiles). The upper whisker extends from the hinge to the largest value no further than 1.5 times the 
inter-quartile range. 
2.3.5 Total peptides in skin secretions 
For R. pipiens from Vermont at both one-month and two-months post-metamorphosis, 
the best model for variation in total peptides secreted was the simplest one, which included 
temperature treatment as a main effect but did not include any other main effects or interactions 
with temperature treatment (one-month: AIC = 9.867, ΔAIC = 1.591; two-months: AIC = 3.759, 
ΔAIC = 0.795; Table 2.3). At both time points, Vermont frogs that developed in the current 
temperature treatment secreted more peptides than the frogs from the future temperature 
treatment (LMs: one-month F1,10 = 5.735, p = 0.038; two-months F1,10= 10.840, p = 0.008; 
Figures 2.7A, 2.7B).  
For Pennsylvania R. pipiens, at one-month and two-months post-metamorphosis, I chose 
the simplest model (with only temperature treatment as a main effect) one-month: AIC = 1.301, 
ΔAIC = 0.265; two-months: AIC = 14.010, ΔAIC = 1.846; Table 2.3). However, at neither time 
point was there a significant effect of temperature treatment on the amount of peptides secreted 
(LMs: one-month F1,16 = 0.700, p = 0.416; two-months F1,16 = 0.622, p = 0.442). Frogs that 
developed in the current temperature treatment secreted a mean of 1.805 (range: 1.472 – 2.208) 
log (ug/gbw) at one month and a mean of 2.147 (range: 1.289 – 2.485) log (ug/gbw) peptides at 
two months post-metamorphosis. Frogs that developed in the future temperature treatment 
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secreted a mean of 1.711 (range: 1.424 – 2.087) log (ug/gbw) at one month and a mean of 2.020 
(range: 1.660 – 2.351) log (ug/gbw) peptides at two months post-metamorphosis. 
For Louisiana R. sphenocephala, the model with the lowest AIC at one-month post-
metamorphosis included an interaction between temperature treatment and growth rate (from 
metamorphosis to one month old) (AIC = -4.917, ΔAIC = 4.001; Table 2.3). The model with the 
lowest AIC at two-months post-metamorphosis included an interaction between temperature 
treatment and time to metamorphosis (AIC = 1.242, ΔAIC = 5.308; Table 2.3). At both time 
points, frogs that developed as larvae in the current temperature treatment secreted more peptides 
than frogs from the future temperature treatment (LMs: one-month F1,13 = 5.990, p = 0.030; two-
months F1,10 = 8.334, p = 0.017; (Figure 2.7C, 2.7D). Growth rate (one-month: F1,13 = 1.710, p = 
0.214) and time to metamorphosis (two-months: F1,10 = 0.083, p = 0.780) did not have significant 
main effects on total peptides. At the one-month time point, frogs that had a faster growth rate in 
the future chamber secreted a lower quantity of peptides (LM, temperature treatment x growth 
rate interaction: F1,13 = 28.714, p < 0.001, β = -185.522, Figure 2.7C). At two-months post-
metamorphosis, frogs that took longer to metamorphose in the future chamber secreted lower 
quantities of peptides (LM, temperature x time to metamorphosis interaction: F1,10 = 9.195, p = 
0.013, β = -0.058, Figure 2.7D). The number of samples for this population at two months post 




Figure 2.7 Box plots showing total peptides secreted (in μg per g body weight, or μg/gbw) for R. pipiens from 
Vermont. 
(A) one month post-metamorphosis: current temperature treatment mean = 2.303, range = 1.844 to 2.642 log 
(μg/gbw); future temperature treatment mean = 1.867, range = 1.355 – 2.180 log (μg/gbw), and (B) two months 
post-metamorphosis: current temperature treatment mean = 2.516, range = 2.338 – 2.711 log (μg/gbw); future 
temperature treatment mean = 2.050, range = 1.681 – 2.483 log (μg/gbw). In (C), the scatter plot and lines of best fit 
are for the relationships between total peptides, in log (μg/gbw), and growth rate (g/day) for R. sphenocephala from 
Louisiana at one month post metamorphosis. (D) scatter plot and lines of best fit for the relationships between total 
peptides, in log (μg/gbw), and time to metamorphosis (days) for R. sphenocephala from Louisiana at two months 
post-metamorphosis. Each point represents one individual and the shaded area represents 95 % confidence intervals.  
In the boxplots, the middle line corresponds to the median. The lower and upper hinges correspond to the first and 
third quartiles (the 25th and 75th percentiles). The upper whisker extends from the hinge to the largest value no 
further than 1.5 times the inter-quartile range. 
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2.3.6 Secretion of antimicrobial peptides 
I found 14 out of the 19 peptides described by Tennessen (2009) for R. pipiens in 
different parts of the United States in our samples from Vermont frogs. The best model to 
describe variation in the number of AMPs present in skin secretion samples from this population 
included the interaction between temperature treatment and time to metamorphosis for frogs at 
both one months (AIC = 48.302, ΔAIC = 2.643; Table 2.3) and two months (AIC = 51.865, 
ΔAIC = 4.555; Table 2.3) post-metamorphosis. At both time points, frogs reared under the 
current temperature treatment had a greater number of AMPs present in their secretions (GLM; 
one-month: χ21 = 5.132, p = 0.024, two-months: χ21 = 11.995, p < 0.001; Figure 2.8A, 2.8B) but 
the main effect of time to metamorphosis was not significant (GLM: one-month: χ21 = 0.037, p = 
0.847, two-months: χ21 = 0.185, p = 0.668). There was also a significant interaction between 
temperature treatment and time to metamorphosis at one and two months old. At both time 
points, frogs in the future temperature treatment that took longer to reach metamorphosis had a 
greater number of AMPs present in their secretions, but for frogs in the current temperature 
treatment the number of peptides we recovered did not appear to be correlated with 
developmental timing (GLM; one month: χ21 = 4.643, p = 0.031; two months: χ21 = 9.515, p < 
0.001; Figure 2.8A, 2.8B). However, given the small sample sizes per month for this population 





Figure 2.8 Scatter plot and lines of best fit for the relationships between the number of antimicrobial peptides 
(AMPs) detected and time to metamorphosis (days)  for R. pipiens from Vermont reared in current and future 
temperature treatments. 
At one (A) and two (B) months post-metamorphosis. Each point represents one individual, and the shaded area 
represents 95 % confidence intervals. 
 
I found 13 out of the 19 peptides described by Tennessen (2009) for R. pipiens in 
different parts of the United States in our samples from Pennsylvania frogs. The best model to 
describe variation in the number of AMPs present from this population at one-month post-
metamorphosis included temperature and mass at metamorphosis as main effects (AIC = 36.991, 
ΔAIC = 1.788; Table 2.3). At two months post-metamorphosis, the best model included the main 
effects of temperature and growth rate (AIC = 92.875, ΔAIC = 0.455; Table 2.3). At one-month 
post-metamorphosis, there was not a significant difference in the number of AMPs present in 
skin secretions for Pennsylvania frogs from different temperature treatments (GLM: χ21 = 0.188, 
p = 0.665), nor was there a significant main effect of mass at metamorphosis χ21 = 3.458, p = 
0.063. At the two-month time point, there was not a significant effect temperature or growth rate 
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on the number of AMPs detected (GLM: χ21 ≤ 2.949, p ≥ 0.086). Frogs tended to secrete fewer 
AMPs at one-month post-metamorphosis (current temperature treatment mean = 1, range 0 to 3; 
future temperature treatment mean = 0.417, range 0 to 2) than at two months post-metamorphosis 
(current temperature treatment mean = 4.167, range: 0 to 7; future temperature treatment mean = 
1.667, range 0 to 7). 
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Temp. * Time to 
metamorphosis 
ΔAIC 
White Blood Cell Counts 
VT1 9.636 11.306 10.475 7.351 9.833 4.662 -3.669 8.331 
VT2 11.137 12.739 12.965 11.704 14.290 12.378 13.620 0.567 
PA1 -7.510 -5.713 -5.969 -9.736 -5.077 -6.247 -7.755 1.981 
PA2 -4.790 -3.624 -3.239 -2.890 -5.642 -3.095 -2.890 1.166 
LA1 -1.332 -0.099 0.281 -0.581 1.572 2.260 -1.327 0.005 
LA2 2.348 3.128 -1.350 3.818 5.056 0.328 5.804 1.678 
Thymocyte Counts 
VT1 19.670 21.658 20.885 19.992 20.998 19.296 15.484 3.812 
VT2 20.299 14.377 22.103 18.429 16.246 23.765 19.970 1.869 
PA2 13.545 15.530 12.455 9.450 15.443 8.703 10.502 1.052 
PA2 -7.187 -6.474 -5.652 -7.224 -5.850 -8.714 -5.232 0.713 
LA2 36.668 37.567 28.044 35.456 28.882 29.952 32.681 0.838 
LA2 3.083 -1.991 4.381 4.270 -0.398 3.835 4.687 -2.389 
Splenocyte counts 
VT1 16.020 17.466 17.291 13.280 18.128 15.412 9.564 3.717 
VT2 5.948 7.945 7.881 6.743 7.993 9.641 8.388 0.795 
PA1 32.169 33.348 23.869 29.626 32.717 25.154 25.839 1.285 
PA2 9.499 8.456 -7.181 10.857 10.453 -6.775 5.696 0.407 
LA1 29.184 30.701 26.030 31.184 30.676 27.331 30.992 1.301 





Table 2.3 (continued) 
B-cell proliferation 
VT2 -4.411 -7.653 -2.418 -3.741 -6.270 -0.987 -2.623 1.3825 
PA2 -3.846 -2.121 -5.258 -1.846 -0.317 -3.279 -3.689 -1.412 
LA2 9.018 10.501 9.870 10.740 12.435 -1.215 10.528 10.233 
T-cell proliferation 
VT1 22.565 24.536 24.516 22.935 26.443 23.496 20.387 2.1779 
PA1 30.956 32.722 32.587 28.084 33.573 33.621 27.934 2.8711 
LA1 22.670 19.278 22.639 24.485 21.146 24.638 23.742 1.868 
BCA (Mucosal peptides) 
VT1 9.867 11.458 11.575 12.112 13.036 12.111 12.708 1.591 
PA1 1.301 3.142 3.276 1.566 3.490 2.746 3.010 0.265 
LA1 11.531 9.344 12.903 13.171 0.916 -4.917 10.793 4.001 
VT2 3.759 8.239 4.554 5.261 6.809 5.202 5.450 0.795 
PA2 14.010 15.856 15.241 15.884 17.353 16.280 17.410 1.846 
LA2 6.551 7.915 7.394 8.371 9.799 9.367 1.242 5.308 
Total AMPs 
VT1 59.51915 55.70955 55.43057 50.94563 57.05001 52.443 48.3024 2.64323 
PA1 41.1108 36.991 38.779 40.25659 38.986 38.926 42.9522 1.788 
LA1 24.71222 24.251 23.938 23.691 26.13 25.548 25.662 0.247 
VT2 66.70279 63.927 62.01169 59.3802 64.989 56.42 51.865 4.555 
PA2 97.30482 93.33 92.875 97.693 95.22 91.711 95.747 0.455 
LA2 14.81899 15.238 15.049 15.673 17.238 17.049 17.673 0.23001 





The Louisiana R. sphenocephala population was not included in this analysis because we 
were only able to detect a small number of AMPs in a few individuals. There are only four 
AMPs that have been described for R. sphenocephala (Holden et al. 2015) and among my 38 
samples taken from Louisiana frogs at one- and two-months post-metamorphosis I only detected 
two of these, and only 6 animals had any detectible AMPs. 
The PERMANOVA (taking into account the 19 peptides from R. pipiens from across the 
United States) considering peptide presence/absence only, did not show any significant 
differences between the AMP communities in secretions collected from R. pipiens that 
developed in current vs. future temperature treatments. This was true at both one month (Bray–
Curtis distances; Vermont: F1,6 = 2.381, p = 0.176; Pennsylvania: F1,5 = 0.485, p = 0.760) and 
two months (Bray–Curtis distances; Vermont: F1,6 = 3.057, p = 0.072; Pennsylvania: F1,7 = 1.468, 
p = 0.218) after metamorphosis. The results were very similar when intensity of the mass signal 
for each peptide (i.e., peptide relative abundances) was considered (Bray–Curtis distances: 
Vermont one month: F1,6 = 0.905, p = 0.519; Vermont two months: F1,6 = 1.284, p = 0.242; 
Pennsylvania one month: F1,5 = 1.065, p = 0.343). The only exception was for Pennsylvania R. 
pipiens at two months where there was a significant difference in number and intensity of AMPs 
detected between the two temperature treatments (Bray-Curtis distance: F1,7 = 2.346, p = 0.048; 
Figure 2.9) such that frogs that developed in the current temperature treatment had AMP 
communities that were more tightly clustered than frogs that developed in the future temperature 
treatment. However, due to the small sample sizes for each population and time point, all of 




Figure 2.9 Non-multidimensional scaling (NMDS) plot of Bray-Curtis distances between AMP communities from R. 
pipiens from Pennsylvania at two months post-metamorphosis. 
Distances were calculated using both presence/absence and relative intensity information for each AMP, as 
measured by MALDI mass spectrometry. The ellipses are 95 % confidence intervals. 
 
I repeated the same analysis but this time using only using the seven AMPs previously 
described from Vermont R. pipiens (Tennessen 2009) for both the Vermont and Pennsylvania 
samples even though the AMPs for Pennsylvania R. pipiens have not previously been described. 
I found six of the seven peptides previously described from Vermont in both populations. 
However, in Pennsylvania at one month post-metamorphosis, only three of them were detected 
(Temporin 1P, Brevinin 1 Pa, and Brevinin 1Pe). The PERMANOVA considering peptide 
presence/absence only did not show any significant differences between the AMP communities 
in secretions collected from R. pipiens that developed in current vs. future temperature 
treatments. This was true at both one month (Bray–Curtis distances: Vermont one month F1,7 = 
1.848, p = 0.329, two months F1,7 = 2.176, p = 0.124). For Pennsylvania there were too few 
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samples to run this analysis. For AMP intensities I also didn’t find a significant difference 
between R. pipiens that developed in current vs. future temperature treatments. This was true at 
both one month (Bray–Curtis distances: Vermont one month F1,7 = 0.457, p = 0.907, two months 
F1,7 = 0.939, p = 0.578). 
2.3.7 White blood cell counts 
For R. pipiens from Vermont, the best model to describe variation in white blood cell 
counts at one-month post-metamorphosis included the interaction between temperature treatment 
and time to metamorphosis (AIC = -3.669, ΔAIC = 8.331; Table 2.3). At two-months post-
metamorphosis, the best model included only the main effect of temperature treatment (AIC = 
11.137, ΔAIC = 0.567; Table 2.3). At one-month post-metamorphosis, frogs that developed in 
the current temperature treatment had more white blood cells than frogs from the future 
temperature treatment (LM: F1,8 = 15.094, p = 0.005). However, the interaction between 
temperature treatment and time to metamorphosis was also significant (LM: F1,8 = 15.675, p = 
0.004, β = 0.010), such that frogs from the future temperature treatment that had spent more time 
as larvae had more white blood cells, but frogs from the current temperature treatment with 
longer larval periods had similar white blood cell counts no matter how long their larval period 
was (Figure 2.10A). At two months post-metamorphosis there were no differences in white 
blood cell counts between the two temperature treatments (LM: F1,9 = 1.740, p = 0.220).  Current 
temperature mean: 7.556, range: 7.267 – 8.311 log (cells/ml); future temperature mean: 7.276, 
range: 6.845 – 7.488 log (cells/ml) (Table 2.4). 
For R. pipiens from Pennsylvania, the best model to describe variation in white blood cell 
counts at one-month post-metamorphosis included the main effect of temperature treatment and 
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time to metamorphosis (AIC = -9.736, ΔAIC = 1.981: Table 2.3). At two months, it included 
only temperature treatment as a main effect (AIC = -4.790, ΔAIC = 1.166; Table 2.3). At one 
month, the effects of temperature treatment and time to metamorphosis on white blood cell count 
were not significant (LM: F1,13 ≤ 3.951, p ≥ 0.067). At two months post-metamorphosis, the 
effect of temperature treatment on white blood cell counts was not significant (LM: F1,16 = 0.037, 
p = 0.851). Current temperature mean at one month: 7.027, range: 6.829 – 7.217 log (cells/ml); 
future temperature mean: 7.041 range: 6.628 – 7.317 log (cells/ml). Current temperature mean at 
two months: 7.104, range: 6.903 – 7.337 log (cells/ml); future temperature mean: 7.124, range: 
6.653 – 7.415 log (cells/ml) (Table 2.4). 
For R. sphenocephala from Louisiana, the model that best fit the data at one month 
included only the main effect of temperature (AIC = -1.332, ΔAIC = 0.005: Table 2.3). At two 
months post-metamorphosis the best model included temperature treatment and growth rate as 
main effects (AIC = -1.350, ΔAIC = 1.678; Table 2.3). At one-month post-metamorphosis, there 
was no significant effect of temperature treatment on white blood cell counts (LM: F1,17 = 0.360, 
p = 0.557). Current temperature mean at one month: 6.935, range: 6.544 – 7.176 log (cells/ml); 
future temperature mean: 6.873 range: 6.544 – 7.154 log (cells/ml). At two months, there was no 
significant effect of temperature treatment (LM: F1,8 = 1.972, p = 0.198) but there was a 
significant positive effect of growth rate on white blood cell count (LM: F1,8 = 5.429, p = 0.048) 
(Figure 2.10B). Current temperature mean at two months: 6.843, range: 6.699 - 7.041 log 





Figure 2.10 Scatter plot and lines of best fit for the relationships between log-transformed white blood cell counts 
(cells/ml). 
and (A) time to metamorphosis (days) for R. pipiens from Vermont at one month post-metamorphosis, or (B) growth 
rate (g/days) at two month post-metamorphosis for R. pipiens from Louisiana. Each point represents one individual, 
and the shaded areas represent 95 % confidence intervals.
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Table 2.4 Table showing the mean and log10 transformed mean of immune measures at one- and two-months post-metamorphosis in frogs reared in current and 
future temperature treatments. 













White blood cells, Vermont 14,208,333 7.149 11,208,333 6.906 66,375,000 7.555 20,500,000 7.276 
White blood cells, Pennsylvania 11,100,000 7.027 11,812,500 7.041 13,700,000 7.104 14,312,500 7.124 
White blood cells, Louisiana 9,326,923 6.935 8,541,667 6.872 7,312,500 6.842 6,785,714 6.772 
Thymocytes, Vermont 74,886 4.678 64,564 4.617 245,630 5.183 216,509 5.176 
Thymocytes, Pennsylvania 41,764 4.544 16,696 4.143 17,187 4.200 30,770 4.460 
Thymocytes, Louisiana 138,215 4.960 197,717 5.172 82,458 4.859 312,913 5.441 
Splenocytes, Vermont 30,098 4.411 36,797 4.350 29,851 4.429 38,914 4.525 
Splenocytes, Pennsylvania 174,227 5.106 126,081 4.889 181,666 5.204 342,447 5.446 
Splenocytes, Louisiana 15,758 4.059 17,120 4.085 10,203 3.769 12,843 3.976 
B-cell proliferation, Vermont     1.151 0.043 1.609 0.163 
B-cell proliferation, Pennsylvania     1.380 0.091 1.586 0.166 
B-cell proliferation, Pennsylvania     3.126 0.321 1.130 0.033 
T-cell proliferation, Vermont 7.474 0.736 17 0.874     
T-cell proliferation, Pennsylvania 107 1.908 45 1.345     
T-cell proliferation, Louisiana 10 0.862 12 0.858     
BCA (mucosal peptides), Vermont 234.563 2.303 89.896 1.866 349.159 2.516 134.729 2.050 
BCA (mucosal peptides), Pennsylvania 74.566 1.805 57.239 1.711 192.507 2.147 118.878 2.020 
BCA (mucosal peptides), Louisiana 39.519 1.57062 27.640 1.309 76.794 1.852 76.365 1.762 
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2.3.8 Thymocyte counts 
For R. pipiens from Vermont, the best model to explain variation in thymocyte counts 
included the interaction between temperature treatment and time to metamorphosis (AIC = 
15.484, ΔAIC = 3.812; Table 2.3). For two-months post-metamorphosis, the best model included 
the main effects of temperature treatment and mass at metamorphosis (AIC = 14.377, ΔAIC = 
1.869; Table 2.3). The main effects of temperature treatment and time to metamorphosis were 
not significant (LMs: F1,8 ≤ 4.820, p ≥ 0.059). There was, however, a significant interaction 
between temperature treatment and time to metamorphosis (LM: F1,8 = 5.761, p = 0.043, β = 
0.013). In the future temperature treatment, the thymocyte count tended to increase with time to 
metamorphosis whereas in the current temperature treatment, thymocyte counts were slightly 
lower for frogs that took longer to metamorphose. (Figure 2.11A). At two months post-
metamorphosis, the main effect of temperature treatment was not significant (LM: F1,11 = 2.866, 
p = 0.118). There was, however, a positive effect of mass at metamorphosis on thymocyte counts 
(LM: F1,11 = 8.369, p = 0.015, β = 0.617) (Figure 2.11B). 
For R. pipiens from Pennsylvania, the best model at one-month post-metamorphosis 
included the main effects of temperature and time to metamorphosis (AIC = 9.450, ΔAIC = 
1.052; Table 2.3). At two months, the best model included only temperature treatment as a main 
effect (AIC = -7.187, ΔAIC = 0.713: Table 2.3). For this population at one month, there was no 
significant difference between thymocyte counts in frogs from current and future temperature 
treatments (LM: F1,15 = 2.209, p = 0.158). However, there was a significant positive effect of 
time to metamorphosis on thymocyte count (LM: F1,15 = 0.460, p = 0.027; Figure 2.11C). At two 
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months post-metamorphosis, frogs from the future temperature treatment had more thymocytes 
than frogs from the current temperature treatment (LM: F1,20 = 10.435, p = 0.004; Figure 2.11D).  
For R. sphenocephala from Louisiana, the model that best fit our data for frogs at one-
month post-metamorphosis was the one with temperature treatment and growth rate as main 
effects (AIC = 28.044, ΔAIC = 0.838; Table 2.3). At two months post-metamorphosis, the best 
model included temperature treatment and mass at metamorphosis as main effects (AIC = -1.991, 
ΔAIC = -2.389: Table 2.3). At one month, there was a significant positive effect of growth rate 
on (LM: F1,22 = 11.650, p =0.002, β = 50.041, Figure 2.11E) but the main effect of temperature 
treatment was not significant (LM: F1,22 = 3.920, p = 0.060). At two months, frogs that developed 
in the future temperature treatment had more thymocytes than frogs from the current temperature 
treatment (LM: F1,11 = 16.951, p = 0.002). Across both temperature treatments, frogs with a 
greater mass at metamorphosis also had more thymocytes (LM: F1,11 = 7.233, p = 0.021, β = 




Figure 2.11 Scatter plot and lines of best fit for the relationships between log-transformed thymocyte counts (cells 
/g). 
and (A) time to metamorphosis (days) for R. pipiens from Vermont at one month post-metamorphosis, (B) mass at 
metamorphosis (g) for R. pipiens from Vermont at two months, and (C) time to metamorphosis (days) for R. pipiens 
from Pennsylvania at one month post-metamorphosis. Plot (D) shows box plots of log-transformed thymocyte 
counts (cells/g) for R. pipiens from Pennsylvania at two months post-metamorphosis. Plot (E) shows growth rate 
(g/day) for R. sphenocephala from Louisiana at one month and (F) show mass at metamorphosis (g) for R. 
sphenocephala from Louisiana at two months post-metamorphosis. Each point represents one individual and the 
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shaded areas represent 95 % confidence intervals. In the boxplots, the middle line corresponds to the median. The 
lower and upper hinges correspond to the first and third quartiles (the 25th and 75th percentiles). The upper 
whisker extends from the hinge to the largest value no further than 1.5 times the inter-quartile range. 
2.3.9 Splenocyte counts 
For R. pipiens from Vermont, the best model to describe variation in splenocyte counts at 
one-month post-metamorphosis included the interaction between temperature treatment and time 
to metamorphosis (AIC = 9.564, ΔAIC = 3.717; Table 2.3). For two-month-old frogs, the best 
model included only the main effect of temperature treatment (AIC = 5.948, ΔAIC = 0.795; 
Table 2.3). At one-month post-metamorphosis, none of the main or interaction effects in the 
model were significant (LMs: F1,8 ≤ 4.882, p ≥ 0.058) though small sample sizes (n = 6 current, 6 
future temperature treatment) likely impacted my power to detect anything but a very large effect 
size. The mean splenocyte count for all frogs at one-month post-metamorphosis was 4.381 
log/ml/g (range: 3.769 to 4.951 log/g). At two months post-metamorphosis, with a slightly larger 
sample size (n = 5 current, n = 9 future), the main effect of temperature was also not significant, 
(LM: F1,12 = 0.436, p = 0.522). The mean splenocyte count for all frogs at two months was 4.491 
log/ml/g (range: 4.041 to 4.808) log cells/g (Table 2.4). 
For R. pipiens from Pennsylvania at one- and two-months post-metamorphosis the best 
model was the one that included the main effects of temperature treatment and growth rate (one 
month: AIC = 23.869, ΔAIC =1.285; two months: AIC = -7.181, ΔAIC = 0.407; Table 2.3). At 
one month, there was not a significant effect of temperature treatment (LM: F1,15 = 2.596, p = 
0.128), however splenocyte counts were positively correlated with growth rate (LM: F1,15 = 
11.582, p = 0.004; Figure 2.12A). At two months, with a slightly larger sample size, frogs from 
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the future temperature treatment had greater splenocyte counts (LM: F1,19 = 12.867, p = 0.002) 
and splenocyte counts were again positively correlated with growth rate (LM: F1,19 = 25.413, p < 
0.001; Figure 2.12B).  
For R. sphenocephala from Louisiana at one-month post-metamorphosis, the best fitting 
model included temperature treatment and growth rate as main effects (AIC = 26.030, ΔAIC = 
1.301; Table 2.3). At two months old, the best model included only temperature treatment (AIC 
= 20.449, ΔAIC = 0.642; Table 2.3). At one-month post-metamorphosis, splenocyte counts were 
not significantly different between frogs from the two temperature treatments (LM: F1,23 = 0.244 
p = 0.626) but frogs that grew faster after metamorphosis had more splenocytes (LM: F1,23 = 
5.043, p = 0.034, β = 115.223; Figure 2.12C). At two months post-metamorphosis there was 
again no difference in splenocyte counts between frogs from the current and future temperature 
treatments (LM: F1,12 = 0.640, p = 0.439). 
 
 
Figure 2.12 Scatter plots and lines of best fit for the relationships between log-transformed splenocyte counts 
(cells/g). 
and growth rate (g/day) for R. pipiens from Pennsylvania at one month (A) and two months (B) post-metamorphosis, 
and for (C) R. sphenocephala from Louisiana at one-month post-metamorphosis. Each point represents one 
individual, and the shaded areas represent 95 % confidence intervals. 
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2.3.10 T-lymphocyte proliferation 
For T-lymphocyte proliferation the assay was only performed at one-month post-
metamorphosis. The best model for R. pipiens from Vermont included the interaction between 
time to metamorphosis and temperature treatment (AIC = 20.387, ΔAIC = 2.178; Table 2.3). For 
Pennsylvania, the best model was the one with temperature treatment and time to metamorphosis 
as main effects (AIC = 28.084, ΔAIC = 2.871: Table 2.3). For R. sphenocephala from Louisiana, 
the best model included temperature and mass at metamorphosis as main effects (AIC = 19.278, 
ΔAIC = 1.868; Table 2.3). At one-month post-metamorphosis, none of the main effects or 
interactions in the model were significant (LM: F1,8 ≤ 3.687, p ≥ 0.091; current temperature 
mean: 1.694, range: 0.601- 2.879 log (fold T-lymphocyte proliferation); future temperature 
mean: 2.011, range: 0.008 - 4.170 log (fold T-lymphocyte proliferation) (Table 2.5). However, 
small sample sizes (n = 6 current, 6 future temperature treatment) would have precluded 
detection of all but the largest effect sizes.  
For the R. pipiens frogs from Pennsylvania, T-lymphocyte proliferation was not 
significantly different among frogs from the two temperature treatments (F1,15 = 1.799, p = 
0.200). However, time to metamorphosis had a significant positive relationship with T-
lymphocyte proliferation (F1,15 = 4.663, p = 0.047, β = 0.052, Figure 2.13A).  For R. 
sphenocephala from Louisiana, the main effect of temperature treatment was not significant 
(F1,12 = 0.231, p = 0.640) but there was a significant negative relationship between T-cell 




Figure 2.13 Scatter plot and lines of best fit for the relationships between log-transformed T-lymphocyte 
proliferationat one-month post-metamorphosis. 
and (A) time to metamorphosis (days) in R. pipiens from Pennsylvania and (B) mass at metamorphosis (g) in R. 
sphenocephala from Louisiana. Each point represents one individual, and the shaded area represents 95 % 
confidence intervals. 
2.3.11 B-lymphocyte proliferation 
The B-lymphocyte proliferation assay was only performed at two months post 
metamorphosis. For R. pipiens from Vermont, the best model to describe B-lymphocyte 
proliferation had temperature treatment and mass at metamorphosis as main effects (AIC = -
7.653, ΔAIC = 1.3825; Table 2.3). Frogs from this population that were reared in the future 
temperature treatment had greater B-cell proliferation than frogs from the current temperature 
treatment (LM: F1,11 = 5.941, p = 0.033). However, there was also a positive correlation between 
B-cell proliferation and mass at metamorphosis (LM: F1,11 = 4.995, p = 0.048, β = 0.499, Figure 
2.14A). For R. pipiens frogs from Pennsylvania, the best model to describe B-lymphocyte 
proliferation had only temperature treatment as main effect (AIC = -3.846, ΔAIC = -1.412; Table 
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2.3). B-lymphocyte proliferation did not differ significantly among frogs from the two 
temperature treatments for this population (LM: F1,20 = 0.746, p = 0.398). Current temperature 
mean: 0.091, range: -0.356- 0.482 log (fold proliferation); future temperature mean: 0.166, 
range: -0.164 - 0.470 log (fold proliferation) (Table 2.4). 
For R. sphenocephala from Louisiana, the best model contained the interaction between 
growth rate and temperature treatment (AIC = -1.215, ΔAIC = 10.233). For this population, the 
main effect of temperature treatment was not significant (LM: F1,15 = 0.085, p = 0.775) but there 
was a significant positive relationship between B-lymphocyte proliferation and growth rate (LM: 
F1,15 = 15.853, p = 0.002, β = 171.748). The interaction between temperature treatment and 
growth rate was also significant for Louisiana frogs (LM: F1,15 = 14.867, p = 0.002, β = -
197.624), such that frogs reared in the current temperature treatment had a strong positive 
correlation between growth rate and B-lymphocyte proliferation whereas for frogs from the 
future temperature treatment, B-cell proliferation was slightly negatively correlated with growth 




Figure 2.14 Scatter plot and lines of best fit for the relationships between log-transformed B-lymphocyte 
proliferation at two months post-metamorphosis. 
and (A) mass at metamorphosis (g) for R. pipiens from Vermont, and (B) growth rate (g/day) for R. sphenocephala 
from Louisiana. Each point represents one individual, and the shaded areas represent 95 % confidence intervals. 
2.3.12 Bd infections 
I compared the Bd infection load (log10 Bd DNA copies per swab) and the probability that 
a frog was infected (yes/no) among treatment groups during the four weeks of the Bd exposure 
experiment using skin swabs and a qPCR assay. I also compared scaled mass index (a measure 
of body condition) and survival among frogs reared under the two temperature treatments. For 
infection load, probability of infection, and scaled mass index, I tested for main and interaction 
effects of time since first exposure and the temperature treatment in which the frogs were reared.  
For Bd-exposed R. pipiens from Vermont, none of these main or interaction effects were 
significant for Bd infection load (GLMM: χ21 ≤ 1.100, p ≥ 0.294), probability of infection 
(GLMM: χ21 ≤ 0.002, p ≥ 0.951, or scaled mass index (LME: χ21 ≤ 2.176, p ≥ 0.151). However, 
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Bd-exposed frogs reared in the current temperature treatment had greater survival after exposure 
to Bd than frogs from the future temperature treatment (Cox regression: χ21 = 5.146, p = 0.023, n 
=10 current, n=15 future temperature treatment; Figure 2.15).  
 
 
Figure 2.15 Survival curves for R. pipiens from Vermont that were exposed to Bd. 
Labelled by temperature treatment and for all frogs (regardless of temperature treatment) in the control (sham 
exposure) group from week one after metamorphosis (Gosner stage 46) until day sixty after the first Bd exposure 
(COXPH: p = 0.023). 
 
For Bd-exposed R. pipiens from Pennsylvania, frogs from the future temperature 
treatment experienced a lower Bd infection load (GLMM: χ21 = 17.383, p ≤ 0.001, Figure 2.16 n 
=15 current, n= 15 future temperature treatment). Overall, infection load decreased with time 
since first exposure to Bd (GLMM: χ21 = 18.645, p ≤ 0.001), but there was also a significant 
interaction between temperature treatment and time since first exposure (GLMM: χ21 = 11.666, p 
≤ 0.001); frogs from the current temperature treatment decreased in Bd load over time while 
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frogs from the future temperature saw their infection loads increase slightly (Figure 2.16). There 
was also a difference in infection probability among frogs reared under the two temperature 
treatments (GLMM: χ21 = 4.172, p = 0.041) such that Pennsylvania frogs reared in the current 
temperature treatment were more likely to become infected after exposure to Bd than frogs from 
the future temperature treatment (Figure 2.17). However, the main effect of time since first 
exposure and the interaction between time and temperature treatment were not significant 
(GLMM: χ21 ≤ 1.922, p ≥ 0.166). There was a significant main effect of temperature treatment on 
scaled mass index during the exposure experiment (LMER: χ21 = 19.430, p < 0.001, Figure 2.18) 
such that frogs reared in the future temperature treatment had a greater scaled mass index. 
However, this difference existed at the start of the exposure experiment and there was no 
significant effect of time since first Bd-exposure or interaction between time and temperature 
treatment on body mass index (χ21 ≤ 2.770, p ≥ 0.103), which suggests that the difference among 
temperature treatments was a holdover from development under those temperatures and not 
generated by exposure to Bd. There was no difference in survival after Bd exposure between 
Pennsylvania frogs from the two temperature treatments (Cox regression: χ21 =1.386, p = 0.239). 
Most of the Bd-exposed frogs survived until the end of the experiment mean was 58.533 days 
(range: 16 – 60 days). For the Bd-exposed frogs in the current temperature treatment, the survival 
mean was 57 days (range: 16 – 60 days) and for the exposed frogs in the future temperature 





Figure 2.16 Scatter plot and lines of best fit for the relationship between Bd infection load, in log (DNA copies + 1), 
and since first exposure for Bd-exposed R. pipiens from Pennsylvania that were reared in current and future 
temperature treatments. 




Figure 2.17 Relationship between the mean proportion of frogs infected with Bd, as determined by qPCR, and time 
since first exposure for Bd-exposed R. pipiens from Pennsylvania reared in current and future temperature 
treatments. 
Error bars represent 95% confidence intervals calculated using the Clopper-Pearson method (Clopper 1934). 
 
 
Figure 2.18 Scatter plot and lines of best fit for the relationship between body condition, measured as scaled mass 
index, and time since first exposure for Bd-exposed R. pipiens from Pennsylvania reared under current and future 
temperature treatments. 
Each point represents one individual, and the shaded areas represent 95 % confidence intervals. 
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For Bd-exposed R. sphenocephala from Louisiana, there were no significant main or 
interaction effects of temperature treatment or time since first exposure on Bd infection load 
(GLMM: χ21 ≤ 1.891, p ≥ 0.169; n = 15 current, n = 16 future temperature treatment; mean: 
3.765, range 2.089 to 7.143 log (DNA copies +1). For probability of infection, the main effect of 
temperature treatment and the interaction between temperature treatment and time since first 
exposure were not significant (GLMM: χ21 ≤ 1.562, p ≥ 0.211; n =15 current, n =16 future 
temperature treatment) but there was a significant main effect of time since first exposure 
(GLMM: χ21 =8.272, p = 0.004, β = 0.266) such that frogs from the future temperature treatment 
were more likely to become infected later in the experiment and the current temperature 
treatment tended to lose infections over the course of the experiment (Figure 2.19). Scaled mass 
index differed among frogs from the two temperature treatments (LM: χ21 = 13.105, p ≤ 0.001) 
and frogs from both temperature treatments increased in body mass index over the course of the 
exposure experiment (LM: χ21 = 9.381, p = 0.003, Figure 2.20). However, similar to the 
Pennsylvania population, there was no significant interaction between temperature treatment and 
time since first Bd exposure (LM: χ21 = 0.007, p = 0.936) suggesting that the main effect of 
temperature treatment on body condition was a result of their rearing conditions and not an effect 
of Bd exposure. There was no difference in survival after Bd exposure between frogs from the 
two temperature treatments for this population (Cox regression: χ21 = 0.144, p = 0.7041). Most of 
the Bd-exposed frogs survived until the end of the experiment (mean 57 days, range: 19 – 60 
days survived). For the exposed frogs in the current temperature treatment the survival mean was 
57 days (range: 19 – 60 days) and for the exposed frogs in the future temperature treatment the 




Figure 2.19 Relationship between the mean proportion of frogs infected with Bd, as determined by qPCR, and time 
since first exposure for Bd-exposed R. sphenocephala from Louisiana reared in current and future temperature 
treatments. 
Error bars represent 95% confidence intervals calculated using the Clopper-Pearson method (Clopper 1934). 
 
 
Figure 2.20 Scatter plot and lines of best fit for the relationship between body condition, measured as scaled mass 
index, and time since exposure for Bd-exposed R. sphenocephala from Louisiana reared in current and future 
temperature treatments. 
Each point represents one individual and the shaded areas represent 95 % confidence intervals. 
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2.3.13 Splenocyte counts after Bd exposure 
I compared splenocyte counts among frogs from the two temperature treatments and two 
Bd exposure treatments (Bd vs. sham exposed) one week after the end of the Bd exposure 
experiment. The model that best fit the data for R. pipiens from Vermont included the interaction 
between temperature treatment and Bd exposure group and the main effect of growth rate (AIC = 
-11.581, ΔAIC = 1.649, Table 2.5). There were significant main effects of temperature treatment 
(LM: F1,30 = 9.787, p = 0.004, Figure 2.21) and growth rate (LM: F1,30 = 5.569, p = 0.025, β = -
11.670) on splenocyte counts. Frogs from the future temperature treatment had more splenocytes 
and the faster the frogs grew after metamorphosis, the lower the number of splenocytes (Figure 
2.22 A). There was not a significant effect of exposure group, or interaction between temperature 
treatment and exposure group for Vermont frogs (LM: F1,30 ≤ 2.063, p ≥ 0.162).  
For R. pipiens from Pennsylvania, the best model to explain variation in splenocyte 
counts after the Bd exposure experiment only included the interaction between temperature 
treatment and Bd exposure group (AIC = -14.185, ΔAIC = 1.859, Table 2.5). Here I found a 
significant difference between frogs reared in the current and future temperature treatments (LM: 
F1,48 = 10.374, p = 0.003, Fig 21); the frogs from the future temperature treatment had more 
splenocytes than the ones from the current temperature treatment (Figure 2.21). However, there 
was no significant difference in splenocyte counts between frogs that had been exposed to Bd 
and sham exposed frogs (LM: F1,48 = 0.034, p = 0.855) and the interaction between Bd-exposure 
group and temperature treatment was also not significant (LM: F1,48 = 1.199, p = 0.280) (Table 
2.6) 
For R. sphenocephala from Louisiana, the best model for splenocyte counts after Bd 
exposure contained two- and three-way interactions between temperature treatment, Bd exposure 
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group, and mass at metamorphosis (AIC = -33.767, ΔAIC = 5.242; Table 2.5). There was a 
significant main effect of mass at metamorphosis (LM: F1,35 = 6.623, p = 0.015, β = -0.226, 
Figure 2.22 B) such that the frogs that metamorphosed with a greater body mass had fewer 
splenocytes. There was also a significant difference in the number of splenocytes between frogs 
reared in the current and future chambers (F1,35 = 7.065, p = 0.012, Figure 2.21) with frogs from 
the future temperature treatment having more splenocytes. There was also a significant 
interaction between temperature treatment and mass at metamorphosis (F1,35 = 7.501, p = 0.010, 
β = -0.391) such that splenocyte counts from frogs reared in the future temperature treatment 
decreased faster with mass at metamorphosis than did the counts for frogs from the current 
temperature treatment (Figure 2.22 B). There was not a significant effect of exposure group and 
none of the other two-or three-way interactions in the model were significant (LM: F1,30 ≤ 0.786, 
p ≥ 0.382) (Table 2.6). 
 
 
Figure 2.21 Box plots showing the relationship between log-transformed splenocyte counts (cells/gbw)for R. pipiens 
from Vermont and Pennsylvania, and R. sphenocephala from Louisiana at one week after the last exposure to Bd. 
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Each point represents one individual. The middle line corresponds to the median. The lower and upper hinges 
correspond to the first and third quartiles (the 25th and 75th percentiles). The upper whisker extends from the hinge 




Figure 2.22 Scatter plots and lines of best fit for the relationship between log-transformed splenocyte counts 
(cells/gbw). 
and (A) growth rate (day/g) for R. pipiens from Vermont and (B) mass at metamorphosis in R. sphenocephala from 
Louisiana. Each point represents one individual, and the shaded areas represent 95 % confidence intervals. 
 
2.3.14 Inhibition of Bd growth by mucosome samples 
After the Bd exposure experiment, I compared the ability of mucosome samples collected 
from frogs in my two exposure groups and the two temperature treatments to inhibit the growth 
of Bd in vitro. The model that best fit the data for R. pipiens from Vermont included the main 
and interactive effects of temperature treatment and exposure group and also included mass at 
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metamorphosis as a main effect (AIC = 239.546, ΔAIC = 0.076, Table 2.5). For this population, 
there was a significant main effect of temperature treatment (LM: F1,21 = 7.395 p = 0.013, Figure 
2.23 A) such that the mucosome of frogs reared in the current temperature treatment was more 
inhibitive of Bd growth than the mucosome of frogs from the future temperature treatment. There 
was not a significant main effect of exposure group, or mass at metamorphosis, nor an 
interaction between temperature treatment and exposure group (LM: F1,21 ≤ 2.562, p ≥ 0.124).  
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Table 2.5 AIC values for models compared for each immune variable after Bd exposure. 
 Temp. * 
Exposure 
Temp. * 






Exposure + Time 
to metamorphosis 
Temp. * Exposure 










VT 255.754 239.546 257.698 239.622 241.685 260.071 244.769 0.076 
PA 251.432 243.473 249.804 250.303 248.144 254.830 250.855 4.671 
LA 239.136 232.934 223.204 231.302 237.902 223.476 235.945 0.272 
Spleen 
VT -7.621 -5.622 -11.581 -7.340 -3.677 -13.230 -2.886 3.96 
PA -14.185 -12.326 -12.248 -12.275 -7.531 -7.152 -7.072 1.859 
LA -9.304 -28.524 -7.316 -9.929 -33.767 -8.237 -9.042 5.243 
 
 
Table 2.6 Table showing the mean and log10 mean of splenocyte counts from exposed and sham exposed frogs from current and future temperature treatments. 















5080.055 3.642 10719.33 4.001 5402.877 3.691 5962.976 3.747 
Splenocytes, 
Pennsylvania 
4537.472 3.603 7926.385 3.847 4463.719 3.617 5977.512 3.739 
Splenocytes, 
Louisiana 
1274.18 3.071 1419.042 3.081 1381.251 3.123 1600.263 3.169 
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For R. pipiens from Pennsylvania, the model that best fit the mucosome inhibition data 
included the main and interactive effects of temperature treatment and exposure group and also 
included mass at metamorphosis as a main effect (AIC = 243.473 ΔAIC = 4.671, Table 2.5). For 
this population there were significant main effects of temperature treatment (LM: F1,23 = 21.851, 
p < 0.001) and exposure group (LM: F1,23 = 7.035, p < 0.014) and a significant interaction 
between temperature treatment and exposure group (F1,23 = 8.233, p = 0.009, β = 37.905); frogs 
reared in the future temperature treatment had more effective mucosome against Bd when they 
had been previously exposed to that pathogen, whereas in the current temperature treatment, Bd-
exposed frogs had mucosome with a lower capacity to inhibit Bd growth (Figure 2.23 B). There 
was also a significant main effect of mass at metamorphosis (LM: F1,23 = 9.824, p = 0.005, β = -
25.861) such that inhibition of Bd growth by mucosome decreased with mass at metamorphosis 
(Figure 2.23C).  
For R. sphenocephala from Louisiana, the best model to explain variation in mucosome 
inhibition of Bd growth after the exposure experiment included the main and interactive effects 
of temperature treatment and exposure group along with growth rate as a main effect (AIC = 
223.204, ΔAIC = 0.272, Table 2.5). For this population only temperature treatment was 
significant (F1,23 = 5.006, p = 0.035), with frogs in the future temperature treatment having more 
inhibitive mucosome than frogs from the current temperature treatment (Figure 2.23D). The 
main effect of exposure group and all interaction effects in the model were not significant (LM: 





Figure 2.23 Boxplots showing the relationship between inhibition (%) of Bd growth by mucosome. 
(A) Bd- and sham-exposed R. pipiens from Vermont from current and future temperature treatments: current 
temperature treatment mean  = 45.0373 % (range = -7.693 to 103.904 %) and future temperature treatment mean  =  
11.258 % (range = -1.621 to 29.085 %) and (B) Bd- and sham-exposed R. pipiens from Pennsylvania from the 
current and future temperature treatments: current temperature treatment mean for sham-exposed = 50.803 % (range 
= 32.578 to 71.372 %) and for Bd-exposed 24.547 % (range = 9.046 to 42.256 %), future temperature treatment 
mean for sham-exposed = 21.698 % (range = 1.697 to 89.726 %) and for Bd-exposed 33.525 % (range = 15.750 – 
56.184 %). Plot (C) is a scatter plot and line of best fit for the relationship between inhibition (%) of Bd growth by 
mucosome and mass at metamorphosis (g) for R. pipiens from Pennsylvania, with shaded areas representing 95% 
confidence intervals. Plot D shows boxplots of the relationship between inhibition (%) of Bd growth by mucosome 
from Bd- and sham-exposed R. sphenocephala from Louisiana from the current and future temperature treatments: 
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current temperature treatment mean = 11.652 % (range = 3.536 – 30.154 %) and future temperature treatment mean 
= 17.687 % (range = 2.258 –55.854 %). For all plots, each point equals one individual. In the boxplots the middle 
line corresponds to the median. The lower and upper hinges correspond to the first and third quartiles (the 25th 
and 75th percentiles). The upper whisker extends from the hinge to the largest value no further than 1.5 times the 
inter-quartile range. 
2.4 Discussion 
I measured the direct and indirect effects of developing as larvae under simulated climate 
change temperatures on Northern and Southern leopard frogs’ immune systems. For nearly all of 
the aspects of development and immune function that I measured, the patterns with temperature 
treatment differed among populations and species. From what I observed, each population did 
respond to the stressor of elevated developmental temperature, but they did so through changes 
to different suites of factors, each of which may affect their fitness (both overall and in the face 
of pathogens). Other studies investigating the effects of stressors on immune function have found 
similarly inconsistent results among populations and species. For example, fish exposed to heavy 
metals, such as copper, often show a decrease in lymphocytes (Dick and Dixon 1985, Dethloff 
1998). However, one study done in tilapia found more lymphocytes in fish exposed to higher 
levels of copper (Nussey 1995). Plasticity in response to developmental stressors (e.g., 
temperature, water level, predators) at the larval stage have been well documented in amphibians 
(Gervasi and Foufopuolos 2008, Brannelly et al. 2019). However, the carry-over effects of those 
stressors in later life stages, and especially on the immune system, have rarely been studied. 
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Let’s first consider the developmental aspects of elevated temperature, like larval survival, 
time to metamorphosis, size and mass at metamorphosis, on the animals in my experiment. 
Survival was very low in all the populations compared to the experiment in Chapter 1 where 
animals were reared in mesocosms outside. In this experiment, more than half the tadpoles in 
each environmental chamber died prior to metamorphosis. The low survival in this study could 
be due to a negative effect of frequent water changes on development of a beneficial microbiome 
(as compared with more natural conditions in our mesocosm study). The artificial lighting 
conditions, the noise inside the working chambers, and the diet I fed the tadpoles could have 
affected tadpole survival as well.  Based on what has been seen in other frog species, I predicted 
that the tadpoles developing at a higher temperature would metamorphose faster, at a smaller 
size, and would have lower survival to metamorphosis. In the Northern leopard frog, larvae in 
the future temperature treatment developed faster and metamorphosed at a smaller size but there 
was no difference in survival to metamorphosis. In the Southern leopard frogs from Louisiana 
(the only population of this species where animals survived to metamorphosis), animals from the 
future temperature treatment developed faster, but there was no difference in size at 
metamorphosis. In these frogs, survival to metamorphosis was lower in the future temperature 
than in the current temperature treatment. 
It seems logical that toward the southern part of their range, northern hemisphere temperate 
zone species would be better adapted to tolerate higher-than-average temperatures and more 
northern populations would be better adapted to colder and shorter summers (Conover and 
Schlutz 1995). However, in my experiment, the only population showing reduced survival to 
metamorphosis in the future temperature treatment was the R. sphenocephala population from 
Louisiana. Survival was similar between both temperature treatments in both of the R. pipiens 
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populations. This could be explained by the Louisiana R. sphenocephala larvae, which live 
closer to the southern edge of their species range, having a narrower range of thermal tolerance 
than the more northern R. pipiens populations I studied. Recent comparisons have found support 
for this pattern in comparisons between tadpoles of tropical and temperate amphibian species 
(Gutiérrez‐Pesquera et al. 2016).  
As predicted, the frogs exposed to the future temperatures metamorphosed faster in all the 
populations studied. The frogs that developed as larvae in my future temperature treatments were 
also smaller body length and mass after metamorphosis. This pattern, where tadpoles reared in 
warmer water metamorphose faster but at a smaller size, has been observed in many amphibians 
(Uhlenuth 1919, Etkin 1964, Gilbert 2020) and may be a general pattern for ectotherms (Howe 
1967, Lock and McLaren 1970). The impacts of these plastic responses to elevated temperature 
may have lingering consequences later in life. Larger juveniles often grow to be larger adults, 
and smaller juveniles can take longer to reach sexual maturity (Berven 1990, Cabrera‐Guzmán et 
al. 2013). A larger body size at the time that metamorphosis is complete has been correlated with 
greater terrestrial survival since, as reported for Bufo calamita (Reques and Tejedo 1997), 
Pelohylax lessonae and P. esculentus (Altwegg and Reyer 2003), larger frogs are better able to 
cope with different stressors, such as predation and desiccation, in their terrestrial habitats. 
Elevated temperature is just one of many aspects of climate change that can cause morphological 
and physiological stresses on amphibian larvae. But do these effects include negative impacts on 
the immune system? 
Stressors can have more dramatic negative effects on health when experienced during 
formative stages of life. In this study and in previous work (Morey and Reznick 2001; Van 
Buskirk and Saxer 2001; Relyea and Hoverman 2003) it has been shown that the quality of a 
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tadpole’s environment early in development has post-metamorphic effects on survival, growth, 
and morphology. Here I examined the carry-over effects of elevated temperature on multiple 
measures of both the innate and adaptive immune function in newly-metamorphosed leopard 
frogs. I hypothesized that elevated temperature is a stressor that will have a negative impact on 
immune response. The few other studies that have examined the effects of environmental 
stressors on immune response in amphibians have found support for this hypothesis. For 
example, adult southern leopard frogs forced to metamorphose faster due to drying and warming, 
developed antimicrobial peptides (AMPs) much later than animals that did not experience these 
stressors (Holden et al. 2015). In this study, as predicted, Vermont and Louisiana animals reared 
in the future temperature treatment secreted lower quantities of hydrophobic peptides in their 
mucus. The number of AMPs secreted was also lower in animals from Vermont that developed 
in the future temperature treatment. This suggests that developing as a tadpole in a warmer than 
normal environment, as is expected under climate change, could compromise this aspect of the 
amphibian innate immune system. Mucosal peptides are the first line of defense against the 
amphibian chytrid fungus, Bd (Carey et al. 1999). When I compared aspects of the adaptive 
immune system among temperature treatments, however, I saw a different pattern. 
For the adaptive immune system, I hypothesized that the production of white blood cells, 
thymocytes, splenocytes, and T and B cells would be lower for frogs that developed under the 
stress of elevated temperatures. This is because under acute stress, non-essential processes such 
as immune function are inhibited by the hormonal stress response (Sapolsky et al. 2000). I found, 
as predicted, that the R. pipiens from Vermont that developed in the current temperature 
treatment had more white blood cells. However, this pattern was not seen in frogs from the other 
populations studied. Contrary to my predictions, the R. pipiens from Pennsylvania that developed 
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in the future temperature treatment produced more thymocytes and splenocytes than the current 
temperature and the R. sphenocephala from Louisiana that developed in the future temperature 
treatment also produced more thymocytes. There were no differences in T-lymphocyte 
proliferation between the temperature treatments, however the Vermont R. pipiens from the 
future temperature treatment had greater B-lymphocyte proliferation than frogs from the current 
temperature treatment. Another potential explanation might be that the immune system 
undergoes a major reorganization during metamorphosis and the greater number of lymphocytes 
might be due to a catch-up phenomenon experienced by frogs that developed in more stressful 
larval conditions. Taken together, these studies suggest that developing as larvae under elevated 
temperatures might actually stimulate the immune system, potentially creating an advantage for 
protection against infectious diseases. A strong between-season temperature dependence of 
circulating lymphocytes and eosinophils has been documented in Red-Spotted Newts (Raffel et 
al. 2006). However, the impacts of smaller changes in temperature on the adaptive immune 
system, as in this study, have never been investigated before in amphibians. It is possible that in 
this study, an increase of two or three degrees Celsius might not have been enough for 
temperature to act as a stressor on the leopard frog immune system. Other studies have found 
that higher temperatures within an amphibian’s optimal temperature range usually stimulate the 
immune system whereas at temperatures near the bottom end of the optimal temperature range 
the immune system slows down, perhaps due to low energy supply (Rollins-Smith and 
Woodhams 2012).  
In many of the immune parameters I measured, instead of temperature during 
development having a direct effect on later-life immune parameters, I found that growth rate, 
mass at metamorphosis and time to metamorphosis, which were themselves affected by 
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temperature, had carry over effects on different aspects of the immune system. These 
measurements could also reflect how relatively costly the developmental responses to elevated 
temperature were (i.e., how much energy was left for immune development), or perhaps, 
different strategies for mitigating the stressor. Phenotypic plasticity is often costly, and trade-offs 
exist between the benefits given by plasticity in one trait and the consequences of that plasticity 
on other traits that affect fitness (Newman 1992, Roff 1992). I hypothesized that there would be 
a positive correlation between time to metamorphosis and immune parameters because frogs 
with shorter larval periods have less time to acquire the resources they need to build their 
immune system. Frogs that are smaller at metamorphosis, I hypothesized, would have lower 
immune defenses because they have invested more energy into metamorphosing faster. For frogs 
with a fast growth rate after metamorphosis, I predicted a negative relationship with immune 
function since fast growers are likely prioritizing putting resources into growing large over 
investment in the immune system. 
While the developmental temperature did not directly affect some aspects of the immune 
system, I found that, in the Northern population (Vermont) of R. pipiens, mass at metamorphosis 
was positively correlated with thymocyte counts and B-lymphocyte proliferation. This matched 
my prediction because the higher the mass at metamorphosis, the more reserves they would have 
had available to build the immune system. As predicted, at one-month post-metamorphosis, 
Vermont frogs from the future temperature treatment that took longer to metamorphose had more 
white blood cells. Perhaps this is because they had ample time to build the immune system. 
However, in frogs from the current temperature treatment, the amount of white blood cells was 
not correlated with larval period.  Perhaps when not under temperature stress even animals with 
shorter larval periods have enough resources to build up ample white blood cells. 
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In the other population of R. pipiens (Pennsylvania), the faster the frogs grew after 
metamorphosis the greater the number of splenocytes, regardless of the temperature. During the 
rapid climax of metamorphosis, the lymphocyte numbers in circulation and in the thymus and 
spleen decrease (Rollins-Smith et al. 1984). But soon after, there is a burst of lymphocyte 
development (Du Pasquier and Weiss 1973). This burst seemed to happen more quickly for frogs 
with a faster growth rate after metamorphosis. In the future temperature treatment for this 
population, frogs that spent more time as a tadpole secreted more peptides. T-lymphocyte 
proliferation also increased with larval period both in current and future temperature treatments. 
Perhaps animals that spend longer periods as tadpoles and metamorphose larger do not have to 
spend as much time investing in energetically demanding life-history processes (such as foraging 
for food) after metamorphosis, and as a result, they can invest more energy into the immune 
system (Lochmiller & Deerenberg 2000; Norris & Evans 2000). 
For the southern leopard frogs from Louisiana from the future temperature treatment, 
animals that grew faster during their first month after metamorphosis secreted less peptides and 
had lower B-lymphocyte proliferation. However, those correlations were not seen in animals 
from the current temperature treatment, suggesting that developing under elevated temperature, 
which often leads to smaller metamorphs that have to quickly catch up in growth in order to 
compete with their peers, can result in lower innate immune function. It seems logical that these 
frogs are investing more in growth, than in immune system development. However, for this 
population, as for the Northern leopard frogs, the faster animals grew after metamorphosis the 
greater their white blood cell and splenocyte counts, regardless of the temperature. In this 
population, greater mass at metamorphosis also was also correlated with greater thymocyte 
counts at two months post-metamorphosis. This matched my prediction, possibly because the 
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higher the mass at metamorphosis, the more reserves an animal may have available to build the 
immune system. However, as in R. pipiens, a higher mass at metamorphosis was associated with 
lower T- lymphocyte proliferation. Since this assay was done when the frogs were only one 
month old, most of them were less than one 1 g in body weight. It is possible that by this point 
they simply hadn’t had enough time or resources to develop this aspect of the adaptive immune 
system. For this population, contrary to what we saw in the Pennsylvania R. pipiens, the longer 
an animal from the future temperature treatment spent as tadpole the less mucosal peptides it 
secreted. Taken together, my results suggest that developing in an elevated, future temperature 
can have indirect effects on the immune system that act through differences in size and growth 
rate after metamorphosis but that the aspects of the immune system that are affected often differs 
among populations and species. 
Most of the Bd-exposed frogs in my exposure experiment did not exhibit clinical signs of 
chytridiomycosis, even though they maintained infections for the duration of the experiment with 
moderately heavy infection loads. Developmental temperature seemed to affect the course of 
infection after exposure, however. For example, in my Pennsylvania R. pipiens, Bd exposed 
frogs from the future temperature treatment increased in Bd load and prevalence throughout the 
exposure experiment whereas frogs from the current temperature treatment decreased in load and 
prevalence. These results suggest that the larval developmental temperature impacts a frog’s 
susceptibility to Bd, perhaps through effects on pathogen resistance. Similarly, the scaled mass 
index, a measure of body condition, increased more quickly in Pennsylvania frogs from the 
current temperature treatment. This suggests that even in the absence of clinical signs of 
chytridiomycosis, developing as a tadpole in warmer than average conditions can lead to greater 
sub-lethal effects of Bd infection later in life. In Louisiana R. sphenocephala, however, body 
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mass index decreased at the same rate frogs from the current and future temperature treatments, 
suggesting that this effect may be species and/or population specific. In Vermont R. pipiens, Bd-
exposed frogs from the future temperature treatment had significantly lower survival than Bd-
exposed frogs from the current temperature treatment and control (sham exposed) animals. This, 
it appears that developing in elevated, future temperature conditions as a tadpole made these 
frogs more susceptible to lethal effects of Bd infection after metamorphosis.  
In addition to effects of developmental temperature, I also hypothesized that exposure to 
Bd might affect the immune system of juvenile leopard frogs. To test this hypothesis, I compared 
splenocytes counts one week after the last Bd exposure in my exposure experiment. However, I 
did not find any effects of prior infection with Bd on splenocyte counts. This could be because 
the animals didn’t develop heavy enough infections to trigger an increase in this type of adaptive 
immune response or because the splenocyte response was not playing an important role in 
fighting Bd infection. In a study in Xenopus laevis with low level Bd infections splenocyte 
counts were also found not to differ between Bd- and sham-exposed frogs (Fites et al. 2014). 
However, studies of the highly susceptible frog Atelopus zeteki late in infection, when animals 
had heavy Bd loads, supports that idea that fungal products from the skin infection can decrease 
splenic lymphocyte numbers (Ellison et al. 2014). While I did not find an effect of Bd exposure 
on splenocytes, after the Bd exposure experiment I did see an effect of developmental 
temperature on splenocytes; the frogs from the future temperature treatments had more 
splenocytes than the ones from the current temperature treatments. This could be due to higher 
metabolic rates during development at elevated temperatures (Rollins-Smith and Woodhams, 
2012). However, this effect of temperature, like others we observed in animals prior to the 
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exposure experiment, was only seen in some populations (in this case in both populations of 
Rana pipiens).  
After the Bd-exposure experiment, as in the younger froglets sampled prior to the 
exposure experiment, faster growth rate after metamorphosis and greater mass at were negatively 
correlated with splenocyte counts. After the exposure experiment, the ability of the mucosome, 
which includes bacterial products as well as inhibitory proteins and peptides and possibly 
lysozymes (Woodhams et al. 2014), to inhibit Bd seemed to have been affected by 
developmental temperatures in different ways for the two leopard frog species. In R. pipiens 
from Vermont, as I predicted, frogs that developed in the current temperature treatment had 
mucus that was more effective at inhibiting Bd growth than frogs from the future temperature 
treatment. However, in R. sphenocephala the opposite pattern with temperature was seen. In 
Pennsylvania R. pipiens, there was an effect of Bd exposure on mucosome inhibition. However, 
the pattern ran counter to my predictions. The mucosome of sham exposed frogs from the current 
temperature treatment inhibited Bd growth more than that of the Bd exposed frogs, however the 
mucosome of frogs from the future temperature treatment was more effective at inhibiting Bd 
growth if the animal had been exposed to Bd. Contrary to my predictions, the magnitude of Bd 
growth inhibition by mucosome decreased with an animal’s mass at metamorphosis. Without a 
more detailed analysis of changes in different components of the mucosome it is difficult to 
understand what may be driving these patterns. Perhaps under some sets of conditions inhibitory 
bacteria are more dominant and actively secret more Bd-inhibitory products? In general, despite 
finding several significant differences in immune parameters among temperature treatments and 
Bd exposure groups, the complex results I found suggests that more work needs to be done to 
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tease apart what is happening with the immune system after exposure to the stressors of elevated 
temperatures and Bd. 
It is striking to see so many significant differences among the many immune parameters 
between frogs that developed in my two temperature treatments, especially considering that the 
frogs reared as tadpoles under these different temperatures had all been treated the same for 
months after metamorphosis. Taken together, my study’s results suggest that the combined 
threats of temperature and infectious disease across life stages may interact to put amphibians at 
a greater risk of mortality than would be expected from one of these threats alone. Temperature 
had direct effects on development, size, and the innate immune system. There were also indirect 
effects of temperature and carry-over effects of temperature on either later life stages or on 
development, which also generated differences in immune measures. Because temperature 
impacts development in different ways for different populations, the impacts of temperature 
stress can be many and varied and really challenging to predict. This study shows that different 
impacts to the innate and adaptive immune system are there, and they are likely impacting many 
aspects of fitness, especially given the risk that emerging infectious diseases pose to amphibians 








3.0 Understanding the landscape-level movement of an emerging wildlife pathogen 
3.1 Introduction 
As infectious diseases emerge with increasing frequency and impact on wildlife 
populations (Johnson and Paull 2011) it becomes ever more critical to understand the links 
between environment, host-pathogen biology, and disease dynamics (Raffel et al. 2013). Fungal 
pathogens such as white nose syndrome in bats (Foley et al. 2011), colony collapse disorder in 
bees (Bromenshenk et al. 2010), and chytridiomycosis in amphibians (Berger et al. 1998; 
Casadevall et al. 2005) have been important drivers of recent wildlife declines and extinctions 
(Fisher et al. 2009).  Although we have learned a lot about the biology of these host-pathogen 
systems in recent years, important questions remain elusive, including how pathogens move 
across the landscape. The goal of this study was to better understand the dynamics and 
movement of Batrachochytrium dendrobatidis (Bd), the chytrid fungal pathogen that causes the 
sometimes-lethal skin disease chytridiomycosis in amphibians, across a landscape where 
amphibian hosts inhabit both ephemeral and permanent ponds. My study was designed to answer 
three key questions: (1) how does pathogen load and prevalence change across the amphibian 
active season in ephemeral versus permanent ponds, and (2) which amphibian hosts play the 
largest role in moving Bd across the landscape, and (3) how is genetic variation in Bd structured 
across the landscape? To answer these questions, I conducted a field study in Northwest 
Pennsylvania, though due to the nearly global distribution and impact of Bd on amphibians, my 
findings are likely to shed light on the mechanisms that underlie Bd dynamics and spread in other 
areas of the world as well. 
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The infectious life stage of Bd is the zoospore, which is motile in aquatic environments 
and has the potential to transmit to new hosts (Longcore et al. 1999; Greenspan et al. 2012). As a 
consequence of the aquatic nature of the fungus, which cannot survive desiccation, frog species 
associated with permanent ponds (Kriger and Hero, 2007) and streams (Hero et al. 2005; 
Gründler et al. 2012) are significantly more likely to be infected with Bd than more terrestrial 
species and those associated with ephemeral waterbodies, which dry out each year. The 
proportion of individuals infected can also differ among species and life stages. While the factors 
that underlie a species’ susceptibility to Bd remain unclear, variation in skin defenses appear to 
be important. The skin mucus of many amphibian hosts contains antimicrobial peptides (AMPs), 
which the amphibians produce and store in granular glands in the skin (Rollins-Smith 2009). 
Additionally, amphibian skin is home to a diverse microbiota, which can be an important 
component of the defense against Bd and other skin pathogens (Kruger 2020). Habitat use may 
also be an important factor in determining the likelihood of infection with Bd. Post-metamorphic 
hosts can move between aquatic habitats (Regosin et al. 2003), potentially spreading the 
pathogen, but tadpoles are generally restricted to their natal aquatic environment (Hoff et 
al. 1999) and as a result, the likelihood of infection on new metamorphs emerging from their 
natal pond likely depends on the zoospore pool in that pond environment. For example, in 
Eastern North America, leopard frogs (Rana pipiens), green frogs (R. clamitans) and bullfrogs 
(R. catesbeiana) overwinter and/or reproduce in permanent ponds but migrate to ephemeral 
ponds in late spring/early summer, making them potential vectors for Bd.  
The zoospore pool in a pond, and hence the Bd prevalence and load on infected hosts, 
may also depend on abiotic factors like pH, temperature, canopy cover, or depth, and any non-
amphibian species that act as reservoirs for Bd (Raffel et al. 2010). Johnson and Speare (2003) 
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suggested that Bd can persist in aquatic environments for long periods of time (7 weeks in a 
pond) probably using the high level of nutrients and the nonliving organic substrate given by 
algae in the absence of amphibian hosts. The growth of Bd in vitro is strongly temperature 
dependent, suggesting that temperature may be an important predictor of Bd infections on hosts 
as well. In culture, Bd grows well at cool temperatures and can even withstand freezing, whereas 
maximum growth occurs between 17 °C and 25 °C (Piotrowski et al. 2004). The pathogen 
appears to grow more slowly in temperatures exceeding 26°C, and it dies after 5 minutes at 60 
°C (Johnson et al. 2003). Bd growth in culture also appears to depend on pH. In one study, 
Bd grew and reproduced at pHs between 4 and 8 while growth was greatest at pH 6 to 7 
(Piotrowsky et al. 2004). In a study with newts (Notophthalmus viridescens), Bd load was higher, 
and animals were less able to clear infections, when ponds were more completely covered by 
canopy vegetation. The shade this vegetation provides appears to reduce the ability of ponds to 
warm up, and warmer temperatures help the newts to clear their infections (Raffel et al. 2010). 
Seasonal variation in both temperature and humidity have both been suggested to control the 
prevalence of Bd infections, and the timing of chytridiomycosis outbreaks, in the wild (Berger et 
al. 2004; Retallick et al. 2004). However, Bd dynamics may also depend on the presence of 
amphibian and/or non-amphibian reservoir host species in the pond. 
There are a few Bd reservoir taxa that could act as vectors of the pathogen between 
ponds. Bd infects the keratinized skin of post-metamorphic amphibians and the keratinized 
mouthparts of amphibian larvae, but it also survives in parts of other animal taxa that contain 
keratin. For example crustaceans, which contain keratin in their digestive tract, may serve as 
reservoir hosts. Bd has been shown to survive and even complete its life cycle in crayfish 
(McMahon et al. 2013) and Brannelly et al. (2015) found that crayfish (Procambarus spp. and 
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Orconectes spp.) can be infected with Bd in the wild. Crayfish can also transmit Bd to tadpoles 
under laboratory conditions (McMahon et al. 2013). In the laboratory, some studies have shown 
that certain fish could serve as reservoirs, with samples taken from zebrafish displaying various 
stages of Bd development, including discharged mature zoosporangia (Liew et al. 2017). It 
seems most likely, however, that the most important reservoirs for Bd are probably amphibian 
species, like the North American bullfrog (Rana catesbeiana, Daszak et al. 2004), and the 
Pacific treefrog (Pseudacris regilla, Padgett-Flohr and Hopkins 2009) which can harbor large Bd 
loads and do not usually develop disease symptoms.  
Bd’s aquatic zoospores cannot survive extended dry periods (Johnson et al. 2003), thus, I 
hypothesize that the multi-year persistence of Bd in ephemeral ponds, must be dependent upon 
infected animals bringing zoospores back to the pond each spring. Ephemeral ponds are a 
unique, often predator-free habitat that support the reproduction and early development of a suite 
of species depend upon them, including a number of invertebrates and amphibians (Hopey and 
Petranka 1994). In contrast, permanent ponds are larger habits that hold water throughout the 
year and also often contain predatory fish and a diverse community of small-bodied invertebrates 
and vertebrates (Wellborn et al. 1996). Because they do not freeze solid all they way to their 
bottoms, many species overwinter in permanent ponds, including larval and adult amphibians, 
which can act as reservoir hosts for aquatic pathogens like Bd, allowing them to persist across 
years (McDonald and Alford, 1999). 
In Eastern North America, some amphibian hosts, like leopard frogs (R. pipiens) and 
green frogs (R. clamitans) overwinter and/or reproduce in permanent ponds (Neill, 1948) but 
migrate to ephemeral ponds in late spring/early summer, making these species potential vectors 
for Bd to ephemeral pond communities. Other species, like wood frogs (R. sylvatica) and spring 
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peepers (Pseudacris crucifer), use only ephemeral ponds. These species, which overwinter 
terrestrially (Storey and Storey, 1984) and reproduce very early in spring, could also bring Bd to 
ephemeral ponds if they emerge infected from hibernation. Understanding how pathogens spread 
to and from ephemeral ponds, and how both types of pond communities contribute to the 
landscape-level dynamics of host-pathogen interactions, will be important for predicting disease 
risk and developing mitigation strategies. 
Thus far, five lineages of Bd have been described worldwide (BdCAPE, BdAsia1, 
BdAsia2/Brazil, BdAsia3 and Bd GPL; O’Hanlon et al. 2018). The Bd lineage associated with 
amphibian declines, the Global Pandemic Lineage (GPL; Farrer et al. 2011; Rosenblum et al. 
2013), appears to have spread worldwide within the last 100 years, and is thought to have 
reached North America in 1980s-1990s. (O’Hanlon et al. 2018). The phylogenetic relationships 
among the lineages suggest that BdAsia is the most basal lineage and that BdGPL is the most 
recent lineage (Farrer et al. 2011, O’Hanlon et al. 2018). The GPL has been divided in two 
genetic groups BdGPL-1, which is primarily found in North America and Europe, and BdGPL-2, 
which is distributed worldwide (Rosenblum et al. 2013). The arrival of Bd-GPL-1 caused 
declines in North America and Bd-GPL-2 in Central America (Schloegel et al. 2012). Our recent 
work suggests that several groups belonging to the GPL strain are infecting amphibians in 
Northwest Pennsylvania, and that many are shared across ponds and host species (Byrne et al. 
unpublished). Using a new genomic assay, I was able to distinguish which amphibian hosts are 
bringing which strains into ephemeral ponds, which strains end up dominating the community, 
and which are carried out of the pond in this region. This information is novel and will aid in 
predicting the dynamics and spread of Bd across landscapes.  
Here I test six hypotheses about the dynamics and spread of Bd at my study sites:  
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(H1) At the start of each amphibian active season, ephemeral pond host communities will 
have little to no Bd whereas permanent pond host communities, where many host species 
hibernate, will have more Bd.  
(H2) Bd load (number of zoospores per host) and prevalence (proportion of hosts infected 
in a population) in both types of pond will fluctuate with host temperature and pond pH. 
(H3) Bd moves from permanent to ephemeral ponds each year via hosts that overwinter 
and breed in permanent ponds but occasionally visit ephemeral ponds. 
Alternatively (H4), Bd is primarily brought to ephemeral ponds by ephemeral pond 
specialist species that emerge infected from terrestrial hibernacula and breed in ephemeral ponds 
soon thereafter. In this case, I predict that Bd load and prevalence in ephemeral ponds will be 
high on ephemeral pond species as they enter the pond 
(H5) New metamorphs emerging from ephemeral ponds will have infection prevalences 
and loads similar to the adult amphibians using the pond at the same time. 
(H6) The genetic variation present in Bd at my field sites will be structured by pond, host 
species, and time of year.  
To test these hypotheses, I surveyed ephemeral and permanent ponds during three years 
and tested for differences in infection load and probability of infection. I used drift fences (fences 
surrounding each pond that amphibians cannot pass through or over without my help) and pitfall 
traps (i.e., buckets buried in the ground which amphibians trying to pass through the fence fall 
into) to sample all amphibians entering and leaving two ephemeral ponds from the start of 
the breeding season until the pond dried. 
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3.2 Methods 
3.2.1 Surveys at permanent and ephemeral ponds 
I sampled field sites in the spring, summer, and fall across 3 different years. I conducted 
this research from 2017 to 2019 in Northwestern Pennsylvania, near the Pymatuning Lab of 
Ecology (PLE). Sampling was conducted at ten sites (Table 3.1): five ephemeral ponds and five 
permanent sites that are separated from one another by from 1 km to 15 km. Each site was 
sampled once per month from March to September in 2017 and 2018. In 2019 the ponds were 
sampled twice per season. I attempted to collect data from 20 individuals from each amphibian 
species present at each site during each survey. 
 
Table 3.1 Field site names, locations, and pond types 
Field site code and name Coordinates Pond Type 
PA01 Wood lab 41.569722 N -80.452500 W Ephemeral 
PA02 RV 41.691933 N -80.500450 W Permanent 
PA03 Sanctuary lake 41.644136 N -80.429444 W Ephemeral 
PA04 Cow Pit 41.672083 N -80.513067 W Permanent 
PA06 Tuttle 41.638883 N -80.495116 W Permanent 
PA07 Beaver 41.665167 N -80.514650 W Permanent 
PA09 David's pond 41.621208 N -80.469131 W Permanent 
PA10 Phelps 41.690883 N -80.512467 W Ephemeral 
PA11 Church 41.650494 N -80.423694 W Ephemeral 




At each field site I placed data loggers to record air temperature and humidity (Onset 
HOBO U23-001) in full sun and in shade and water temperature (Onset HOBO UA-002-64, 5 
cm below surface) every hour. A soil temperature logger (Onset HOBO UA-001-64) was also 
buried in a hole next to each pond (5 cm deep) to record every hour.  
At the start of each field survey, a handheld weather meter (Kestrel 3000) was placed 2 
meters above the ground in a tree and allowed to adjust to the air temperature. When it was 
stable, I recorded the air temperature, wind speed, barometric pressure, and humidity. Using a 
calibrated water quality meter (Oakton waterproof double junction pH Meter I-1000), I measured 
water temperature, conductivity, TDS and pH, 5 cm below the surface and 3 m (or as close as 
safely possible) from the water’s edge. To look for amphibians, I waded into the pond and 
walked around the perimeter to look for amphibians. For the fences, I used the same method, but 
I didn’t wade into the pond, I only walked along the fence looking inside the buckets or around 
the fence. When an amphibian was sighted, I used a non-contact infrared thermometer (Dual 
laser IR thermometer, Model EC400L2) to measure surface body temperature and the surface 
temperature of their microhabitat (the site where the frog was located). I then attempted to catch 
the amphibian and if successful, recorded its time of capture. Most of the amphibians were 
caught by hand using a fresh pair of nitrile gloves to reduce pathogen transmission (Phillot et al. 
2010). If nets were used, they were cleaned between sites with F10 SC (a veterinary disinfectant 
that has been shown to kill Bd (Van Rooij et al. 2017). I also disinfected my waders with F10SC 
between ponds. Captured amphibians were placed individually in Ziploc plastic bags for 
processing and handling. Bags were discarded after one use. 
At the end of a sampling night, I weighed, measured, and swabbed each animal that had 
been captured. A dial caliper was used to measure the snout-to-vent length (SVL) as a measure 
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of body size. The tail length was measured separately for salamanders. To record body mass, I 
used a Pesola scale and first recorded the total mass of the frog inside the plastic bag. Then, I 
recorded the mass of the bag alone and subtracted this from the mass of the animal and bag. I 
also recorded the animal’s sex (when possible) and life-stage. To collect skin swab samples for 
Bd diagnostics, I swabbed adult and juvenile amphibians five times on dorsal, ventral, right, and 
left sides, and feet with a sterile swab (Medical Wire MW113). For tadpoles, I swabbed the 
mouthparts only, five times. For salamanders, I swabbed five times on the dorsal and ventral 
surfaces, right and left sides, each foot, and the dorsal and ventral surface of the tail for a total of 
45 strokes. After the swabbing was complete, the swab was placed into a labeled 1.5 mL tube 
and frozen at -20˚C. Once all measures were taken, the animals were released near the location 
where they were collected.  
3.2.2 Surveys at fenced ephemeral ponds 
I conducted surveys at the two fenced ephemeral pond sites (Wood Lab and Sanctuary 
Lake, Table 3-1) from March to August 2019. The hydroperiod of these ephemeral ponds 
depends on localized precipitation and recharge from groundwater. The Sanctuary Lake pond 
usually holds water for eight months of the year and Wood Lab pond for ten months of the year. 
The maximum recorded depth was 80 cm for both sites. I installed the drift fences 1-3 m from 
the edge of the pond to intercept all amphibians moving to and from the pond. I installed the 
fences in the fall preceding the study and left them open until the early spring, just before the 
first amphibians began to emerge from hibernation, to allow animals to go to and from the pond. 
The drift fences were made from 35 cm wide fine aluminum mesh buried 7-10 cm in the ground 
and held in place with wooden stakes every 1.5 m. The fences, when closed, entirely surrounded 
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each pond. I buried 1-gallon buckets as pitfall traps along the inside and outside of each fence to 
capture amphibians moving along the fence. The lids of the buckets each had a 12 x 8 cm hole to 
allow the amphibians to fall in the bucket. In the bottom of each bucket I punched four holes to 
allow water to drain. Into each bucket I also placed a plastic bag liner with two holes in its 
bottom to avoid cross contamination among sampling nights. The liner was replaced with a clean 
one each time an amphibian was found in a bucket. I placed these pitfall traps every 4 m outside 
and every 5 m inside along each fence for a total of 18 buckets inside and 25 buckets outside at 
the Sanctuary Lake pond and 22 buckets inside and 31 buckets outside at the Wood Lab pond. 
The fence total circumference of the fence was 131 m at the Sanctuary Lake site and 156 m at 
the Wood Lab site. 
I sampled at the fenced ephemeral ponds for 40 nights between March 14 and August 8 
of 2019. During each survey, I checked each pitfall trap by removing the bucket lid and 
searching through any organic material that may have accumulated in the trap. All animals 
captured were processed as described below and released approximately 4 m from the trap on the 
opposite side of the fence from where they were collected. I checked pitfall traps, on average, for 
three nights per week, prioritizing rainy nights, between 1900 and 0200 h. On days when the 
pitfall traps were not checked lids without holes were placed on the buckets to prohibit 
amphibians from falling in. During the breeding season and when new metamorphs were 
emerging from the ponds, I checked the pitfall traps one to two times per day. When animals 
were not breeding or metamorphosing, I checked the ponds two or three times a week. Mostly 
when it was raining. 
At the fenced ponds, I only sampled amphibians from along the fences and in the pitfall 
traps. I did not wade into the ponds or use nets to capture animals in the ponds. Each animal was 
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handled using a clean pair of nitrile gloves. I placed each animal individually in a plastic Ziploc 
bag until the entire length of the fence and all pitfall traps had been searched. Then, I recorded 
sex and life stage of each animal, as well as whether it was captured on the outside or inside of 
the fence or in one of the pitfall traps. I also recorded instances where multiple amphibians were 
captured in the same bucket. Animals captured on the outside of the fence were processed before 
the ones that were captured inside the fence (water side). I weighed, measured, and swabbed the 
animals using the methods previously described. Amphibians captured from the fenced ponds 
were then marked by toe-clipping the same single digit on all the adult animals using a nail 
clipper (model 5X-3GPL-MUFZ) that had been sterilized in 100% ethanol prior to each use. The 
toes were clipped and stored individually in 100% ethanol. 
3.2.3 DNA extraction and qPCR protocol 
Bd-DNA was extracted from each swab using the “animal tissue” protocol and the 
Qiagen DNeasy Extraction Kit with a final elution volume of 200 µL. I then ran a qPCR assay 
(Blooi et al. 2013) using a QuantStudio™ 3 Real Time PCR system. I used 25 µL reactions 
containing 12.5 µL of 2x SensiFast probe Lo-Rox Mix, PCR primers at a concentration of 900 
nM, the MGB probe at 240 nM, 400 ng/µL BSA, 3 µL water per well and 5 µL of template DNA 
(diluted 1:10 in DI water). The negative controls had the same master mix but with water added 
instead of a DNA template. The default QuantStudio amplification (V.1.4) software conditions 
(2 min at 50°C and 10 min at 95°C, followed by 40 cycles of 15 s at 95°C and 1 min at 60°C) 
were used (Boyle et al. 2004; Hyatt et al. 2007). Each swab sample was run once and each qPCR 
run contained a positive and negative control, and a series of plasmid dilution standards (Pisces 
Molecular, CO). Samples were run in singlicate and whole-swab Bd load was calculated by 
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multiplying results by 40. I excluded from analysis any wells where the internal positive control 
DNA did not amplify. I also excluded data from any qPCR runs where the negative extraction 
control was positive. 
3.2.4 Isopropanol precipitation of samples containing Bd DNA 
For samples that tested positive for Bd by qPCR, I used an isopropanol precipitation to 
prepare the remaining volume of the 200 µl DNA extraction for genotyping. To each sample I 
added 250 µL low TE, 50µl 3M Sodium Acetate (NaOAc), 2.5µl glycogen. I then added 500 µL 
of isopropanol and inverted the sample 10 times.  I placed the samples at 4°C overnight and then 
spun them at 13,000 g for 10 min, after which I decanted the supernatant without disturbing the 
pellet. I then dislodged the pellet using 500 µL of cold 70% ethanol by inverting the sample a 
couple of times. The samples were then spun for 1 min at 13,000 g to get the pellet to the bottom 
of the tube. The ethanol was then decanted with a pipette, and I let the pellet dry before 
resuspending the pellet in 15 µL of low TE. These samples were stored at 4°C. 
3.2.5 Sequencing and cleaning 
The Bd DNA samples were genotyped from 110 swab samples collected from the two 
ephemeral pond sites that had fences using a custom genotyping assay (see Byrne et al. 2017). 
However only 57 amplified. Briefly, this assay uses the Fluidigm Access Array platform to 
perform microfluidic multiplex PCR on 191 regions of the Bd genome and one diagnostic locus 
for the closely related fungus Batrachochytrium salamandrivorans (Bsal). Each target locus is 
150-200 base pairs long and the targets are distributed across the Bd nuclear and mitochondrial 
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genomes. All samples were pre-amplified in two separate PCR reactions, each containing 96 
primer pairs, at a final concentration of 500nM. For each preamplification PCR reaction the 
FastStart High Fidelity PCR System (Roche) was used at the following concentrations: 1x 
FastStart High Fidelity Reaction Buffer with MgCl2, 4.5mM MgCl2, 5% DMSO, 200 µM PCR 
Grade Nucleotide Mix, 0.1 U/µL FastStart High Fidelity Enzyme Blend. 1 µL of DNA was 
added to each preamplification reaction and used the following thermocycling profile: 95˚C for 
10 min, 15 cycles of 95˚C for 15 sec and 60˚C for 4 min. Pre-amplified products were treated 
with 4 µL of 1:2 diluted ExoSAP-it (Affymetrix Inc.) and incubated for 15 min at 30˚C, then 30 
min at 80˚C. Treated products were diluted 1:5 in PCR-grade water. The diluted products from 
each of the two preamplification reactions were combined in equal proportions and used for 
downstream amplification and sequencing. 
Each preamplified sample was loaded into the Fluidigm Access Array IFC (Fluidigm, 
Inc.) for amplification. All samples were barcoded and amplified, then pooled for sequencing on 
an Illumina MiSeq lane using the 300 bp paired-end kits at the University of Idaho IBEST 
Genomics Resources Core. All sequencing data was pre-processed as described in Byrne et al. 
(2017) and generated consensus sequences for all variants present for each sample at each locus 
using IUPAC ambiguity codes for multiple alleles. Reads were filtered by selecting sequence 
variants that were present in at least five reads and represented at least 5% of the total number of 
reads for that sample/locus using dbcAmplicons (https://github.com/msettles/dbcAmplicons). 
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3.2.6 Statistical analysis 
All statistical analyses were performed using R Studio 2019 (RStudio 2019) and R 
version 1.1.5019 ( R Core team 2019). To do the figures I used ggplot2 Wickham (2009). Tables 
of statistical model outputs can be found in Appendix C (Tables C1-C10). 
To test for differences in Bd infection load across ephemeral and permanent ponds 
sampled between 2017-2019, I built generalized linear mixed models (function ‘lme’) using 
Template Model Builder (package ‘lme4’). The response variable in each analysis was the log-
transformed Bd load [log (Bd DNA copies +1)] detected on each skin swab sample and the fixed 
effects were pond type (ephemeral or permanent), pond pH and amphibian body temperature. 
Frog species and site were included as random effects in each model. I also tested for differences 
in Bd infection (yes/no) among ephemeral and permanent ponds by coding individuals as 
positive/negative for Bd for a given sampling period based on whether (or not) Bd DNA was 
detected on their swab sample using qPCR. For this analysis, I used generalized linear mixed 
models (package ‘lme4’) with a binomial (function ‘glmer’) distribution, the pond type, pond pH 
and amphibian body temperature were the fixed effects. Frog species and site were included as 
random effects in each model. 
For the fenced ponds, to determine whether Bd load was higher in species hibernating in 
permanent ponds relative to those hibernating in soil, I analyzed a subset of data that included 
only amphibians that were captured outside the fences (on their way to the pond). I used a linear 
mixed model (‘nlme’ package, function ‘lme’) with hibernation type (terrestrial vs. permanent 
pond), pond, and their interaction. Species was included as a random effect. To compare Bd 
infection (yes/no) between the two hibernation types, I used a generalized linear mixed model 
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(package ‘lme4’, function ‘glmer’) with a binomial distribution including hibernation type, site, 
and their interaction as fixed effects. Species was included as a random effect.  
To test whether tadpoles metamorphosing in the fenced ephemeral ponds left the pond Bd 
loads similar to other frogs inside the pond I used linear models (nlme package, function ‘lm’) 
with the categories of metamorph vs. all other amphibians present as a fixed effect. I ran the 
linear models for the three species that metamorphosed in these ponds (northern leopard frog 
Rana pipiens, wood frog Rana sylvatica, and spotted salamander Ambystoma maculatum) 
separately. 
I used a gene-tree to species-tree approach to construct a phylogeny to explore the 
relationship of the Bd collected for this study to previously-published Bd samples representing 
all known Bd lineages (N=13, Byrne et al. 2019, Rosenblum et al. 2013). First, I trimmed the 
consensus sequence dataset to eliminate loci that had more than 50% missing data, resulting in 
117 loci. Next, I individually aligned all loci using the MUSCLE package (Edgar 2004) in R 
(v.3.4.3), checked the alignments for errors in Geneious v.10.2.3 (Kearse et al. 2012), and used 
the RAxML plugin in Geneious to search for the best scoring maximum likelihood tree for each 
locus using rapid bootstrapping (100 replicates). I then collapsed all branches in all trees with 
<10 bootstrap support and used Astral III to generate a consensus tree. Astral generates an 
unrooted species tree given a set of unrooted gene trees (Zhang et al. 2018). 
To further explore the genetic variation of Bd sampled from amphibians at the two fenced 
ponds, I used a principal components analysis (PCA). First, I aligned all reads for all samples to 
a reference FASTA with target sequences from Bd isolate JEL423 using bwa mem (Li and 
Durbin, 2009). I then used freebayes to call variants based on haplotypes (Garrison and Marth, 
2012). I called variants using the following flags to ensure high quality: --0 --min-coverage 5. A 
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total of 166 variants were then used to calculate a PCA using the R package adegenet (v.2.1.1) 
(Jombart 2008). I plotted the first two PCs, which together explain 20.3% of the variation in our 
data.  I compared the PCA data between the two ponds, between animals captured inside vs. 
outside the fences, between seasons (spring vs. summer) and between amphibian species. 
3.3 Results 
More than one third (37.5%) of the 4,898 amphibians we swabbed in Pennsylvania tested 
positive by qPCR for the presence of Bd. To test for correlations between the independent 
variables of pond type (ephemeral vs permanent), pond pH, and amphibian body temperature and 
the dependent variable of Bd infection (yes/no) over the three years of sampling I used a 
generalized linear mixed model (GLME).  In this model there were no significant main effects of 
pond type or pH and the interactions between pH and pond type and between body temperature 
and pond type were also non-significant (GLME: t ≤ 0.857, p ≥ 0.392). However, body 
temperature was correlated with Bd infection (GLME: t = -5.497, p < 0.001, Figure 3.1), with the 
probability of infection increasing with body temperature in both permanent and ephemeral 
ponds until ~12 -17 ºC and decreasing with body temperature above that point. I also did not find 
a significant effect of pond type, pond pH or a significant interaction between pH and pond type 
when considering Bd load as the dependent variable (LMM: t ≤ 1.846, p ≥ 0.065). However, Bd 
load was significantly correlated with animal body temperature (LMM: t = -7.404, p < 0.001) and 
the interaction between pond type and body temperature was also significant (LMM: t = -2.820, 
p = 0.005). In permanent ponds, Bd load decreased with increasing body temperature (β = -
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10.018, p = 0.005, Figure 3.2) while in ephemeral ponds and Bd load decreased only very 
slightly as body temperatures increased. 
 
Figure 3.1 Relationship between the proportion of sampled animals that tested positive for Bd (via skin swab) and 
body temperature for amphibians sampled from ephemeral and permanent ponds. 
The lines represent smoothed generalized additive model regressions, and the shaded areas are 95% confidence 
intervals. The size of the dot indicates the number of frogs from each pond type that were captured with a particular 




Figure 3.2  Relationship between amphibian body temperature and Bd infection load in ephemeral and permanent 
ponds. 
The lines represent linear model fit between body temperature and Bd load and the shaded areas are 95% confidence 
intervals. 
 
At the end of winter, when amphibians emerged from hibernation, both Bd infection 
loads and the proportion of infected individuals were lower in ephemeral ponds than in 
permanent ponds (Figure 3-3).  To isolate the cause of these differences, I focused on data from 
the two ephemeral ponds that had been surrounded by drift fences and pitfall traps and asked 




Figure 3.3 Relationship between time in Julian days for frogs collected from ephemeral and permanent ponds. 
and (A) the proportion of animals infected with Bd, and (B) Bd infection load. The lines represent smoothed 
generalized additive model regressions, and the shaded areas are 95% confidence intervals. The size of the dot 
indicates the number of animals sampled in a given survey. 
 
I started sampling in Wood Lab pond, on March 14 of 2019, ten days after the ice 
covering the pond had completely melted. On the first night of sampling, I found Wood frogs 
(Rana Sylvatica), red-backed salamanders (Plethodon cinereus) and spotted salamanders 
(Ambystoma maculatum) along the fence and in the traps. None of the wood frogs or red-backed 
salamanders sampled were infected that night, however two of 21 spotted salamanders were 
infected. Amphibians did not start arriving at Sanctuary Lake pond until April and the first 
species to enter the pond infected with Bd was the Spring peeper (Pseudacris crucifer). On April 
5 of 2019,  three of five P. crucifer captured were infected, as were the single bullfrog (Rana 
catesbeiana) and American toad (Anaxyrus americanus) I captured. 
The leopard frog (Rana pipiens), green frog (Rana clamitans) and bullfrog (Rana 
catesbeiana) are considered permanent pond hibernating species whereas the wood frog (Rana 
sylvatica), the spring peeper (Pseudacris crucifer), the American toad (Anaxyrus americanus), 
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the red-backed salamander (Plethodon cinereus) and the spotted salamander (Ambystoma 
maculatum) usually hibernate in the soil or under logs close to the pond (Neil 1948, Willis et al. 
1956). To test the hypothesis that species which hibernate in permanent ponds bring more Bd 
into ephemeral ponds than the terrestrially hibernating species do, I compared the Bd infection 
load (log10 Bd DNA copies per swab) and the probability that an animal was infected (yes/no) at 
the time when it entered a fenced pond among the hibernation types. The Bd load on infected 
animals was significantly correlated with hibernation type (LMM: t = -2.760, p = 0.028). I did 
not find any significant main effect of pond (Wood Lab pond vs. Sanctuary Lake pond) or a 
significant interaction between hibernation type and pond (LMM: t ≤ 1.334, p ≥ 0.185). 
However, the Bd load on infected animals entering the fenced ephemeral ponds was greater for 
species that hibernate in permanent ponds than for species that hibernate terrestrially (LMM: t = 
-2.760, p = 0.028) (Figure 3.4). For Bd infection (yes/no) there was also a significant effect of 
hibernation type (GLME: t = -6.084, p < 0.001) (Figure 3.5) such that animals that hibernate in 
permanent ponds had a greater probability of entering the fenced ephemeral pond infected. There 
was also a significant main effect of pond (Wood Lab vs. Sanctuary Lake, GLME: t = -3.794, p 
< 0.001) and a significant interaction between hibernation type and pond (GLME: t = 3.848, p < 
0.001). In Wood lab pond, frogs that hibernated in a permanent pond before entering were much 
more likely to be infected than frogs that hibernated in the soil (Figure 3.5). However, in 
Sanctuary Lake pond the proportion of animals entering the pond infected was similar regardless 




Figure 3.4 Box plots showing the relationship between Bd infection load, in log (DNA copies + 1), for animals 
entering the two fenced ponds and the hibernation typefor their species (permanent pond vs. terrestrial). 
Each dot represents one individual. 
 
 
Figure 3.5 Proportion of individuals infected with Bd, upon arrival to (but before entering) the fenced ephemeral 
ponds, by hibernation type. 




The two species that bred and emerged as juveniles from Wood Lab pond were wood 
frogs and spotted salamanders. For the wood frogs, 29 of 131 individuals captured emerging 
from the pond after metamorphosis tested positive for Bd (mean DNA copies per swab = 17,324, 
range = 1 – 330,629). For spotted salamanders, two of 10 metamorphs emerged infected (mean 
DNA copies per swab = 173, range = 125 - 220]. Leopard frogs were the only species that bred 
and emerged as juveniles from Sanctuary Lake pond and 16 of 44 individuals were found to 
infected when leaving the pond (mean DNA copies per swab = 1,871, range = 34 - 15,136).  
For the leopard frogs metamorphosing in the Sanctuary Lake pond, there was no difference in Bd 
infection load between these metamorphs and the rest of the infected amphibians captured 
leaving the pond (LM: t = -0.755, p = 0.458; leopard frog metamorphs mean Bd DNA copies per 
swab =1,871, range = 34 - 15,136; other amphibians mean DNA copies per swab = 20,423, range 
= 1 – 162,112). There was also no difference in the probability of infection between leopard frog 
metamorphs and all other animals leaving that pond (GLME: t = 0.011, p = 0.991; leopard frog 
metamorphs mean proportion infected = 0.531, Clopper Pearson CI = 0.347- 0.709 other 
amphibians mean proportion infected = 0.667, Clopper Pearson CI = 0.348 – 0.901) for 
proportion infected. Similarly, there was also no difference in Bd load between spotted 
salamanders emerging from the Wood Lab pond and all other animals leaving that pond (LM: t = 
1.753, p = 0.097; spotted salamander metamorphs mean Bd DNA copies per swab = 173, range = 
125 - 220; other amphibians mean DNA copies per swab = 921,308, range = 116 - 15,661,890). 
However, the spotted salamander metamorphs had a lower probability of being infected with Bd 
than did other animals leaving that pond (GLME: t = 2.996, p = 0.003, Figure 3.6). The wood 
frogs emerging as metamorphs from the Wood Lab pond had both lower Bd loads (LMM: t = 
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3.852, p < 0.001) (Figure 3.7) and a lower probability of infection (GLME: t = 4.709, p < 0.001) 
than the rest of the animals leaving that pond (Figure 3.8).  
 
 
Figure 3.6 Proportion of individuals infected comparing spotted salamander (Ambystoma maculatum) metamorphs 
to all other animals leaving the Wood Lab pond. 
Error bars represent 95% confidence intervals calculated using the Clopper-Pearson method (Clopper 1934). 
 
 
Figure 3.7 Box plots showing the relationship between Bd infection load, in log (DNA copies + 1), for leopard frog 
(Rana sylvatica) metamorphs and for all other animals captured leaving the Sanctuary Lake. 
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Each dot represents one individual. The middle line corresponds to the median. The lower and upper hinges 
correspond to the first and third quartiles (the 25th and 75th percentiles). The upper whisker extends from the 
hinge to the largest value no further than 1.5 times the inter-quartile range. 
 
 
Figure 3.8 Proportion of individuals infected comparing wood frog (Rana sylvatica) metamorphs to all other 
animals leaving the Sanctuary Lake pond. 
Error bars represent 95% confidence intervals on the proportion calculated using the Clopper-Pearson method 
(Clopper 1934). 
3.3.1 Genetic variation in the fenced ponds 
For the PCA analysis of Bd genetic variation in the two fenced ephemeral ponds, the first 
two principal components (PCs) together explained 21.3% of the total variance in haplotypes. To 
visualize how the genetic variation was distributed, I plotted the first two principal components 
by pond (Figure 3.9), by whether animals were sampled going into or out of the pond (Figure 
3.10), by species (Figure 3.11), or by season spring vs. summer (Figure 3.12).  In all cases there 




Figure 3.9 Scatter plot of PC1 versus PC2 showing variance among Bd haplotypes from the two fenced ponds. 
The shaded ovals represent 95% confidence intervals. 
 
 
Figure 3.10 Scatterplot of PC1 versus PC2 showing variance among Bd haplotypes from animals entering (outside) 
vs. leaving (inside) the fenced ponds. 




Figure 3.11 Scatterplot of PC1 versus PC2 showing variance among Bd haplotypes from different amphibian 
species in the two fenced ponds. 
Anaxyrus americanus (ANAM, or the American toad), Rana catesbeiana (RACA, or the bullfrog), Rana clamitans 
(RACL, or the green frog), Rana pipiens (RAPI, or the northern leopard frog), Rana sylvatica (RASY, or the wood 
frog), Pseudacris crucifer (PSCR, or the spring peeper). The shaded ovals represent 95% confidence intervals. 
 
 
Figure 3.12 Scatterplot of PC1 versus PC2 showing variance among Bd haplotypes from animals collected in the 
spring vs. summer from the fenced ponds. 
The shaded ovals represent 95% confidence intervals. 
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When looking at the phylogeny of Bd genotypes, I can see structure within the samples 
collected from animals in the fenced ponds. Some samples fell within the Bd GPL1 clade and 
others fell within Bd GPL2. Surprisingly, many of the samples seem to have haplotypes that look 
like a mix between both clades (GPL1 and the GPL2). Most of the sampled species were found 
to harbor both GPL1 and GPL2, as well as the “mixed” lineage suggesting the possibility of 
either recombination among lineages or co-infections with multiple lineages of Bd. I did not find 
any phylogenetic structure among samples from the two ponds or among samples from animals 
entering vs. leaving the ponds (Figure 3.13)
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Figure 3.13 Phylogeny of Bd haplotypes inferred from ASTRAL and RAxML analyses. 
The numbers denote ASTRAL local posterior probability values. The names in green represent the samples collected in Wood Lab pond and the names in pink 
denote the samples collected in Sanctuary Lake pond. Shading indicates clade (pink for GPL1, green for GPL2, blue for “mixed”)
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3.4 Discussion 
Amphibians exhibit a diverse range of breeding (Duellman and Trueb 1986; McDiarmid 
and Altig 1999) and hibernating (Neil 1948) strategies that can influence their susceptibility to 
water-borne pathogens as well as their potential to act as reservoir hosts. Species that spend a 
large proportion of their life in or near permanent water may be more affected by waterborne 
pathogens like Batrchochytrium dendrobatidis and more likely to suffer declines because of 
them (Lips, 1998). The presence of various life stages of amphibian hosts in permanent ponds 
year-round may also play an important role in maintaining pathogens in the landscape as infected 
tadpoles and post-metamorphic amphibians that overwinter in ponds can act as pathogen 
reservoirs. For Bd, both amphibian and non-amphibian hosts may play important roles in 
pathogen maintenance in permanent ponds. For example, crayfish (Procambarus spp. and 
Orconectes spp.) can be infected with Bd in the wild and can transmit the fungus to tadpoles 
under laboratory conditions (McMahon et al. 2013, Brannelly et al. 2015). In the laboratory, 
some studies have shown that certain fish could act as reservoirs for Bd as well, with samples 
taken from zebrafish displaying various stages of development, including discharged mature 
zoosporangia (Liew et al. 2017).  However, little is known about the relative importance of 
amphibian and non-amphibian reservoirs for Bd in the wild. In contrast, because the Bd fungus 
has aquatic, flagellated zoospores (Longcore et al. 1999) and cannot survive desiccation 
(Johnson et al. 2003) for it to be present in ephemeral ponds, which dry out each summer to fall, 
it must be brought there anew each spring, most likely by amphibians that make use of those 
ponds for breeding and larval development.  
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3.4.1 Bd prevalence and load in Pennsylvania  
To better understand the factors that influence Bd dynamics across a landscape, I 
surveyed for Bd prevalence and load on amphibians in five ephemeral ponds and five permanent 
ponds near the Pymatuning Lab of Ecology in Northwest Pennsylvania. I detected Bd infections 
on amphibians in all of the sampled ponds no matter the time of the year and across all ponds 
and sampling periods, more than one third of the amphibians sampled were infected with Bd. 
However, none of them showed clear clinical signs of chytridiomycosis, the disease that Bd 
infection can cause, which can include skin sloughing, abnormal posture, lethargy, and loss of 
righting reflex (Nichols et al. 1998; Nichols et al. 2001). This pattern appears typical for the 
United States as, for example, previous field studies have found similar Bd prevalences in Illinois 
(31%; 55 of 180 samples positive), in California (26%; 5 of 19 samples positive), and in Virginia 
(25%; 15 of 60 samples positive) without clinical signs of disease (Lannoo et al. 2011). It has 
been hypothesized that this pattern of high prevalence without disease is a result of Bd having 
been present in this region for over 100 years, giving hosts and pathogens time to evolve ways of 
coexisting (Talley et al. 2015). 
3.4.2 Bd infections in ephemeral vs permanent ponds 
Because they are home to different suites of species, and because ephemeral ponds dry up 
each year, I hypothesized that there were going to be differences in Bd dynamics between 
ephemeral and permanent ponds. Because ephemeral ponds usually dry completely over the 
summer and do not fill up again until the fall (Colburn 2004) it seems unlikely that Bd zoospores 
would be able to survive from year to year in the pond. Instead, I hypothesize that Bd is brought 
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anew to ephemeral ponds each year after they refill. In the northern United States, even in years 
when ephemeral ponds do not dry completely, because they are shallow, they tend to freeze solid 
the winter (Colburn et al. 2008). This also prohibits amphibians from hibernating in ephemeral 
ponds and means that the species that use these ponds for breeding usually hibernate terrestrially 
by burrowing in soil or under logs. In deeper permanent ponds, however, only the top layer of 
the ice freezes completely and the water underneath that layer stays above freezing (Burn, 2005). 
In the northern parts of North America most frogs in the genus Rana, which includes many of the 
large pond-associated frogs, hibernate in the deep water of permanent ponds (Neil, 1948). Bd can 
survive for weeks in the water (Johnson and Speare, 2003), even at temperatures near freezing. 
Therefore, I hypothesized that the risk of maintaining infection over the winter is much higher 
for these species and that hibernating frogs, as well as tadpoles that overwinter in the water of 
permanent ponds may be important reservoirs for Bd.  
I found that in the early spring, just after amphibians in Northwest Pennsylvania emerge 
from hibernation, Bd prevalence (the proportion of amphibians infected) and load are lower in 
ephemeral ponds than in permanent ponds. For the rest of the year, animals sampled from both 
ephemeral and permanent ponds followed a similar pattern of infection.  In both pond types Bd 
prevalence and load peaked in the spring, declined in the summer, then increased again to reach a 
second peak in the fall. I hypothesize that the greater prevalence and load of Bd in permanent 
ponds in the spring results from infected animals shedding zoospores throughout the winter in 
these ponds. The larval stage of amphibians breeding in permanent waterbodies can last up to 
several years (Bury and Adams, 1999) and the keratinized mouthparts of these tadpoles have 
ample opportunity to become infected with the waterborne zoospores of Bd (Woodhams and 
Alford 2005; Narayan et al. 2014). These tadpoles, in addition to post-metamorphic life stages of 
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amphibians that hibernate within these ponds (Russell et al. 2010), are a likely source of shed 
zoospores, which can be transmitted to uninfected individuals (Rachowicz and Vredenburg 
2004) increasing prevalence, or can reinfect the same host increasing Bd loads. I hypothesize that 
the similar pattern of Bd prevalence and load during the rest of the year in permanent vs. 
ephemeral ponds is a product of other abiotic environmental factors. 
I hypothesized that pH and temperature are important abiotic influences on Bd dynamics 
in both permanent and ephemeral ponds in Northwest Pennsylvania. However, the pH of pond 
water was not a significant predictor of Bd infection probability or Bd load in either pond type in 
this study. My pH measurements were similar for both pond types; in permanent ponds, pH 
ranged from 5.61 to 10.3 (mean 7.245) and in ephemeral ponds from 4.41 to 10.44 (mean 7.41). 
Previous in vitro studies have shown that Bd survives from pH 4 to 8 but with an optimum 
between pH 6 and 7 (Piotrowsky et al. 2004). The fact that the pH values I measured span and 
exceed this range but yet I still found no correlation with Bd infections on amphibians inhabiting 
those ponds suggests that when on amphibian hosts, Bd may not be as sensitive to pH as it is in 
vitro. It is also possible that the long history of Bd in ponds of varying pH in the northeastern US 
might have influenced the relationship between pH and growth/survival for the lineages that 
inhabit this region.  
 Temperature, on the other hand, was a significant predictor of Bd infection in both 
ephemeral and permanent ponds. In both pond types Bd load decreased with amphibian body 
temperature, though it did so more markedly in permanent ponds. The weaker correlation with 
temperature in ephemeral ponds may be caused by shallow nature of these ponds, which causes 
temperatures to fluctuate more rapidly (Griffiths 1997). Bd prevalence, on the other hand, was 
lowest at the extremes of amphibian body temperature and reached a peak in the middle of the 
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range of body temperatures I measured. In permanent ponds, Bd infections reached a peak at a 
lower temperature (~12 ºC) than in ephemeral ponds (~ 17 ºC). It is not clear why the 
temperature of peak infection might differ between the two pond types if temperature is the main 
driver of Bd dynamics. Possible explanations might include differences in the thermal 
physiology of distinct Bd lineages in these pond types (see below) or differences in the thermal 
sensitivity of the defenses of hosts that inhabit these two pond types. Previous studies have 
attributed higher Bd prevalence in the spring to the fact that Bd survives well at cool 
temperatures (Piotrowski et al. 2004; Woodhams et al. 2008; Voyles et al. 2012; Martel et al. 
2013) whereas the immune defenses of amphibians tend to be sluggish (Matutte et al. 2000; 
Robak et al. 2019).  
I used drift fences to investigate which species bring Bd into ephemeral ponds each 
spring and to test alternative hypotheses about the source(s) of genetic variation in Bd. I 
hypothesized that permanent pond hibernating species that visit ephemeral ponds in the spring 
might be an important source of Bd zoospores and genetic variation for ephemeral ponds. 
Alternatively, the ephemeral pond breeders, which hibernate terrestrially, may emerge from 
hibernation infected and bring Bd to ephemeral ponds each spring. I found that the spotted 
salamander, Ambystoma maculatum, an ephemeral pond breeding species that hibernates in 
moist upland forest burrows next to ephemeral ponds (Stebbins and Cohen 1995; Petranka 1998), 
was the first species to enter one of my fenced ponds infected with Bd. The American toad, 
Anaxyrus americanus, which breeds in ephemeral ponds and hibernates in burrows one to two 
feet into the ground (Wright and Wright, 1949) and the spring peepers (Pseudacris crucifer), 
another ephemeral pond breeder that hibernates beneath debris on the forest floor (Layne and 
Kefauver, 1997) were the first species to enter the other fenced pond with Bd infections. This 
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suggests that ephemeral pond breeding species, despite hibernating terrestrially, may be an 
important source of Bd zoospores for ephemeral ponds each spring and that transmission from 
permanent to ephemeral ponds is not needed to sustain Bd in ephemeral pond communities over 
the long term. However, both the prevalence and load of Bd on ephemeral pond breeders in the 
early spring was low, suggesting that stochastic variation could be important to the dynamics of 
Bd in ephemeral ponds.  Low prevalence in frogs inhabiting ephemeral waterbodies has been 
seen in other regions as well. For example, in a study that took place along the Nerang River in 
Australia, Bd was detected in only one individual (of the pouched frog Assa darlingtoni) of 117 
that were found at ephemeral ponds, ephemeral streams, or terrestrial sites (Kriger and Hero, 
2007). Little is known about how hibernation affects the course or outcome of Bd infections in 
amphibian hosts. In vitro, Bd grows more slowly, but with longer periods of zoospore activity, at 
temperatures near freezing than it does near its thermal optimum of 23 ºC (Voyles et al. 2012). It 
appears that some of the terrestrial hibernating animals in our study emerged infected, which 
suggests they were able to survive with infection over the long winter, however whether their Bd 
loads increased or decreased during this time remains unknown. It may also be possible for 
species hibernating underground to contract Bd infections while hibernating. Bd has been shown 
to be able to persist in moist sand for extended periods of time (12 weeks, Johnson and Speare 
2005) and soil in which amphibians hibernate might remain moist at deeper levels due to plant 
roots (Van Leeuwen 2010). If so, this could explain how Bd makes it to ephemeral ponds each 
year. It could also be possible that visiting the ponds in fall before they froze (and before the 
fences were closed) left the zoospores in the pond that survived there until spring.   
While they breed, develop, and hibernate in more permanent water, some amphibian species in 
my study area, like bullfrogs, green frogs, and leopard frogs, often spend time in and around 
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ephemeral ponds. I also hypothesized that these species, due to their time spent in permanent 
ponds, may bring more Bd into ephemeral ponds than the terrestrially hibernating species do. 
Kinney et al. (2011) saw this pattern in Indiana where Bd prevalence was greater in amphibians 
living in deeper, cooler, permanent pools than in shallow, warmer, semi-permanent systems. In 
this study, I found that both the probability of infection and the load of Bd on animals entering 
the fenced ephemeral ponds were greater for amphibian species that hibernate in permanent 
ponds than for species that hibernate terrestrially. This supports the idea that species associated 
with permanent ponds, while only transient visitors, play an important role in the dynamics of Bd 
in ephemeral ponds. It also suggests that permanent ponds, and the species associated with them, 
have a large influence on the distribution of this pathogen across the landscape.  
In the summer, before they dry up, ephemeral ponds, too, may be a source of Bd 
movement across the landscape if animals leave these ponds infected. Since new metamorphs are 
often the life stage that is most susceptible to Bd (Sauer et al. 2020), and assuming that the 
likelihood of transmission is high, I hypothesized that the tadpoles that develop in ephemeral 
ponds would emerge from those ponds with similar infection loads and prevalences to other 
amphibian species and life stages present in the ponds. However, the tadpoles that developed in 
the fenced ponds metamorphosed with lower Bd loads than the other species and life stages 
present, and presumably responsible for creating the pool of zoospores in those ponds. Even 
though many studies in the tropics, like in Australia, Brazil, and Peru, have suggested that 
tadpoles are potential reservoirs for Bd (Narayan et al. 2014, Ruggeri et al. 2018, das Neves-da-
Silva et al. 2021, Catenazzi et al. 2013), in the ephemeral ponds I studied, the tadpoles rarely got 
infected with Bd. Across three years of sampling in Northwest Pennsylvania, out of the 590 
tadpoles sampled from six species, I only found eight individuals to be infected with Bd. For 
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comparison, at the Savannah River Site in South Carolina, Bd was identified in 64% of the R. 
catesbeiana tadpoles sampled and no R. sphenocephala tadpoles from this site (n = 50) were 
infected (Peterson et al. 2007).  My swabbing technique might also have missed infections in 
tadpoles, as one previous study found that there is 1 in 2 chance of detecting Bd using oral swabs 
of infected tadpoles (Retallick et al. 2006). 
3.4.3 Genotyping Bd in and out of the ponds  
Genotyping Bd from skin swab samples allowed me to test hypotheses about the 
distribution of Bd lineages across a landscape and over time, something that until recently has 
not been possible. I hypothesized that genetic variation in Bd across the landscape I studied 
would be structured among the two ephemeral ponds since the ponds are too far apart (9 km) to 
expect amphibians to be able to move between them. I also hypothesized that genetic variation 
might be structured among species if there has been coevolution between particular Bd strains or 
lineages and the immune systems of particular amphibian hosts. However, despite finding a 
surprising amount of genetic diversity in Bd across the two ponds, there was a large amount of 
overlap between ponds and among the amphibian species from which the Bd samples were 
taken. I also hypothesized that, given the shifts in environmental conditions and the species and 
life stages of hosts that make use of ephemeral ponds throughout the time they hold water each 
year that we might see differences in the Bd lineages present on hosts entering versus leaving the 
pond and across seasons. For example, if certain strains or lineages were more virulent or 
transmissible than others we might see greater genetic diversity of Bd on animals entering the 
pond in early spring than on those leaving it, often in late summer, who have had time to contract 
new infections from the pond’s zoospore pool. However, there was a large amount of overlap in 
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the Bd genetic variants found on animals entering vs. leaving the ponds and also across the 
spring and summer seasons when the ponds were full.  
In both ponds we found a diversity of genotypes from within the globally invasive 
panzootic lineage (GPL), which has been divided in 2 sublineages (Schloegel et al. 2012). One 
of these, GPL-1, is often thought of as a North American lineage and is proposed to be ancestral 
to GPL-2, which is globally distributed and is the lineage responsible for declines in Central 
America (James et al. 2015). My findings support previous work reporting the presence of two 
sublineages of Bd-GPL in the United States (Schloegel et al. 2012). However, surprisingly, I also 
evidence for a clade with less than 0.7 posterior support that has a genotype that appears to be a 
mix of Bd GPL1 and GPL2. This finding could be explained by a large number of the animals 
we swabbed having been coinfected with Bd strains belonging to both sublineages. Alternatively, 
it could indicate recombination has been occurring among the two sublineages. Lab experiments 
have demonstrated the potential for coinfection. For example, in a coinfection experiment 
between Bd GPL1 and Bd Brazil in the African dwarf frog (Hymenochirus curtipes), Bd GPL1 
was found to have a competitive advantage in spore production over Bd Brazil, especially and on 
frogs that eventually succumbed to Bd infection (Jenkinson et al. 2018).  
Hybrids between clades of Bd have been reported as well. For example, a hybrid lineage 
between Bd Brazil and Bd GPL has been described from Brazil and in some host species, 
infection by this hybrid lineage has been associated with increased mortality (Greenspan et al. 
2018).  
In summary, my results show that all of the sampled host species in Northwest 
Pennsylvania have some prevalence of Bd infection and that the prevalence and severity of these 
infection tends to differ between ephemeral and permanent ponds. The difference is more 
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pronounced in the beginning of the amphibian breeding season in the springtime when hosts that 
hibernate terrestrially and breed in ephemeral ponds are less often, and less heavily, infected. 
This initial difference lessens as the amphibian active season progresses and the dynamics of Bd 
infections for the remainder of this time seem to be largely explained by temperature. While it is 
not common, species that hibernate terrestrially appear to occasionally enter ephemeral ponds to 
breed already infected with Bd. This suggests that movement of infected animals from permanent 
pond reservoirs to ephemeral ponds is not necessary for Bd to reach ephemeral pond 
communities each spring. The permanent pond hibernating species who often visit ephemeral 
ponds, however, often arrive there infected with Bd, and with greater loads than the species that 
use the ephemeral pond for breeding and larval development. Surprisingly, the tadpoles of 
ephemeral pond breeders, which coexist for several months with infected hosts of many species 
and life stages in ephemeral ponds, do not often contract infections themselves suggesting that 
this life stage does not act as an important reservoir for Bd in this region. Whether new 
metamorphs emerge from ephemeral ponds with a similar or lower prevalence and intensity of 
Bd infection to the rest of the host community appears to differ by species, though in no case 
were metamorphs found to be more infected than the rest of the host community. And finally, I 
found a wealth of genetic variation but little evidence of structure in Bd on hosts from two 
ephemeral ponds, including both the GPL1 and GPL2 sublineages and a third sublineage that 
appears to be a mix of both. Further study is needed to better understand what this mixed lineage 
represents. The combination of field and molecular techniques implemented in this study, 
including drift fences to monitor host movement and genotyping of pathogen samples from non-
invasive skin swabs, has enabled a new and more detailed window into biotic and abiotic factors 
that shape the dynamics of this host-pathogen interaction across a landscape. 
169 
4.0 Conclusion 
Effects of environmental variation on immunity, and the ability of hosts to regulate 
immune activity in the context of other physiological demands, may play important roles in 
shaping disease risk for wildlife. Because they are threatened globally by the fungal pathogen 
Batrachochytrium dendrobatidis (Bd), amphibians are an ideal taxon in which to study the 
effects of climate change on susceptibility to emerging infectious diseases. In North America, 
many amphibians develop and undergo metamorphosis in ephemeral ponds that are sporadically 
filled with rainwater and then desiccate at differing rates each year. Global climate change is 
predicted to alter temperature, precipitation, and humidity patterns, which will ultimately alter 
the conditions amphibians experience in these ephemeral ponds. Prior research has shown that 
decreases in water level and increases in pond temperature, as are predicted to occur more 
frequently under global climate change, are two of a handful of environmental stressors that can 
cause amphibians to accelerate larval development and metamorphosis. This can allow 
amphibians to metamorphose and escape harsh aquatic conditions faster, but little is known 
about how environmental stress experienced during larval development impacts the immune 
system later in life. Given the threat posed by chytridiomycosis (the disease caused by Bd) and 
other emerging infectious diseases, impacts on immunity may be an important yet often 
overlooked consequence of global climate change for amphibians. In this dissertation, I used 
experiments to investigate how pond drying and an increase in pond temperature impact not only 
the timing of metamorphosis, but also the development of immune defenses in North American 
leopard frog species. To better understand the dynamics and spread of Bd, I also conducted a 
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field study comparing infection among amphibian communities that inhabit permanent vs. 
ephemeral ponds. 
In my experiments, accelerated pond drying and elevated pond temperatures, which are 
predicted to happen more frequently under global climate change, had direct effects on the 
survival, time to metamorphosis, size, and immune function of leopard frogs. In general, even 
when they did not exhibit developmental plasticity (i.e., did not speed development in response 
to the stressor), frogs that developed as larvae in the more stressful environments (fast drying and 
elevated temperature) had lower survival to, and size at, metamorphosis. Previous work has 
shown that small size at metamorphosis can have long‐term negative consequences for frogs. For 
example, juvenile size is often positively correlated with adult survival (Berven 1990, Cabrera‐
Guzmán et al. 2013). Larger juveniles often grow to be larger adults, and smaller juveniles can 
take longer to reach sexual maturity (Berven, 1990), all of which suggests that developing in 
ponds affected by climate change may have impacts on fitness throughout an amphibian’s 
lifetime. 
In my study, individuals that developed in a faster-drying pond were not only smaller at 
metamorphosis, but they also often exhibited more rapid growth during their first months after 
metamorphosis. While I did find some direct effects of drying, I also saw indirect effects of size 
at metamorphosis, and the fast rate of post-metamorphic “catch up” growth these small frogs 
exhibited, on immune defenses and susceptibility to Bd. For example, the probability of a Bd-
exposed frog becoming infected increased with a faster growth rate after metamorphosis and 
frogs that were larger at metamorphosis had skin mucus that was better able to inhibit the growth 
of Bd. The Bd-exposed frogs that experienced fast drying during development also expressed 
fewer antimicrobial peptides (AMPs, an important part of the innate immune defense against Bd) 
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and exhibited the lowest survival of all treatment groups when exposed to Bd. In summary, 
experiencing the stress of rapid pond drying during development appears to have negatively 
impacted the fitness of leopard frogs and their ability to fight infection later in life. Similar 
studies in other species are needed to determine how generalizable these findings are. However, 
the results of this study do suggest that management actions aimed at preventing the early drying 
of ephemeral ponds may produce benefits for the health and survival of at-risk amphibian 
populations. 
When I exposed leopard frog tadpoles (two populations from each of two species) to 
elevated temperatures, simulating the warming of ponds under a moderate climate change 
scenario, I also saw both direct and indirect effects of this stressor on immune defenses and 
susceptibility to Bd. However, each population’s immune system seemed to have responded to 
the temperature difference in a different way. The direct effects of increased temperature I 
observed most often included faster metamorphosis, smaller size at metamorphosis, lower innate 
immune function and higher adaptive immune function. My study was the first, to my 
knowledge, to investigate the effects of small (2 - 3ºC, as predicted under climate change) on 
amphibian immune function, and also the first to include multiple populations and species, 
making comparisons with past studies is difficult. However, this pattern, where various parts of 
the immune system differ in their directionality of change in response to shifts in temperature, 
has been seen in other studies. For example, during periods of low temperature (e.g., 
hibernation), amphibians often decrease the production of AMPs (Matutte et al. 2000), T and B-
lymphocytes (Maniero and Carey, 1997), and antibodies (Cooper at al. 1992). However, some 
aspects of immune activity appear to be robust to shifts in temperature, including phagocytic 
activity, respiratory burst (Hardie et al. 1994), and the number of circulating neutrophils (Raffel 
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et al. 2013). One take away from this experiment, since the innate and adaptive branches of the 
immune system seemed to respond differently to changes in temperature, is the importance of 
taking into account both the aspects of immunity when studying the impacts of climate change. 
My finding that responses to small temperature shifts differed among species, and even among 
populations within species, was unexpected but suggests that the effects of climate change on 
complex traits like immune function may themselves be very complex, and likely hard to predict. 
The indirect effects of increased temperature in my pond warming experiment, as with 
the pond drying experiment, often acted through effects on larval period, size at metamorphosis, 
and growth rate after metamorphosis. The most consistent patterns I saw were for immune 
parameters to be higher in frogs that had longer larval periods, were larger at metamorphosis, 
and grew more slowly after metamorphosis, though instances of other relationships were also 
seen. Interestingly, after exposure to the Bd pathogen, there was no difference in the probability 
of infection or in Bd load among temperature treatments. However, frogs reared in warmer water 
exhibited more mortality after Bd exposure. These frogs were dying at Bd loads where frogs 
reared in current temperature conditions were not, which suggests that climate change may 
impact how tolerant hosts are to infection. My finding that small increases in temperature can 
affect immune function and disease susceptibility in amphibians seems like an important one, 
though additional research that considers the impacts of climate-change relevant shifts in 
temperature on the immune system and disease susceptibility is needed to determine whether 
there are predictable patterns across populations and species. Unlike for pond drying, the most 
obvious management response, regulating pond temperatures in the face of rising air 
temperatures, unfortunately seems like a difficult prospect.  
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My field sampling, conducted over four years at the Pymatuning Lab of Ecology, showed 
that amphibians in this region often have a high prevalence of Bd but usually have low to 
intermediate infection loads. I did not detect Batrachochytrium salamandrivorans (Bsal) or 
observe clinical signs of chytridiomycosis in any of the amphibians sampled for this study. Non-
detection of Bsal is good news, as the arrival of this pathogen could threaten the future of 
amphibian (and in particular salamander) diversity in North America. Not finding signs of 
disease is also good news, as it suggests that amphibians in this region are largely able to coexist, 
despite infection, with the now endemic Bd pathogen.  
The proportion of individuals infected with Bd at my study sites increased with body 
temperature until ~16°C and decreased with increasing temperature after that. Interestingly, the 
proportion of individuals infected and pathogen load was lower in ephemeral pond associated 
amphibian species than in permanent pond associated species. This finding motivated me to ask 
which species bring Bd into to ephemeral ponds; specifically, what is the first species that brings 
the infection to the pond and where does it hibernate? Since Bd cannot tolerate desiccation I 
assumed that it must need to be brought to ephemeral ponds anew once they fill each spring and I 
predicted that species that hibernate in permanent ponds (where they can sustain infections more 
easily) might be the ones to bring it there. Interestingly, the a few individuals of the ephemeral 
pond breeding species that hibernate on land emerge infected with Bd and were the first to bring 
the pathogen to ephemeral ponds. When I compared the Bd genotypes on animals entering and 
leaving the ponds I found little evidence of genetic structure among ponds, among species, or 
among animals entering in spring vs. leaving in fall. However, I did find a surprisingly large 
amount of genetic variation in the Bd infecting amphibians at my field sites, including genotypes 
belonging to both sublineages of the global pandemic lineage of Bd (Bd-GPL1 and Bd-GPL2 ) 
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and genotypes that appeared to be a mix of both lineages that I hypothesize was due to 
coinfection of individual hosts with genotypes of Bd from both subclades. Overall, the lack of 
structure in the large amount of genetic variation I found suggest that Bd has likely been 
coexisting with amphibian hosts in Northwest Pennsylvania for some time and that strains are 
easily moved from one place to another. Future studies comparing virulence among genotypes, 
especially those including the mixed lineage, will be important to provide a management context 
to this finding of high pathogen genetic diversity.  
In this dissertation, I focused on how two aspects of climate change, pond drying and 
pond warming, will affect the future of interactions between amphibians and their pathogens. 
However, amphibians are just one of many taxa threatened by the intersection of climate change 
and disease and my hope is that my findings and approach may be useful to inform studies on 
other taxa as well. As the climate changes, wildlife pathogens are emerging with increasing 
frequency and having increasingly dire consequences for biodiversity (Cunningham et al. 2017). 
Fungal pathogens, for example white nose syndrome in bats (Foley et al. 2011) and colony 
collapse disorder in bees (Bromenshenk et al. 2010), are especially sensitive to temperature have 
been important drivers of recent wildlife declines and extinctions (Casadevall 2005, Fisher et al. 
2012).  By applying the experimental techniques used here with Bd in amphibians to interactions 
between other hosts and pathogens we could learn more about how these other disease systems 
may be impacted by climate change. Furthermore, the application of non-invasive pathogen 
genotyping, as I did in my field study, to other disease systems could help to shed light on how 
other emerging fungal diseases spread across a landscape to colonize new habitats and host 
species. Using these techniques to resolve the links between climate and the outcomes of 
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host/fungal interactions will provide direction for effective management of threatened 
populations. 
In this study I specifically considered the impacts of climate change on immune 
development and disease susceptibility in two semi-aquatic amphibian species, the northern and 
the southern leopard frogs (Rana pipiens and R. clamitans, respectively). I chose these species 
because the immunological resources had already been developed. However, going forward, it 
would be beneficial to include amphibian species with a greater diversity of ecologies (e.g., more 
aquatic and more terrestrial species) and with a greater taxonomic diversity (e.g., toads and 
salamanders) in studies of this nature as it is unclear whether the patterns, I observed in leopard 
frogs would be found across these species as well. 
My experiments focused on climate as an early life stressor, and therefore after 
metamorphosis animals from all treatments were held under the same climate conditions. This, 
however, is unrealistic to what amphibians would experience as the climate warms in nature. For 
this reason, I would suggest that future studies consider continuing to observe the effects of 
climate stress experienced after metamorphosis on immune function and disease susceptibility. 
These results would yield a more accurate prediction of the effects of climate change pre- and 
post-metamorphosis. However, a tradeoff with this approach is that it would not allow the 
researcher to for carry-over and indirect effects of Bd exposure and climate from direct effects 
experienced during later life stages. Another approach could be to test for direct and indirect 
effects of temperature on the immune system and disease susceptibility by applying climate 
stress only during the post-metamorphic life stages. These results could be completely different 
from what we observed by applying the stressors during the larval stage. Though it is clear that 
the moderate climate change scenarios I considered had some significant impacts on amphibian 
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immunity and susceptibility to Bd, future studies might also consider using a more accelerated 
climate change scenario (generating a larger magnitude of climate stress) as this may result in 
effect sizes that are more amenable to detection using laboratory-scale experiments.  
To follow up on the findings from my field study, it would be very interesting to use a 
similar approach but, in a location where Bd diversity is much lower. For example, in sites like 
the one where my Tennessee leopard frogs came from, where only one of the Bd GPL lineages 
seems to be present, it would be easier to estimate when particular Bd haplotypes enter the pond 
and what host species brings it. At my study site, the North American bullfrog, Rana 
catesbeiana, only appeared to carry Bd GPL-1, despite Bd GPL-2 being present at the same time 
in the ponds where bullfrogs coexist with other species. Using studies like this we can begin to 
understand the properties of host species that may inhibit colonization by particular Bd lineages, 
like Bd GPL-2. To follow up on my finding that some species that hibernate in soil burrows or 
under logs emerge infected with Bd after hibernation, it would be exciting to sample amphibians 
for Bd during hibernation to track changes in infection over time. This could be logistically 
challenging but very informative as little is known about how Bd infections proceed during 
hibernation.  
In conclusion, my dissertation research demonstrated that larval development under 
stressful climate conditions, including pond drying and elevated temperatures, often has a cost in 
terms of reduced fitness of amphibians up to and shortly after metamorphosis. However, I also 
documented negative impacts of climate stressors experienced during the larval stage on 
different aspects of the innate and adaptive immune system, as well as on disease susceptibility, 
several months after metamorphosis. While my field studies suggest that amphibians are 
currently coexisting with the Bd pathogen in Northwest Pennsylvania, my experiments suggest 
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that this may change as the climate puts more stress on amphibian host populations. My research 
suggests that as ponds dry faster and reach warmer temperatures, effects of these changes on the 
ability of hosts to develop their immune defenses could result more mortality and a greater risk 
of disease-related declines. More work on other amphibian hosts, and across a broader range of 
wildlife disease systems, is needed to determine how the interaction between climate change and 
disease may impact biodiversity more generally. 
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Appendix A  
Table A.1 Output from a linear mixed-effect model examining the variation in larval period across drying 
treatments. 
 Dependent variable: 
 log (Larval Period) 
Drying Treatment χ2 = 0.650  p = 0.722 
Moderate Drying 0.009 (-0.018, 0.036) 
 t = 0.630 
 p = 0.537 
No Drying 0.010 (-0.017, 0.037) 
 t = 0.749 
 p = 0.464 
Constant 1.921*** (1.902, 1.941) 
 t = 196.985 
 p < 0.001 
Observations 645 
Log Likelihood 779.129 
Akaike Information Criterion -1548.258 
Bayesian Information Criterion -1525.935 
Note: *p < 0.05; **p < 0.01; ***p < 0.001 
Coefficient estimates and standard errors (in parentheses) are shown for each factor. Mesocosm number was 
included as a random effect. 
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Table A.2 Output from a generalized linear model (quasi-binomial link) examining the number of animals that 
survived through metamorphosis versus the number of animals that did not per mesocosm as a concatenated 
variable. 
 Dependent variable: 
 log (Survival to Metamorphosis) 
Drying Treatment χ2 = 0.388  p = 0.824 
Moderate Drying -0.095 (-0.403, 0.213) 
 t = -0.606 
 p = 0.552 
No Drying -0.028 (-0.338, 0.281) 
 t = -0.180 
 p = 0.859 
Constant 1.570*** (1.349, 1.791) 
 t = 13.928 
 p < 0.0001 
Observations 21 
Residual Deviance 8.920 (df = 18) 
Null Deviance 9.112 (df = 20) 
Note: *p < 0.05; **p < 0.01; ***p < 0.001 
Coefficient estimates and standard errors (in parentheses) are shown for each factor. 
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Table A.3 Output from a Cox proportional hazards model examining survival across the three drying treatments 
from metamorphosis to 42 d post-metamorphosis, clustered by mesocosm. 
 Dependent variable: 
 Survival (0 to 42 d Post-metamorphosis) 
Drying Treatment χ2 = 6.042  p = 0.049 
Moderate Drying -0.107 (0.289) 
 z = -0.407 
 p = 0.685 
No Drying -0.803* (0.399) 
 z = -2.379 
 p = 0.018 
Body size (SVL) χ2 = 5.856  p = 0.016 
 -0.247* (0.090) 
Observations 611 
R2 0.029 
Maximum Possible R2 0.695 
Log Likelihood -354.070 
Wald Test 13.680** (df = 3) (p = 0.004) 
Likelihood Ratio Test 17.788*** (df = 3) (p = 0.0005) 
Log Rank Test 15.780** (df = 3) (p = 0.002) 
Note: *p < 0.05; **p < 0.01; ***p < 0.001 
SVL (mm) was included as a covariate. Coefficient estimates and their standard errors (in parentheses) are shown 
for each factor. 
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Table A.4 Output from a linear model examining body mass at metamorphosis across the three drying treatments, 
clustered by mesocosm. 
 Dependent variable: 
 log (Body Mass) 
Drying Treatment χ2 = 1.571  p = 0.455 
Moderate Drying 0.018 (-0.090, 0.125) 
 t = 0.325 
 p = 0.749 
No Drying -0.048 (-0.150, 0.055) 
 t = -0.913 
 p = 0.373 
Time to metamorphosis χ2 = 22.886  p < 0.001 
 0.002*** (0.001, 0.002) 
Drying Treatment : Time to metamorphosis χ2 = 10.774  p = 0.005 
Moderate Drying : Time to metamorphosis -0.0003 (-0.001, 0.001) 
 t = -0.652 
 p = 0.515 
No Drying : Time to metamorphosis 0.001* (0.0003, 0.002) 
 t = 2.532 
 p = 0.012 
Constant -0.284*** (-0.356, -0.212) 
 t = -7.731 
 p < 0.001 
Observations 644 
Log Likelihood 716.465 
Akaike Information Criterion -1416.930 
Bayesian Information Criterion -1381.263 
Note: *p < 0.05; **p < 0.01; ***p < 0.001 
Coefficient estimates and their standard errors (in parentheses) are shown for each factor. 
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Table A.5 Output from a linear model examining body length (SVL) at metamorphosis across the three drying 
treatments, clustered by mesocosm. 
 Dependent variable: 
 log (Body Length) 
Drying Treatment χ2 = 5.477  p = 0.064 
Moderate Drying -0.015 (-0.054, 0.024) 
 t = -0.763 
 p = 0.455 
No Drying -0.043* (-0.079, -0.006) 
 t = -2.302 
 p = 0.034 
Larval Period χ2 = 2.5016  p = 0.116 
 0.0002 (-0.0001, 0.0005) 
Drying Treatment : Larval Period χ2 = 15.163  p=  0.001 
Moderate Drying: Larval Period 0.0001 (-0.0003, 0.0005) 
 t = 0.406 
 p = 0.685 
No Drying : Larval Period 0.001*** (0.0003, 0.001) 
 t = 3.594 
 p < 0.001 
Constant 1.320*** (1.294, 1.346) 
 t = 100.584 
 p < 0.001 
Observations 643 
Log Likelihood 1351.914 
Akaike Information Criterion -2687.829 
Bayesian Information Criterion -2652.100 
Note: *p < 0.05; **p < 0.01; ***p < 0.001 
Coefficient estimates and their standard errors (in parentheses) are shown for each factor.  
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Table A.6 Generalized linear mixed model with a binomial distribution of the probability of Bd infection across the 
three drying treatments. 
 Dependent variable: 
 Bd Infection (yes/no) 
Drying Treatment χ2 = 4.708  p = 0.095 
Fast Drying -0.416 (-0.897, 0.065) 
 t = -1.695 
 p = 0.090 
Moderate Drying 0.078 (-0.383, 0.540) 
 t = 0.333 
 p = 0.739 
Days Post-exposure -0.266 (-0.559, 0.026) 
 χ2 = 3.195  p = 0.074 
Mass at Metamorphosis (g) -0.109 (-0.468, 0.250) 
 χ2 = 0.355  p = 0.552 
Growth Rate (g/day) 0.301* (0.013, 0.589) 
 χ2=4.191  p = 0.041 
Drying Treatment : Days Post-exposure χ2 = 7.889  p = 0.019 
Fast Drying : Days Post-exposure 0.189 (-0.248, 0.626) 
 t = 0.848 
 p = 0.396 
Moderate Drying : Days Post-exposure 0.589** (0.171, 1.008) 
 t = 2.763 
 p = 0.006 
Drying Treatment : Mass at Metamorphosis χ2 = 4.807  p = 0.090 
Fast Drying : Mass at Metamorphosis 0.490* (0.023, 0.958) 
 t = 2.055 
 p = 0.040 
Moderate Drying : Mass at Metamorphosis 0.473 (-0.067, 1.013) 
 t = 1.717 
 p = 0.086 
Drying Treatment: Growth  Rate χ2 = 0.657  p = 0.720 
Fast Drying : Growth Rate 0.049 (-0.431, 0.528) 
 t = 0.198 
 p = 0.843 
Moderate Drying : Growth Rate -0.150 (-0.602, 0.302) 
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 t = -0.651 
 p = 0.515 
Constant -0.416* (-0.749, -0.083) 
 t = -2.450 
 p = 0.015 
Observations 593 
Log Likelihood -374.910 
Akaike Information Criterion 775.821 
Bayesian Information Criterion 832.829 
Note: *p < 0.05; **p < 0.01; ***p < 0.001 
 
 
Days post exposure, mass at metamorphosis and post-metamorphic growth rate were independent factors and frog 
ID was included as a random effect. Coefficient estimates and their standard errors (in parentheses) are shown for 
each factor.  
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Table A.7 Linear mixed model of Bd infection load with drying treatment. 
 Dependent variable: 
 Bd load [log (DNA copies + 1)] 
Drying Treatment χ2 = 1.465  p = 0.481 
Fast Drying 0.159 (-0.158, 0.475) 
 t = 0.983 
 p = 0.339 
Moderate Drying 0.182 (-0.131, 0.495) 
 t = 1.138 
 p = 0.270 
Days Post-exposure χ2 = 4.771  p = 0.031 
 -0.264* (-0.501, -0.027) 
Pre-exposure Body Mass (g) χ2 = 9.870  p = 0.002 
 -0.242** (-0.393, -0.091) 
Growth Rate (g/day) χ2 = 1.512  p = 0.223 
 0.078 (-0.047, 0.203) 
Drying Treatment : Days Post-exposure χ2 = 6.949  p = 0.031 
Fast Drying : Days post-exposure -0.083 (-0.413, 0.247) 
 t = -0.492 
 p = 0.624 
Moderate Drying : Days Post-exposure 0.284 (-0.014, 0.583) 
 t = 1.867 
 p = 0.064 
Constant 3.008*** (2.769, 3.247) 
 t = 24.660 
 p < 0.001 
Observations 212 
Log Likelihood -284.070 
Akaike Information Criterion 590.140 
Bayesian Information Criterion 626.640 
Note: *p < 0.05; **p < 0.01; ***p < 0.001 
Days post exposure, mass at metamorphosis and post-metamorphic growth rate as fixed effects and frog ID nested 
within mesocosm as random effects. Coefficient estimates and their standard errors (in parentheses) are shown for 
each factor.  
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Table A.8 Linear mixed model of body condition [measured as log (scaled mass index), or log SMI)]. 
 Dependent variable: 
 Body Condition (log SMI) 
Exposure Group (Sham vs. Bd-exposed) χ2 = 3.126  p = 0.077 
 0.016 (-0.002, 0.034) 
Drying Treatment χ2 = 4.085  p = 0.130 
Moderate Drying -0.015 (-0.033, 0.002) 
 t = -1.684 
 p = 0.110 
No Drying -0.017 (-0.034, 0.001) 
 t = -1.817 
 p = 0.086 
Days Post-exposure χ2 = 8.763  p = 0.003 
 0.0003** (0.0001, 0.0005) 
Exposure Group : Drying Treatment χ2 = 0.447  p = 0.800 
Bd Exposed : Moderate Drying 0.008 (-0.017, 0.033) 
 t = 0.643 
 p = 0.521 
Bd Exposed : No Drying 0.006 (-0.019, 0.031) 
 t = 0.483 
 p = 0.630 
Exposure Group : Days Post-exposure χ2 = 37.562  p < 0.001 
Drying treatment : Days Post-exposure χ2 = 0.021  p = 0.989 
Moderate Drying : Days Post-exposure 0.00002 (-0.0002, 0.0003) 
 t = 0.120 
 p = 0.905 
No Drying : Days Post-exposure 0.00002 (-0.0002, 0.0003) 
 t = 0.134 
 p = 0.894 
Exposure Group : Drying Treatment : Days Post-exposure χ2 = 0.410   p =  0.814 
Bd Exposed : Moderate Drying : Days Post-exposure 0.0001 (-0.0003, 0.0005) 
 t = 0.556 
 p = 0.579 
Bd Exposed : No Drying : Days Post-exposure 0.0001 (-0.0003, 0.0005) 
 t = 0.556 
 p = 0.579 
Constant 0.208*** (0.195, 0.221) 
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 t = 32.056 
 p = 0.000 
Observations 1758 
Log Likelihood 2462.216 
Akaike Information Criterion -4894.432 
Bayesian Information Criterion -4812.353 
Note: *p < 0.05; **p < 0.01; ***p < 0.001 
Exposure group, drying treatment, and days post-exposure as the main and interacting effects and frog ID nested 
within mesocosm as random effects. Coefficient estimates and their standard errors (in parentheses) are shown for 
each factor.  
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Table A.9 Output from a Cox proportional hazards model examining survival after Bd exposure. 
 Dependent variable: 
 Survival Post-Bd exposure 
Drying Treatment : Exposure Group χ2 =11.061   p = 0.050 
Fast Drying : Sham Exposed 0.515 (-1.293, 2.322) 
 z = 0.576 
 p = 0.565 
Moderate Drying : Sham Exposed 0.676 (-1.022, 2.373) 
 z = 1.000 
 p = 0.317 
Fast Drying : Bd Exposed 1.803* (0.265, 3.341) 
 z = 2.475 
 p = 0.013 
Moderate Drying : Bd Exposed 1.572* (0.025, 3.120) 
 z = 2.061 
 p = 0.040 
No Drying : Bd Exposed 1.281 (-0.307, 2.869) 
 z = 1.650 
 p = 0.100 
Larval Period (d) 0.005 (-0.009, 0.019) 
 z = 0.971 
 p = 0.332 
 χ2 = 0.942 
Observations 231 
R2 0.048 
Maximum Possible R2 0.803 
Log Likelihood -182.062 
Wald Test 11.770 (df = 6) (p = 0.068) 
Likelihood Ratio Test 11.366 (df = 6) (p = 0.078) 
Log Rank Test 11.153 (df = 6) (p = 0.084) 
Note: *p < 0.05; **p < 0.01; ***p < 0.001 
Larval period and the interaction between drying treatment and exposure group were the fixed effects and mesocosm 




Table A.10 Output from a linear model examining total mucosal peptides after Bd exposure across exposure groups 
and drying treatments. 
 Dependent variable: 
 Total mucosal peptides 
(peptides/ml/gbw) 
Drying Treatment F = 2.225  p = 0.118 
Moderate Drying 0.320 (-50.562, 51.201) 
 t = 0.012 
 p = 0.991 
No Drying 47.589 (-3.292, 98.471) 
 t = 1.833 
 p = 0.073 
Exposure Group F = 0.691  p = 0.410 
 24.466 (-33.228, 82.161) 
Drying Treatment : Exposure Group F = 1.721, p = 0.189 
Moderate Drying : Bd Exposed -55.664 (-133.427, 22.099) 
 t = -1.403 
 p = 0.167 
No Drying: Bd Exposed -72.507 (-152.526, 7.512) 
 t = -1.776 
 p = 0.082 
Constant 108.597*** (72.619, 144.576) 
 t = 5.916 
 p < 0.001 
Observations 58 
R2 0.158 
Adjusted R2 0.077 
Residual Standard Error 60.883 (df = 52) 
F Statistic 1.946 (df = 5; 52) (p = 0.103) 
Note: *p < 0.05; **p < 0.01; ***p < 0.001 
Coefficient estimates and their standard errors (in parentheses) are shown for each factor. 
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Table A.11 Output from a linear model examining Bd inhibition by peptides after Bd exposure across the three 
drying treatments and two exposure groups. 
 Dependent variable: 
 Bd Growth Index 
Drying Treatment F = 0.258, p = 0.773 
Moderate Drying 0.112 (-0.291, 0.514) 
 t = 0.545 
 p = 0.589 
No Drying -0.071 (-0.460, 0.318) 
 t = -0.360 
 p = 0.721 
Exposure group F = 0.258,  p = 0.721 
Drying treatment : Exposure Group F = 0.046,  p = 0.830 
Moderate Drying : Bd Exposed -0.046 (-0.608, 0.516) 
 t = -0.161 
 p = 0.874 
No Drying: Bd Exposed -0.144 (-0.696, 0.408) 
 t = -0.511 
 p = 0.613 
Constant 1.079*** (0.804, 1.354) 
 t = 7.689 
 p < 0.001 
Observations 48 
R2 0.072 
Adjusted R2 -0.039 
Residual Standard Error 0.397 (df = 42) 
F Statistic 0.649 (df = 5; 42) (p = 0.664) 
Note: *p < 0.05; **p < 0.01; ***p < 0.001 




Table A.12 General linear model for presence/absence of AMPs after Bd exposure across the three drying 
treatments. 
 Dependent variable: 
 count of AMPs detected 
Exposure Group (Sham vs. Bd-exposed) χ2 = 6.3256  p = 0.021 
 -0.815* (-1.484, -0.145) 
Drying Treatment χ2 = 2.9324   p = 0.2308 
Moderate Drying -0.473 (-1.030, 0.084) 
 t = -1.664 
 p = 0.102 
No Drying -0.140 (-0.646, 0.366) 
 t = -0.541 
 p = 0.591 
Drying Treatment * Exposure Group χ2 = 1.4962,    p = 0.4733 
Moderate Drying : Bd Exposed 0.144 (-0.880, 1.169) 
 t = 0.276 
 p = 0.784 
No Drying : Bd Exposed 0.529 (-0.357, 1.415) 
 t = 1.170 
 p = 0.247 
Constant 1.836*** (1.491, 2.181) 
 t = 10.426 
 p < 0.001 
Observations 62 
Residual Deviance 152.785 (df = 56) 
Null Deviance 185.784 (df = 61) 
Note: *p < 0.05; **p < 0.01; ***p < 0.001 








Table A.13 Output of a PERMANOVA for AMP presence/absence after Bd exposure. 
 Df Sum of 
squares 
R2 F p 
Exposure Group (Sham vs. Bd Exposed) 1 1.0035 0.22831 14.087 < 0.001 
Drying Treatment 2 0.1385 0.03151 0.972 0.426 
Exposure Group : Drying Treatment 2 0.190 0.0432 1.335 0.257 
Residuals 43 3.0631    




Table A.14 Output of a PERMANOVA for AMP relative intensities after Bd exposure 
 
 Df Sum of 
Squares 
R2 F p 
Exposure Group (Sham vs. Bd-exposed) 1 1.037 0.134 7.160 0.0005 
Drying Treatment 2 0.205 0.026 0.709 0.629 
Exposure Group : Drying Treatment 2 0.294 0.038 1.016 0.399 
Residual 43 6.225 0.802   
Total 48          7.7611            1 
 
Table A.15 Output of an ANOVA for Shannon diversity index comparing the AMP relative intensities between 
exposed and control frogs in the three drying treatments. 
 
 Df Sum of 
Squares 
R2 F p 
Exposure Group (Sham vs. Bd-exposed) 1 1.534 1.534 14.935 0.0004 
Drying Treatment 2 0.021 0.026 0.102 0.903 
Exposure Group : Drying Treatment 2 0.387 0.194 1.886 0.164 
Residual 43 4.416 0.103   
  
 
Table A.16 Similarity percentage (simper) analysis results based on the decomposition of the Bray-Curtis 
dissimilarity index based on presence/absence of AMPs. 
AMP Brevinin 1 Pa Brevinin 1 Pb Brevinin 1 Pc Brevinin 1 Pd Brevinin 1 Pe Brevinin 1 Pla 
Simper 
Index 
0.1471043 0.7325010 0.6763092 0.2927123 0.4293444 0.5549669 
Values show the contribution of individual peptides to the overall Bray-Curtis dissimilarity.  
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Table A.17 Similarity percentage (simper) analysis results based on the decomposition of the Bray-Curtis 
dissimilarity index based on AMP relative intensities. 
AMP Brevinin 1 Pg Brevinin 1 Pk Brevinin 1 Pe 
Simper Index 0.3200824 0.6118018 0.7864296 
Values show the contribution of individual peptides to the overall Bray-Curtis dissimilarity. 
 
Table A.18 Output from a linear model examining inhibition of Bd growth by mucosome samples in Bd-exposed and 
naïve (control) frogs. 
 Dependent variable: 
 Scaled Inhibition 
Exposure Group χ2 = 0.074  p = 0.788 
 0.674 (-4.171, 5.520) 
Drying Treatment χ2 = 0.6634 p = 0.728 
Moderate drying -1.078 (-5.532, 3.376) 
 t = -0.474 
 p = 0.642 
No drying -2.003 (-6.847, 2.841) 
 t = -0.810 
 p = 0.430 
log (Mass at Metamorphosis) χ2 = 7.146  p = 0.013 
 24.854* (6.631, 43.077) 
Exposure Group : Drying Treatment χ2 = 1.969 p = 0.374 
Bd Exposed : Moderate Drying 0.533 (-5.939, 7.005) 
 t = 0.161 
 p = 0.873 
Bd Exposed : No Drying -3.699 (-10.375, 2.977) 
 t = -1.086 
 p = 0.287 
Constant 6.802** (2.588, 11.017) 
 t = 3.163 
 p = 0.004 
Observations 51 
Log Likelihood -136.850 
Akaike Information Criterion 291.701 
Bayesian Information Criterion 307.759 
Note: *p < 0.05; **p < 0.01; ***p < 0.001 
Coefficient estimates and their standard errors (in parentheses) are shown for each factor.  
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Table A.19 Output from a linear model examining the correlation between Bd load and inhibition of Bd growth by 
mucosome samples. 
 Dependent variable: 
 Bd Load [log (DNA copies + 1)] 
Scaled Inhibition -0.105 (-2.680, 2.471) 
 t = -0.080 
 p = 0.930 
Constant 1.265 (-1.472, 4.002) 
 t = 0.906 
 p = 0.381 
Observations 21 
Log Likelihood -62.770 
Akaike Information Criterion 133.540 
Bayesian Information Criterion 137.317 
Note: *p < 0.05; **p < 0.01; ***p < 0.001 









Table B.1 Output from a Cox proportional hazards model examining survival after metamorphosis between the two 
temperature treatments for VT. 
Dependent variable: 
Survival to metamorphosis VT 
Chamber (Future) -0.101 (-0.391, 0.189)
t = -0.681 
p = 0.496 
χ2 = 0.4633 
Observations 300 
R2 0.002 
Maximum Possible R2 0.999 
Log Likelihood -1088.390
Wald Test 0.460 (df = 1) (p = 0.496) 
LR Test 0.463 (df = 1) (p = 0.497) 
Score (Logrank) Test 0.464 (df = 1) (p = 0.496) 
Note: *p<0.05; **p<0.01; ***p<0.001
Coefficient estimates and their standard errors (in parentheses) are shown for each factor. 
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Table B.2 Output from a Cox proportional hazards model examining survival after metamorphosis between the two 
temperature treatments for PA. 
 Dependent variable: 
 Survival to metamorphosis in PA 
Chamber (Future) -0.321* (-0.578, -0.064) 
 z = -2.447 
 p = 0.015 
 χ2 = 6.026 
Observations 374 
R2 0.016 
Maximum Possible R2 0.999 
Log Likelihood -1309.428 
Wald Test 5.990* (df = 1) (p = 0.015) 
LR Test 6.026* (df = 1) (p = 0.015) 
Score (Logrank) Test 6.037* (df = 1) (p = 0.015) 
Note: *p<0.05; **p<0.01; ***p<0.001 
Coefficient estimates and their standard errors (in parentheses) are shown for each factor. 
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Table B.3 Output from a Cox proportional hazards model examining survival after metamorphosis between the two 
temperature treatments for TN. 
 Dependent variable: 
 Survival in TN 
Chamber (Future) -1.104*** (-1.400, -0.808) 
 z = -7.317 
 p = 0.000 
 χ2 = 53.789 
Observations 224 
R2 0.213 
Maximum Possible R2 1.000 
Log Likelihood -964.939 
Wald Test 53.540*** (df = 1) (p = 0.000) 
LR Test 53.789*** (df = 1) (p = 0.000) 
Score (Logrank) Test 56.943*** (df = 1) (p = 0.000) 
Note: *p<0.05; **p<0.01; ***p<0.001 
Coefficient estimates and their standard errors (in parentheses) are shown for each factor.  
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Table B.4 Output from a Cox proportional hazards model examining survival after metamorphosis between the two 
temperature treatments for LA. 
 Dependent variable: 
 Survival to metamorphosis LA 
Chamber (Future) 0.623*** (0.305, 0.940) 
 t = 3.840 




Maximum Possible R2 0.998 
Log Likelihood -850.375 
Wald Test 14.750*** (df = 1) (p = 0.0002) 
LR Test 15.255*** (df = 1) (p = 0.0001) 
Score (Logrank) Test 15.216*** (df = 1) (p = 0.0001) 
Note: *p<0.05; **p<0.01; ***p<0.001 
Coefficient estimates and their standard errors (in parentheses) are shown for each factor.  
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Table B.5 Output from a Cox proportional hazards model examining time to metamorphosis between the two 
temperature treatments for VT. 
 Dependent variable: 
 Metamorphosis time VT 
Chamber (Future) 1.652*** (1.082, 2.222) 
 t = 5.679 
 p = 1.36 x10-8 
 χ2 = 38.752 
Observations 87 
R2 0.359 
Maximum Possible R2 0.999 
Log Likelihood -285.311 
Wald Test 32.250*** (df = 1) (p = 0.000) 
LR Test 38.752*** (df = 1) (p = 0.000) 
Score (Logrank) Test 38.577*** (df = 1) (p = 0.000) 
Note: *p<0.05; **p<0.01; ***p<0.001 
Coefficient estimates and their standard errors (in parentheses) are shown for each factor. 
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Table B.6 Output from a Cox proportional hazards model examining time to metamorphosis between the two 
temperature treatments for PA. 
 Dependent variable: 
 Metamorphosis time PA 
Chamber (Future) 5.750*** (3.723, 7.777) 
 t = 5.560 
 p = 2.7 x10-8 
 χ2 = 173.05 
Observations 135 
R2 0.722 
Maximum Possible R2 1.000 
Log Likelihood -444.060 
Wald Test 30.910*** (df = 1) (p = 0.00000) 
LR Test 173.049*** (df = 1) (p = 0.000) 
Score (Logrank) Test 145.892*** (df = 1) (p = 0.000) 
Note: *p<0.05; **p<0.01; ***p<0.001 












Table B.7 Output from a Cox proportional hazards model examining time to metamorphosis between the two 
temperature treatments for LA. 
 Dependent variable: 
 Metamorphosis time LA 
Chamber (Future) 2.944*** (2.361, 3.527) 
 t = 9.904 




Maximum Possible R2 1.000 
Log Likelihood -456.378 
Wald Test 98.090*** (df = 1) (p = 0.000) 
LR Test 119.026*** (df = 1) (p = 0.000) 
Score (Logrank) Test 144.972*** (df = 1) (p = 0.000) 
Note: *p<0.05; **p<0.01; ***p<0.001 
Coefficient estimates and their standard errors (in parentheses) are shown for each factor. 
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Table B.8 Output from a linear model examining body mass at metamorphosis across the two temperatures in VT. 
 Dependent variable: 
 Mass (g) 
Treatment (Future) -1.591*** (-1.984, -1.197) 
 t = -7.923 
 p = 0.000 
 F = 62.778 
Constant 3.426*** (3.120, 3.732) 
 t = 21.945 
 p = 0.000 
Observations 86 
R2 0.428 
Adjusted R2 0.421 
Residual Standard Error 0.910 (df = 84) 
F Statistic 62.778*** (df = 1; 84) (p = 0.000) 
Note: *p<0.05; **p<0.01; ***p<0.001 
Coefficient estimates and their standard errors (in parentheses) are shown for each factor. 
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Table B.9 Output from a linear model examining body mass at metamorphosis across the two temperatures in PA. 
 Dependent variable: 
 Mass (g) 
Treatment (Future) -0.335*** (-0.391, -0.278) 
 t = -11.592 
 p = 0.000 
 F = 134.39 
Constant 0.879*** (0.836, 0.922) 
 t = 40.021 
 p = 0.000 
Observations 135 
R2 0.503 
Adjusted R2 0.499 
Residual Standard Error 0.166 (df = 133) 
F Statistic 134.386*** (df = 1; 133) (p = 0.000) 
Note: *p<0.05; **p<0.01; ***p<0.001 
Coefficient estimates and their standard errors (in parentheses) are shown for each factor. 
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Table B.10 Output from a linear model examining body mass at metamorphosis across the two temperatures in LA. 
 Dependent variable: 
 Mass (g) 
Treatment (Future) 0.029 (-0.061, 0.119) 
 t = 0.629 
 p = 0.531 
 F = 0.396 
Constant 0.839*** (0.780, 0.899) 
 t = 27.603 
 p = 0.000 
Observations 99 
R2 0.004 
Adjusted R2 -0.006 
Residual Standard Error 0.227 (df = 97) 
F Statistic 0.396 (df = 1; 97) (p = 0.531) 
Note: *p<0.05; **p<0.01; ***p<0.001 
Coefficient estimates and their standard errors (in parentheses) are shown for each factor. 
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Treatment (Future) -4.952*** (-6.014, -3.890)
t = -9.136 
p = 0.000 
F = 83.469 
Constant 28.471*** (27.642, 29.300) 
t = 67.298 
p = 0.000 
Observations 87 
R2 0.495 
Adjusted R2 0.490 
Residual Standard Error 2.467 (df = 85) 
F Statistic 83.469*** (df = 1; 85) (p = 0.000) 
Note: *p<0.05; **p<0.01; ***p<0.001
Coefficient estimates and their standard errors (in parentheses) are shown for each factor. 
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Table B.12 Output from a linear model examining body length (mm) at metamorphosis across the two temperatures 
in PA. 
 Dependent variable: 
 SVL (mm) 
Treatment (Future) -0.142*** (-0.162, -0.121) 
 t = -13.705 
 p = 0.000 
 F = 187.83 
Constant 3.394*** (3.379, 3.410) 
 t = 431.859 
 p = 0.000 
Observations 135 
R2 0.585 
Adjusted R2 0.582 
Residual Standard Error 0.059 (df = 133) 
F Statistic 187.832*** (df = 1; 133) (p = 0.000) 
Note: *p<0.05; **p<0.01; ***p<0.001 
Coefficient estimates and their standard errors (in parentheses) are shown for each factor. 
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Table B.13 Output from a linear model examining body length (mm) at metamorphosis across the two temperatures 
in LA. 
 Dependent variable: 
 SVL (mm) 
Treatment (Future) -0.604* (-1.156, -0.052) 
 t = -2.145 
 p = 0.035 
 F = 4.602 
Constant 21.257*** (20.894, 21.621) 
 t = 114.577 
 p = 0.000 
Observations 99 
R2 0.045 
Adjusted R2 0.035 
Residual Standard Error 1.388 (df = 97) 
F Statistic 4.602* (df = 1; 97) (p = 0.035) 
Note: *p<0.05; **p<0.01; ***p<0.001 
Coefficient estimates and their standard errors (in parentheses) are shown for each factor. 
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Table B.14 Output from a linear model examining mucosal peptides at one month across the two temperatures in 
VT. 
 Dependent variable: 
 Peptide counts/gbw (1 month) 
Treatment (Future) -1.005* (-1.827, -0.182) 
 t = -2.393 
 p = 0.038 
 F = 5.735 
Constant 5.303*** (4.674, 5.931) 
 t = 16.537 
 p = 0.000 
Observations 12 
R2 0.364 
Adjusted R2 0.300 
Residual Standard Error 0.717 (df = 10) 
F Statistic 5.725* (df = 1; 10) (p = 0.038) 
Note: *p<0.05; **p<0.01; ***p<0.001 
Coefficient estimates and their standard errors (in parentheses) are shown for each factor. 
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Table B.15 Output from a linear model examining mucosal peptides at two months across the two temperatures in 
VT. 
 Dependent variable: 
 Peptide counts/gbw (2 months) 
Treatment (Future) -1.072** (-1.710, -0.434) 
 t = -3.292 
 p = 0.008 
 F = 10.84 
Constant 5.793*** (5.306, 6.280) 
 t = 23.301 
 p = 0.000 
Observations 12 
R2 0.520 
Adjusted R2 0.472 
Residual Standard Error 0.556 (df = 10) 
F Statistic 10.840** (df = 1; 10) (p = 0.009) 
Note: *p<0.05; **p<0.01; ***p<0.001 
Coefficient estimates and their standard errors (in parentheses) are shown for each factor 
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Table B.16 Output from a linear model examining mucosal peptides at one month across the two temperatures in 
PA. 
 Dependent variable: 
 Peptide counts/gbw (1 month) 
Treatment (Future) -0.217 (-0.725, 0.291) 
 t = -0.837 
 p = 0.415 
Constant 4.157*** (3.742, 4.572) 
 t = 19.632 
 p = 0.000 
Observations 18 
R2 0.042 
Adjusted R2 -0.018 
Residual Standard Error 0.519 (df = 16) 
F Statistic 0.700 (df = 1; 16) (p = 0.416) 
Note: *p<0.05; **p<0.01; ***p<0.001 
Coefficient estimates and their standard errors (in parentheses) are shown for each factor. 
 
Table B.17 Output from a linear model examining mucosal peptides at two months across the two temperatures in 
PA. 
 Dependent variable: 
 Peptide counts/gbw (2 months) 
Treatment (Future) -0.291 (-1.015, 0.432) 
 t = -0.789 
 p = 0.442 
Constant 4.943*** (4.352, 5.533) 
 t = 16.400 
 p = 0.000 
Observations 18 
R2 0.037 
Adjusted R2 -0.023 
Residual Standard Error 0.738 (df = 16) 
F Statistic 0.622 (df = 1; 16) (p = 0.442) 
Note: *p<0.05; **p<0.01; ***p<0.001 
Coefficient estimates and their standard errors (in parentheses) are shown for each factor  
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Table B.18 Output from a linear model examining mucosal peptides at one month across the two temperatures in 
LA. 
 Dependent variable: 
 Peptide counts/gbw (1 month) 
Treatment (Future) 0.767* (0.153, 1.381) 
 t = 2.447 
 p = 0.030 
 F =5.990 
Growth rate 17.517 (-8.754, 43.789) 
 t = 1.307 
 p = 0.214 
 F = 1.710 
Treatment (future) : Growth.rate -185.522*** (-253.379, -117.664) 
 t = -5.359 
 p = 0.0002 
 F = 28.714 
Constant 3.611*** (3.333, 3.889) 
 t = 25.456 
 p = 0.000 
Observations 17 
R2 0.738 
Adjusted R2 0.678 
Residual Std. Error 0.411 (df = 13) 
F Statistic 12.215*** (df = 3; 13) (p = 0.0005) 
Note: *p < 0.05; **p < 0.01; ***p < 0.001 






Table B.19 Output from a linear model examining mucosal peptides at two months across the two temperatures in 
LA. 
 Dependent variable: 
 Peptide counts/gbw (2 months) 
Treatment (Future) 8.032* (2.579, 13.486) 
 t = 2.887 
 p = 0.017 
 F=8.334 
Time to metamorphosis 0.002 (-0.010, 0.014) 
 t = 0.288 
 p = 0.780 
 F=0.083 
Treatment (future)* Time to metamorphosis -0.058* (-0.096, -0.021) 
 t = -3.032 
 p = 0.013 
 F=9.195 
Constant 3.823* (1.389, 6.257) 
 t = 3.079 
 p = 0.012 
Observations 14 
R2 0.493 
Adjusted R2 0.341 
Residual Standard Error 0.482 (df = 10) 
F Statistic 3.240 (df = 3; 10) (p = 0.069) 
Note: *p<0.05; **p<0.01; ***p<0.001 






Table B.20 Output of a Permanova for AMPs presence/absence between temperature treatments in Vermont at 1 
month. 
 Df Sum of Sqs R2 F p 
Temperature 
treatment 
1 0.253 0.284 2.381 0.176 
Residuals 6 0.638 0.716   
Total 7 0.891 1.000   
notes: *p<0.05; **p<0.01; ***p<0.001 
 
Table B.21 Output of a Permanova for AMPs presence/absence between temperature treatments in Vermont at 2 
months. 
 Df Sum of Sqs R2 F p 
Temperature 
treatament 
1 0.257 0.338 3.057 0.072 
Residuals 6 0.504 0.662   
Total 7 0.762 1.000   
notes: *p<0.05; **p<0.01; ***p<0.001 
 
Table B.22 Output of a Permanova for AMPs presence/absence between temperature treatments in Pennsylvania at 
1 month. 
 Df Sum of Sqs R2 F p 
Temperature 
treatment 
1 0.173 0.088 0.485 0.760 
Residuals 5 1.787 0.912   
Total 6 1.960 1.000   
notes: *p<0.05; **p<0.01; ***p<0.001 
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Table B.23 Output of a Permanova for AMPs presence/absence between temperature treatments in Pennsylvania at 
2 months. 
 Df Sum of Sqs R2 F p 
Temperature 
treatment 
1 0.272 0.173 1.468 0.218 
Residuals 7 1.295 0.827   
Total 8 1.567 1.000   
notes: *p<0.05; **p<0.01; ***p<0.001 
 
Table B.24 Output of a Permanova for AMPs intensities between temperature treatments in Vermont at 1 month. 
 Df Sum of Sqs R2 F p 
Temperature 
treatment 
1 0.241 0.131 0.905 0.519 
Residuals 6 1.598 0.869   
Total 7 1.839 1.000   
notes: *p<0.05; **p<0.01; ***p<0.001 
 
Table B.25 Output of a Permanova for AMPs intensities between temperature treatments in Vermont at 2 months. 
 Df Sum of Sqs R2 F p 
Temperature 
treatment 
1 0.305 0.175 1.284 0.242 
Residuals 6 1.439 0.825   
Total 7 1.745 1.000   
notes: *p<0.05; **p<0.01; ***p<0.001 
 
Table B.26 Output of a Permanova for AMPs intensities between temperature treatments in Pennsylvania at 1 
month. 
 Df Sum of Sqs R2 F p 
Temperature 
treatment 
1 0.456 0.176 1.065 0.343 
Residuals 5 2.155 0.824   
Total 6 2.614 1.000   
notes: *p<0.05; **p<0.01; ***p<0.001 
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Table B.27 Output of a Permanova for AMPs intensities between temperature treatments in Pennsylvania at 2 
month. 
 Df Sum of Sqs R2 F p 
Temperature 
treatment 
1 0.553 0.251 2.346 0.048 
Residuals 7 1.649 0.749   
Total 8 2.202 1.000   
notes: *p<0.05; **p<0.01; ***p<0.001 
 
Table B.28 Output of a Permanova for AMPs presence/absence between temperature treatments with seven known 
peptides for Vermont at 1 month. 
 Df Sum of Sqs R2 F p 
Temperature 
treatment 
1 0.168 0.235 1.848 0.329 
Residuals 6 0.547 0.764   
Total 7 0.715 1.000   
notes: *p<0.05; **p<0.01; ***p<0.001 
 
Table B.29 Output of a Permanova for AMPs presence/absence between temperature treatments with seven known 
peptides in Vermont at 2 months. 
 Df Sum of Sqs R2 F p 
Temperature 
treatment 
1 0.135 0.2661 2.176 0.124 
Residuals 6 0.734 0.734   
Total 7 0.507 1.000   
notes: *p<0.05; **p<0.01; ***p<0.001 
 
Table B.30 Output of a Permanova for AMPs intensities between temperature treatments with seven known peptides 
for Vermont at 1 month. 
 Df Sum of Sqs R2 F p 
Temperature 
treatment 
1 0.122 0.235 0.457 0.907 
Residuals 6 1.600 0.764   
Total 7 1 1.000   
notes: *p<0.05; **p<0.01; ***p<0.001 
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Table B.31 Output of a Permanova for AMPs intensities between temperature treatments with seven known peptides 
in Vermont at 2 months. 
 Df Sum of Sqs R2 F p 
Temperature 
treatament 
1 0.246 0.135 0.939 0.578 
Residuals 6 1.572 0.865   
Total 7 1.818 1.000   
notes: *p<0.05; **p<0.01; ***p<0.001 
 
Table B.32 Output of a generalized linear model with a Poisson distribution for VT at 1 month. 
 LR Chisq Df p 
Treatment 5.132 1 0.024* 
Time to metamorphosis 0.037 1 0.847 
Treatment time to 
metamorphosis 
4.643 1 0.031* 
notes: *p<0.05; **p<0.01; ***p<0.001 
 
Table B.33 Output of a generalized linear model with a Poisson distribution for VT at 2 months. 
 LR Chisq Df p 
Treatment 11.995 1 5.334x10−4*** 
Time to metamorphosis 0.185 1 0.668 
Treatment time to 
metamorphosis 
9.515 1 2.038x10−3** 
notes: *p<0.05; **p<0.01; ***p<0.001 
 
Table B.34 Output of a generalized linear model with a Poisson distribution for PA at 1 month. 
 LR Chisq Df p 
Treatment 0.188 1 0.665 
Mass meta 3.458 1 0.063 
notes: *p<0.05; **p<0.01; ***p<0.001 
 
Table B.35 Output of a generalized linear model with a Poisson distribution for PA at 2 months 
 LR Chisq Df p 
Treatment 2.662 1 0.103 
Growth rate 2.949 1 0.086 





Table B.36 Output of a generalized linear model with a Poisson distribution for LA at 1 month. 
LR Chisq Df p 
Treatment 0.320 1 0.572 
Time to metamorphosis 1.692 1 0.193 
notes: *p<0.05; **p<0.01; ***p<0.001
LR Chisq Df p 
Treatment 1.499 1 0.221 
notes: *p<0.05; **p<0.01; ***p<0.001
Table B.37 Output of a generalized linear model with a Poisson distribution for LA at 2 months. 
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Table B.38 Output from a linear model examining total white blood cell counts at 1 month across the two 
temperatures in VT. 
 Dependent variable: 
 White blood cell counts cells/ml 
Time to metamorphosis (days) 0.0001 (-0.003, 0.003) 
 t = 0.039 
 p = 0.970 
 F = 0.0015 
Treatment (Future) -2.062** (-3.102, -1.022) 
 t = -3.885 
 p = 0.005 
 F = 15.094 
Time to metamorphosis : Treatment (Future) 0.010** (0.005, 0.015) 
 t = 3.959 
 p = 0.004 
 F = 15.675 
Constant 7.135*** (6.383, 7.886) 
 t = 18.613 
 p < 0.001 
Observations 12 
R2 0.801 
Adjusted R2 0.726 
Residual Standard Error 0.168 (df = 8) 
F Statistic 10.721** (df = 3; 8) (p = 0.004) 
Note: *p<0.05; **p<0.01; ***p<0.001 






Table B.39 Output from a linear model examining total white blood cell counts at 2 months across the two 
temperatures in VT. 
Dependent variable: 
White blood cell counts cells/ml 
Treatment (Future) -0.279 (-0.694, 0.136)
t = -1.319 
p = 0.220 
F = 1.740 
Constant 7.556*** (7.224, 7.887) 
t = 44.725 
p = 0.000 
Observations 11 
R2 0.162 
Adjusted R2 0.069 
Residual Standard Error 0.338 (df = 9) 
F Statistic 1.740 (df = 1; 9) (p = 0.220) 
Note: *p<0.05; **p<0.01; ***p<0.001
Coefficient estimates and their standard errors (in parentheses) are shown for each factor. 
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Table B.40 Output from a linear model examining total white blood cell counts at 1 month across the two 
temperatures in PA. 
 Dependent variable: 
 White blood cell counts cells/ml 
Time to metamorphosis (days) 0.013 (0.0002, 0.026) 
 t = 1.988 
 p = 0.067 
 F = 3.951 
Treatment (Future) 0.855 (0.008, 1.701) 
 t = 1.980 
 p = 0.068 
 F = 3.919 
Constant 4.118* (1.246, 6.990) 
 t = 2.811 
 p = 0.014 
Observations 17 
R2 0.221 
Adjusted R2 0.110 
Residual Standard Error 0.158 (df = 14) 
F Statistic 1.988 (df = 2; 14) (p = 0.174) 
Note: *p<0.05; **p<0.01; ***p<0.001 









Table B.41 Output from a linear model examining total white blood cell counts at 2 months across the two 
temperatures in PA. 
 Dependent variable: 
 White blood cell counts cells/ml 
Treatment (Future) 0.019 (-0.176, 0.215) 
 t = 0.192 
 p = 0.851 
 F = 0.037 
Constant 7.104*** (6.940, 7.269) 
 t = 84.704 
 p = 0.000 
Observations 17 
R2 0.002 
Adjusted R2 -0.064 
Residual Standard Error 0.188 (df = 15) 
F Statistic 0.037 (df = 1; 15) (p = 0.851) 
Note: *p<0.05; **p<0.01; ***p<0.001 











Table B.42 Output from a linear model examining total white blood cell counts at 1 month across the two 
temperatures in LA. 
 Dependent variable: 
 White blood cell counts cells/ml 
Treatment (Future) -0.062 (-0.267, 0.142) 
 t = -0.600 
 p = 0.557 
 F = 0.360 
Constant 6.935*** (6.821, 7.050) 
 t = 118.555 
 p = 0.000 
Observations 19 
R2 0.021 
Adjusted R2 -0.037 
Residual Standard Error 0.211 (df = 17) 
F Statistic 0.360 (df = 1; 17) (p = 0.557) 
Note: *p<0.05; **p<0.01; ***p<0.001 











Table B.43 Output from a linear model examining total white blood cell counts cells/ml at 2 months across the two 
temperatures in LA. 
 Dependent variable: 
 White blood cell counts cells/ml 
Treatment (Future) -0.175 (-0.419, 0.069) 
 t = -1.404 
 p = 0.198 
 F = 1.972 
Growth rate (g/day) 39.159* (6.219, 72.099) 
 t = 2.330 
 p = 0.048 
 F = 5.429 
Constant 6.697*** (6.477, 6.916) 
 t = 59.842 
 p = 0.000 
Observations 11 
R2 0.420 
Adjusted R2 0.275 
Residual Standard Error 0.186 (df = 8) 
F Statistic 2.898 (df = 2; 8) (p = 0.114) 
Note: *p < 0.05; **p < 0.01; ***p < 0.001 









Table B.44 Output from a linear model examining log Thymocyte counts cells/g at 1 month across the two 
temperatures in VT. 
 Dependent variable: 
 log (Thymocyte counts cells/g) 
Time to metamorphosis (days) -0.001 (-0.008, 0.006) 
 t = -0.365 
 p = 0.725 
 F = 0.133 
Treatment (Future) -2.588 (-4.899, -0.278) 
 t = -2.195 
 p = 0.059 
 F = 4.820 
Time to metamorphosis : Treatment (Future) 0.013* (0.002, 0.024) 
 t = 2.400 
 p = 0.043 
 F = 5.761 
Constant 4.983*** (3.314, 6.652) 
 t = 5.853 
 p = 0.0004 
Observations 12 
R2 0.497 
Adjusted R2 0.308 
Residual Standard Error 0.372 (df = 8) 
F Statistic 2.635 (df = 3; 8) (p = 0.122) 
Note: *p<0.05; **p<0.01; ***p<0.001 






Table B.45 Output from a linear model examining log Thymocyte counts cells/g at 2 months across the two 
temperatures in VT. 
 Dependent variable: 
 log (Thymocyte counts cells/g) 
Treatment (Future) 0.403 (-0.064, 0.870) 
 t = 1.693 
 p = 0.119 
 F = 2.867 
Mass at metamorphosis (g) 0.617* (0.199, 1.035) 
 t = 2.893 
 p = 0.015 
 F = 8.369 
Constant 3.806*** (2.825, 4.786) 
 t = 7.607 
 p = 0.00002 
Observations 14 
R2 0.432 
Adjusted R2 0.329 
Residual Standard Error 0.343 (df = 11) 
F Statistic 4.185* (df = 2; 11) (p = 0.045) 
Note: *p<0.05; **p<0.01; ***p<0.001 








Table B.46 Output from a linear model examining log Thymocyte counts cells/g at 1 month across the two 
temperatures in PA. 
 Dependent variable: 
 log (Thymocyte counts cells/g) 
Time to metamorphosis (days) 0.015* (0.003, 0.028) 
 t = 2.459 
 p = 0.027 
 F = 6.044 
Treatment (Future) 0.692 (-0.221, 1.604) 
 t = 1.486 
 p = 0.158 
 F = 2.209 
Constant 1.022 (-1.795, 3.839) 
 t = 0.711 
 p = 0.488 
Observations 18 
R2 0.491 
Adjusted R2 0.424 
Residual Standard Error 0.276 (df = 15) 
F Statistic 7.247** (df = 2; 15) (p = 0.007) 
Note: *p<0.05; **p<0.01; ***p<0.001 








Table B.47 Output from a linear model examining log Thymocyte counts cells/g at 2 months across the two 
temperatures in PA. 
 Dependent variable: 
 log (Thymocyte counts cells/g) 
Treatment (Future) 0.260** (0.102, 0.418) 
 t = 3.230 
 p = 0.004 
 F = 10.435 
Constant 4.200*** (4.083, 4.316) 
 t = 70.616 
 p = 0.000 
Observations 22 
R2 0.343 
Adjusted R2 0.310 
Residual Standard Error 0.188 (df = 20) 
F Statistic 10.435** (df = 1; 20) (p = 0.005) 
Note: *p<0.05; **p<0.01; ***p<0.001 











Table B.48 Output from a linear model examining log Thymocyte counts cells/g at 1 month across the two 
temperatures in LA. 
 Dependent variable: 
 Log (Thymocyte counts cells/g) 
Treatment (Future) 0.313 (0.003, 0.623) 
 t = 1.980 
 p = 0.060 
 F = 3.920 
Growth rate (g/day) 50.041** (21.306, 78.775) 
 t = 3.413 
 p = 0.002 
 F = 11.650 
Constant 4.796*** (4.573, 5.019) 
 t = 42.203 
 p = 0.000 
Observations 25 
R2 0.380 
Adjusted R2 0.324 
Residual Standard Error 0.385 (df = 22) 
F Statistic 6.752** (df = 2; 22) (p = 0.006) 
Note: *p<0.05; **p<0.01; ***p<0.001 








Table B.49 Output from a linear model examining log Thymocyte counts cells/g at 2 months across the two 
temperatures in LA. 
 Dependent variable: 
 Log (Thymocyte counts cells/g) 
Mass at metamorphosis (g) 0.756* (0.205, 1.307) 
 t = 2.689 
 p = 0.021 
 F = 7.232 
Treatment (Future) 0.487** (0.255, 0.719) 
 t = 4.117 
 p = 0.002 
 F = 16.951 
Constant 4.239*** (3.750, 4.729) 
 t = 16.986 




Adjusted R2 0.709 
Residual Standard Error 0.191 (df = 11) 
F Statistic 16.867*** (df = 2; 11) (p = 0.0005) 
Note: *p<0.05; **p<0.01; ***p<0.001 








Table B.50 Output from a linear model examining log Splenocyte count (cells/g) at 1 month across the two 
temperatures in VT. 
 Dependent variable: 
 Log (Splenocyte counts cells/g (1 month)) 
Treatment (Future) -3.991 (-8.148, 0.166) 
 t = -1.882 
 p = 0.097 
 F = 3.541 
Time to metamorphosis (days) 0.004 (-0.009, 0.016) 
 t = 0.585 
 p = 0.575 
 F = 0.343 
Treatment (Future) : Time to metamorphosis 0.022 (0.003, 0.042) 
 t = 2.209 
 p = 0.059 
 F = 4.8818 
Constant 9.275*** (6.273, 12.277) 
 t = 6.055 
 p = 0.0004 
Observations 12 
R2 0.585 
Adjusted R2 0.429 
Residual Standard Error 0.670 (df = 8) 
F Statistic 3.752 (df = 3; 8) (p = 0.060) 
Note: *p<0.05; **p<0.01; ***p<0.001 






Table B.51 Output from a linear model examining log Splenocyte count (cells/g) at 2 months across the two 
temperatures in VT. 
 Dependent variable: 
 Log (Splenocyte counts cells/g (2 months)) 
Treatment (Future) 0.221 (-0.435, 0.878) 
 t = 0.660 
 p = 0.522 
 F = 0.436 
Constant 10.198*** (9.671, 10.724) 
 t = 37.962 
 p = 0.000 
Observations 14 
R2 0.035 
Adjusted R2 -0.045 
Residual Standard Error 0.601 (df = 12) 
F Statistic 0.436 (df = 1; 12) (p = 0.522) 
Note: *p<0.05; **p<0.01; ***p<0.001 











Table B.52 Output from a linear model examining log Splenocyte count (cells/g) at 1 month across the two 
temperatures in PA. 
 Dependent variable: 
 Log (Splenocyte counts cells/g (1 month)) 
Treatment (Future) -0.775 (-1.718, 0.168) 
 t = -1.611 
 p = 0.128 
 F = 2.596 
Growth rate (g/days) 63.618** (26.981, 100.256) 
 t = 3.403 
 p = 0.004 
Constant 11.878*** (11.116, 12.641) 
 t = 30.547 
 p = 0.000 
 F = 11.582 
Observations 18 
R2 0.458 
Adjusted R2 0.386 
Residual Standard Error 0.948 (df = 15) 
F Statistic 6.346* (df = 2; 15) (p = 0.011) 
Note: *p<0.05; **p<0.01; ***p<0.001 









Table B.53 Output from a linear model examining log Splenocyte count (cells/g) at 2 months across the two 
temperatures in PA. 
 Dependent variable: 
 Log (Splenocyte counts cells/g (2 months)) 
Treatment (Future) 0.656** (0.297, 1.014) 
 t = 3.587 
 p = 0.002 
 F = 12.867 
Growth rate (g/days) 55.054*** (33.650, 76.459) 
 t = 5.041 
 p = 0.0001 
 F = 25.413 
Constant 11.179*** (10.770, 11.587) 
 t = 53.658 
 p = 0.000 
Observations 22 
R2 0.647 
Adjusted R2 0.610 
Residual Standard Error 0.425 (df = 19) 
F Statistic 17.424*** (df = 2; 19) (p = 0.0001) 
Note: *p<0.05; **p<0.01; ***p<0.001 









Table B.54 Output from a linear model examining log Splenocyte count (cells/g) at 1 month across the two 
temperatures in LA. 
 Dependent variable: 
 Log (Splenocyte count (cells/g) (1 month)) 
Treatment (Future) 0.166 (-0.493, 0.825) 
 t = 0.494 
 p = 0.627 
 F = 0.244 
Growth (g/day) 69.234* (8.811, 129.658) 
 t = 2.246 
 p = 0.035 
 F = 5.043 
Constant 9.153*** (8.696, 9.609) 
 t = 39.288 
 p = 0.000 
Observations 26 
R2 0.181 
Adjusted R2 0.110 
Residual Standard Error 0.838 (df = 23) 
F Statistic 2.537 (df = 2; 23) (p = 0.101) 
Note: *p<0.05; **p<0.01; ***p<0.001 








Table B.55 Output from a linear model examining log Splenocyte count (cells/g) at 2 months across the two 
temperatures in LA. 
 Dependent variable: 
 Log (Splenocyte counts cells/g (2 months)) 
Treatment (Future) 0.477 (-0.692, 1.646) 
 t = 0.800 
 p = 0.439 
 F = 0.640 
Constant 8.679*** (7.691, 9.667) 
 t = 17.215 
 p = 0.000 
Observations 14 
R2 0.051 
Adjusted R2 -0.028 
Residual Standard Error 1.008 (df = 12) 
F Statistic 0.640 (df = 1; 12) (p = 0.440) 
Note: *p<0.05; **p<0.01; ***p<0.001 












Table B.56 Output from a linear model examining log T lymphocyte proliferation proportion at 1 month across the 
two temperatures in VT. 
 Dependent variable: 
 Log (T-lymphocyte proliferation) 
Treatment (Future) -5.324 (-11.850, 1.203) 
 t = -1.599 
 p = 0.149 
 F = 2.556 
Time to metamorphosis -0.002 (-0.021, 0.018) 
 t = -0.171 
 p = 0.869 
 F = 0.029 
Treatment (Future) : Time to metamorphosis 0.030 (-0.001, 0.061) 
 t = 1.920 
 p = 0.092 
 F = 3.6865 
Constant 2.097 (-2.616, 6.811) 
 t = 0.872 
 p = 0.409 
Observations 12 
R2 0.414 
Adjusted R2 0.195 
Residual Standard Error 1.052 (df = 8) 
F Statistic 1.887 (df = 3; 8) (p = 0.211) 
Note: *p<0.05; **p<0.01; ***p<0.001 






Table B.57 Output from a linear model examining log T lymphocyte proliferation proportion at 1 month across the 
two temperatures in PA. 
 Dependent variable: 
 Log (T-lymphocyte proliferation) 
Treatment (Future) 2.412 (-1.112, 5.936) 
 t = 1.341 
 p = 0.200 
 F = 1.799 
Time to metamorphosis (days) 0.052* (0.005, 0.100) 
 t = 2.159 
 p = 0.048 
 F = 4.663 
Constant -7.559 (-18.441, 3.324) 
 t = -1.361 
 p = 0.194 
Observations 18 
R2 0.413 
Adjusted R2 0.335 
Residual Standard Error 1.066 (df = 15) 
F Statistic 5.287* (df = 2; 15) (p = 0.019) 
Note: *p<0.05; **p<0.01; ***p<0.001 








Table B.58 Output from a linear model examining log T lymphocyte proliferation proportion at 1 month across the 
two temperatures in LA. 
 Dependent variable: 
 Log (T-lymphocyte proliferation) 
Treatment (Future) -0.231 (-1.170, 0.709) 
 t = -0.481 
 p = 0.640 
 F = 0.231 
Mass at metamorphosis (g) -2.219* (-4.127, -0.310) 
 t = -2.278 
 p = 0.042 
 F = 5.191 
Constant 4.117** (2.178, 6.056) 
 t = 4.161 
 p = 0.002 
Observations 15 
R2 0.302 
Adjusted R2 0.186 
Residual Standard Error 0.907 (df = 12) 
F Statistic 2.596 (df = 2; 12) (p = 0.116) 
Note: *p<0.05; **p<0.01; ***p<0.001 








Table B.59 Output from a linear model examining log B lymphocyte proliferation proportion at 2 months across the 
two temperatures in VT. 
 Dependent variable: 
 Log (B-lymphocyte proliferation) 
Treatment (Future) 0.608* (0.119, 1.097) 
 t = 2.437 
 p = 0.033 
 F = 5.941 
Mass at metamorphosis 0.499* (0.061, 0.937) 
 t = 2.235 
 p = 0.048 
 F = 4.995 
Constant -1.017 (-2.045, 0.011) 
 t = -1.938 
 p = 0.079 
Observations 14 
R2 0.385 
Adjusted R2 0.273 
Residual Standard Error 0.359 (df = 11) 
F Statistic 3.446 (df = 2; 11) (p = 0.069) 
Note: *p<0.05; **p<0.01; ***p<0.001 









Table B.60 Output from a linear model examining log B lymphocyte proliferation proportion at 2 months across the 
two temperatures in PA. 
 Dependent variable: 
 Log (B-lymphocyte proliferation) 
Treatment (Future) 0.173 (-0.219, 0.565) 
 t = 0.864 
 p = 0.399 
 F = 0.746 
Constant 0.210 (-0.080, 0.499) 
 t = 1.420 
 p = 0.171 
Observations 22 
R2 0.036 
Adjusted R2 -0.012 
Residual Standard Error 0.467 (df = 20) 
F Statistic 0.746 (df = 1; 20) (p = 0.399) 
Note: *p<0.05; **p<0.01; ***p<0.001 












Table B.61 Output from a linear model examining log B lymphocyte proliferation proportion at 2 months across the 
two temperatures in LA. 
 Dependent variable: 
 Log (B-lymphocyte proliferation) 
Treatment (Future) 0.098 (-0.558, 0.753) 
 t = 0.292 
 p = 0.775 
 F = 0.085 
Growth rate (g/day) 171.748** (87.205, 256.292) 
 t = 3.982 
 p = 0.002 
 F = 15.853 
Treatment (Future) : Growth rate -197.624** (-298.078, -97.169) 
 t = -3.856 
 p = 0.002 
 F = 14.867 
Constant 0.179 (-0.232, 0.590) 
 t = 0.853 
 p = 0.407 
Observations 19 
R2 0.637 
Adjusted R2 0.564 
Residual Standard Error 0.467 (df = 15) 
F Statistic 8.762** (df = 3; 15) (p = 0.002) 
Note: *p<0.05; **p<0.01; ***p<0.001 






Table B.62 Linear mixed model of Bd infection load with temperature treatment, time post exposure as fixed effects 
and their interaction for LA. 
 Dependent variable: 
 Bd infection intensity in LA 
Treatment (Future)  
 Estimate = -0.676 
 Std = 0.505 
 z = -1.338 
 p = 0.181 
 χ 2= 1.790 
Week  
 Estimate= 0.079 
 Std = 0.057 
 Z = 1.375 
 p = 0.169 
 χ 2= 1.891 
Treatment (Future) : Week  
 Estimate= 0.079 
 Std= 0.088 
 z = 0.898 
 p = 0.369 
 χ 2= 0.807 
Note: *p<0.05; **p<0.01; ***p<0.001 








Table B.63 Generalized linear mixed model with a binomial distribution of the probability of Bd infection across the 
two temperatures by week in LA. 
 Dependent variable: 
 Change Bd probability of infection post Bd exposure in LA 
Treatment (Future) -1.155 (-3.061, 0.752) 
 t = -1.187 
 p = 0.235 
 χ 2 = 1.409 
Week 0.266** (0.085, 0.447) 
 t = 2.876 
 p = 0.004 
 χ 2 = 8.272 
Treatment (Future) : Week 0.170 (-0.097, 0.437) 
 t = 1.250 
 p = 0.211 
 χ 2 =1.562 
Constant -2.805*** (-4.251, -1.360) 
 t = -3.804 
 p = 0.0002 
Observations 303 
Log Likelihood -143.292 
Akaike Information Criterion 296.583 
Bayesian Information Criterion 315.152 
Note: *p<0.05; **p<0.01; ***p<0.001 





Table B.64 Linear mixed model of Bd infection load with temperature treatment, days post exposure as fixed effects 
and their interaction for PA. 
 Dependent variable: 
 Bd infection intensity in PA 
Treatment (Future)  
 Estimate = -2.061 
 Std = 0.494 
 z = -4.169 
 p = 3.06x10−5 *** 
 χ 2 = 17.383 
Week  
 Estimate = -0.256 
 Std = 0.059 
 Z = -4.318 
 p = 1.57 x10−5 *** 
 χ 2= 18.645 
Treatment (Future) : Week  
 Estimate= 0.302 
 Std= 0.088 
 z = 3.416 
 p = 0.636 x10−3 *** 
 χ 2= 11.666 
Constant  
 t = -3 .804 
 p = 0.0002 
Note: *p<0.05; **p<0.01; ***p<0.001 






Table B. 65 Generalized linear mixed model with a binomial distribution of the probability of Bd infection across 
the two temperatures by week in PA. 
 Dependent variable: 
 Change in probability of infection post Bd exposure 
Treatment (Future) -3.218* (-6.305, -0.130) 
 t = -2.043 
 p = 0.041 
 χ 2=4.172 
Week -0.121 (-0.587, 0.345) 
 t = -0.510 
 p = 0.610 
 χ 2 = 0.260 
Treatment (Future) : Week 0.392 (-0.162, 0.945) 
 t = 1.386 
 p = 0.166 
 χ 2 = 1.922 
Constant 3.252* (0.513, 5.991) 
 t = 2.327 
 p = 0.020 
Observations 119 
Log Likelihood -44.146 
Akaike Information Criterion 98.291 
Bayesian Information Criterion 112.187 
Note: *p<0.05; **p<0.01; ***p<0.001 







Table B.66 Linear mixed model of Bd infection load with temperature treatment, days post exposure as fixed effects 
and their interaction for VT. 
 Dependent variable: 
 Bd infection intensity in VT 
Treatment (Future)  
 Estimate= 0.669 
 Std = 0.653 
 z = 1.026 
 p = 0.305 
 χ 2= 0.031 
Week  
 Estimate= 8.32 x10−3 
 Std = 0.013 
 z= 0.642 
 p = 0.521 
 χ 2 = 0.055 
Treatment (Future) : Week  
 Estimate= -0.018 
 Std= 0.017 
 z = -1.049 
 p = 0.294 
 χ 2= 1.100 
Constant  
 t = -3.804 
 p = 0.0002 
Note: *p<0.05; **p<0.01; ***p<0.001 







Table B.67 Generalized linear mixed model with a binomial distribution of the probability of Bd infection across the 
two temperatures by week in VT. 
 Dependent variable: 
 Change in probability of infection post Bd exposure 
Treatment (Future) -17.066 (-765.683, 731.551) 
 t = -0.045 
 p = 0.964 
 χ 2= 0.002 
Week -0.015 (-0.497, 0.467) 
 t = -0.061 
 p = 0.951 
 χ 2= 0.003 
Treatment (Future) : Week 7.873 (-366.435, 382.182) 
 t = 0.041 
 p = 0.967 
 χ 2=0.002 
Constant 2.546 (-0.435, 5.527) 
 t = 1.674 
 p = 0.095 
Observations 94 
Log Likelihood -21.466 
Akaike Information Criterion 52.931 
Bayesian Information Criterion 65.648 
Note: *p<0.05; **p<0.01; ***p<0.001 






Table B.68 Linear mixed model of Body condition (measured as log (scaled mass index), or log SMI) in VT and the 
interaction between Bd exposure and time of exposure. 
 Dependent variable: 
 Change in SMI post Bd exposure 
Treatment (Future) -0.029 (-0.127, 0.069) 
 t = -0.579 
 p = 0.568 
 χ 2 = 0.3475 
Week -0.009 (-0.022, 0.003) 
 t = -1.449 
 p = 0.151 
 χ 2 = 2.1760 
Treatment (Future) : Week 0.011 (-0.005, 0.028) 
 t = 1.363 
 p = 0.176 
 χ 2 = 1.9239 
Constant 0.574*** (0.498, 0.650) 
 t = 14.834 
 p = 0.000 
Observations 116 
Log Likelihood 67.676 
Akaike Information Criterion -123.351 
Bayesian Information Criterion -106.830 
Note: *p<0.05; **p<0.01; ***p<0.001 






Table B.69 Linear mixed model of Body condition (measured as log (scaled mass index), or log SMI) in PA and the 
interaction between Bd exposure and time of exposure. 
 Dependent variable: 
 Change in SMI post Bd exposure 
Treatment (Future) 0.133*** (0.073, 0.192) 
 t = 4.348 
 p = 0.0002 
 χ 2 = 19.4301 
Week 0.007 (-0.001, 0.015) 
 t = 1.641 
 p = 0.103 
 χ 2 = 2.7695 
Treatment (Future) : Week -0.007 (-0.019, 0.004) 
 t = -1.239 
 p = 0.218 
 χ 2 = 1.5771 
Constant 0.830*** (0.787, 0.872) 
 t = 38.369 
 p = 0.000 
Observations 147 
Log Likelihood 125.015 
Akaike Information Criterion -238.030 
Bayesian Information Criterion -220.087 
Note: *p<0.05; **p<0.01; ***p<0.001 






Table B.70 Linear mixed model of Body condition (measured as log (scaled mass index), or log SMI) in LA and the 
interaction between Bd exposure and time of exposure. 
 Dependent variable: 
 Change in SMI post Bd exposure 
Treatment (Future) -0.158** (-0.245, -0.071) 
 t = -3.573 
 p = 0.001 
 χ 2 = 13.105 
Week -0.010** (-0.016, -0.003) 
 t = -3.023 
 p = 0.003 
 χ 2 = 9.3812 
Treatment (Future) : Week -0.0004 (-0.009, 0.009) 
 t = -0.080 
 p = 0.936 
 χ 2 = 0.007 
Constant 1.436*** (1.374, 1.497) 
 t = 45.875 
 p = 0.000 
Observations 156 
Log Likelihood 137.531 
Akaike Information Criterion -263.062 
Bayesian Information Criterion -244.763 
Note: *p<0.05; **p<0.01; ***p<0.001 




Table B.71 Output from a Cox proportional hazards model examining survival across the two temperatures after Bd 
exposure in VT. 
 
 Loglik χ 2 Df p 
Null -27.332    
Temperature -24.759 5.146 1 0.023* 
Note: *p<0.05; **p<0.01; ***p<0.001 
 
Table B.72 Output from a Cox proportional hazards model examining survival across the two temperatures after Bd 
exposure in PA. 
 
 Loglik χ 2 Df p 
Null -3.4012    
Temperature -2.7081 1.3863 1 0.239 
Note: *p<0.05; **p<0.01; ***p<0.001 
 
Table B.73 Output from a Cox proportional hazards model examining survival across the two temperatures after Bd 
exposure in LA. 
 
 Loglik χ 2 Df p 
Null -28.772    
Temperature -28.700 0.1443 1 0.7041 










Table B.74 Output from a linear model examining log Splenocyte count (cells/g) after exposure across the two 
temperatures in VT. 
 Dependent variable: 
 Splenocyte counts/g 
Exposure Group (Exposed) -0.007 (-0.202, 0.188) 
 t = -0.075 
 p = 0.942 
 F = 0.006 
Temperature Treatment 0.282** (0.105, 0.458) 
 t = 3.128 
 p = 0.004 
 F = 9.787 
Growth rate (g/day) -11.670* (-21.361, -1.978) 
 t = -2.360 
 p = 0.025 
 F = 5.569 
Exposure Group: Temperature Treatment -0.198 (-0.468, 0.072) 
 t = -1.436 
 p = 0.162 
 F = 2.063 
Constant 3.768*** (3.602, 3.934) 
 t = 44.440 
 p = 0.000 
Observations 35 
R2 0.494 
Adjusted R2 0.426 
Residual Std. Error 0.187 (df = 30) 
F Statistic 7.317*** (df = 4; 30) (p = 0.0004) 
Note: *p**p***p<0.001 





Table B.75 Output from a linear model examining log Splenocyte count (cells/g) after exposure across the two 
temperatures in PA. 
 Dependent variable: 
 Splenocyte counts/g 
Exposure Group (Exposed) 0.014 (-0.137, 0.165) 
 t = 0.184 
 p = 0.855 
 F = 0.034 
Temperature Treatment 0.243** (0.095, 0.391) 
 t = 3.221 
 p = 0.003 
 F = 10.374 
Exposure Group: Temperature Treatment -0.122 (-0.340, 0.096) 
 t = -1.095 
 p = 0.280 
 F = 1.199 
Constant 3.604*** (3.499, 3.708) 
 t = 67.555 
 p = 0.000 
Observations 52 
R2 0.219 
Adjusted R2 0.170 
Residual Std. Error 0.200 (df = 48) 
F Statistic 4.480** (df = 3; 48) (p = 0.008) 
Note: *p**p***p<0.001 







Table B.76 Output from a linear model examining log Splenocyte count (cells/g) after exposure across the two 
temperatures in LA. 
 Dependent variable: 
 Splenocyte counts/g 
Exposure Group (Exposed) -0.139 (-0.512, 0.234) 
 t = -0.730 
 p = 0.470 
 F = 0.533 
Temperature Treatment 0.444* (0.117, 0.772) 
 t = 2.658 
 p = 0.012 
 F = 7.065 
Mass at metamorphosis (g) -0.226* (-0.397, -0.054) 
 t = -2.574 
 p = 0.015 
 F = 6.623 
Exposure Group: Temperature Treatment -0.145 (-0.726, 0.435) 
 t = -0.491 
 p = 0.627 
 F = 0.241 
Exposure Group : Mass at metamorphosis 0.171 (-0.207, 0.550) 
 t = 0.887 
 p = 0.382 
 F = 0.786 
Temperature Treatment : Mass at metamorphosis -0.391** (-0.671, -0.111) 
 t = -2.739 
 p = 0.010 
 F = 7.501 
Exposure Group : Temperature Treatment : Mass at 
metamorphosis 
0.099 (-0.498, 0.696) 
 t = 0.325 
 p = 0.748 
 F = 0.106 
Constant 3.310*** (3.110, 3.510) 
 t = 32.452 




Adjusted R2 0.460 
Residual Std. Error 0.147 (df = 35) 
F Statistic 
6.112*** (df = 7; 35) (p = 
0.0002) 
Note: *p**p***p<0.001 



















Table B.77 Output from a linear model examining total mucosal peptides after Bd exposure across exposure groups 
for VT 
 Dependent variable: 
 Log (Mucosome inhibition %) 
Exposure group (Exposed) -21.475 (-47.772, 4.821) 
 t = -1.601 
 p = 0.124 
 F = 2.562 
Temperature Treatment (Future) -49.139* (-84.554, -13.723) 
 t = -2.719 
 p = 0.013 
 F = 7.395 
Mass at metamorphosis (g) -3.846 (-26.706, 19.014) 
 t = -0.330 
 p = 0.745 
 F = 0.109 
Exposure Group : Temperature Treatment 23.961 (-11.161, 59.083) 
 t = 1.337 
 p = 0.195 
 F = 1.788 
Constant 64.403* (5.131, 123.675) 
 t = 2.130 
 p = 0.046 
Observations 26 
R2 0.414 
Adjusted R2 0.303 
Residual Standard Error 21.407 (df = 21) 
F Statistic 3.712* (df = 4; 21) (p = 0.020) 
Note: *p<0.05; **p<0.01; ***p<0.001 
Coefficient estimates and their standard errors (in parentheses) are shown for each factor. 
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Table B.78 Output from a linear model examining total mucosal peptides after Bd exposure across exposure groups 
for PA. 
 Dependent variable: 
 Log (Mucosome inhibition %) 
Exposure group (Exposed) -27.064* (-47.063, -7.064) 
 t = -2.652 
 p = 0.014 
 F = 7.035 
Temperature Treatment (Future) -43.512*** (-61.755, -25.268) 
 t = -4.675 
 p = 0.0001 
 F = 21.852 
Mass at metamorphosis (g) -25.861** (-42.032, -9.690) 
 t = -3.134 
 p = 0.005 
 F = 9.824 
Exposure Group : Temperature Treatment 37.905** (12.013, 63.798) 
 t = 2.869 
 p = 0.009 
 F = 8.233 
Constant 114.259*** (72.934, 155.585) 
 t = 5.419 
 p = 0.00002 
Observations 28 
R2 0.512 
Adjusted R2 0.427 
Residual Standard Error 16.658 (df = 23) 
F Statistic 6.032** (df = 4; 23) (p = 0.002) 
Note: *p<0.05; **p<0.01; ***p<0.001 





Table B.79 Output from a linear model examining total mucosal peptides after Bd exposure across exposure groups 
for LA. 
 Dependent variable: 
 Log (Mucosome inhibition %) 
Exposure group (Exposed) 3.251 (-8.654, 15.155) 
 t = 0.535 
 p = 0.598 
 F = 0.287 
Temperature Treatment (Future) 14.502* (1.798, 27.206) 
 t = 2.237 
 p = 0.036 
 F = 5.006 
Mass at metamorphosis (g) -348.389 (-954.128, 257.349) 
 t = -1.127 
 p = 0.271 
 F = 1.271 
Exposure Group : Temperature Treatment -12.371 (-29.645, 4.904) 
 t = -1.404 
 p = 0.174 
 F = 1.970 
Constant 13.960* (4.045, 23.875) 
 t = 2.760 
 p = 0.012 
Observations 28 
R2 0.202 
Adjusted R2 0.064 
Residual Standard Error 11.599 (df = 23) 
F Statistic 1.458 (df = 4; 23) (p = 0.248) 
Note: *p<0.05; **p<0.01; ***p<0.001 









Figure B.1 Distance between each pond where the egg masses were collected, and the weather station used to 
collect the temperatures for the experiment.  
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Appendix C  
Table C.1 Output from a generalized linear mixed model with a binomial distribution of the probability of Bd 
infection (yes/no) with pond type (ephemeral vs. permanent), pH and animal body temperature as factors. 
 Dependent variable: 
 Bd Infection 
Pond Type (Ephemeral vs. Permanent) -0.072 (-1.563, 1.419) 
 t = -0.095 
 p = 0.925 
Pond pH 0.004 (-0.094, 0.101) 
 t = 0.071 
 p = 0.944 
Animal Body Temperature -0.075*** (-0.102, -0.048) 
 t = -5.497 
 p < 0.001 
Pond Type : pH 0.017 (-0.148, 0.182) 
 t = 0.203 
 p = 0.839 
Pond Type : Animal Body Temperature -0.014 (-0.046, 0.018) 
 t = -0.857 
 p = 0.392 
Constant 0.082 (-1.071, 1.235) 
 t = 0.140 
 p = 0.889 
Observations 5176 
Log Likelihood -2015.081 
Akaike Information Criterion 4046.162 
Bayesian Information Criterion 4095.212 
Note: *p < 0.05; **p < 0.01; ***p < 0.001 
Coefficient estimates and their standard errors (in parentheses) are shown for each factor.  
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Table C.2 Output from a linear mixed model of Bd load with pond type (ephemeral vs. permanent), pH and animal 
body temperature as factors. 
 Dependent variable: 
 Bd load in log (DNA copies + 1) 
Pond Type (Ephemeral vs. Permanent) -89.491 (-423.975, 244.994) 
 t = -0.524 
 p = 0.600 
Pond pH -16.280 (-37.111, 4.551) 
 t = -1.532 
 p = 0.126 
Animal Body Temperature -21.068*** (-26.644, -15.491) 
 t = -7.404 
 p < 0.001 
Pond Type : pH 33.972 (-2.100, 70.045) 
 t = 1.846 
 p = 0.065 
Pond Type : Animal Body Temperature -10.018** (-16.982, -3.054) 
 t = -2.820 
 p = 0.005 
Constant 675.873*** (413.949, 937.796) 
 t = 5.058 
 p < 0.001 
Observations 5098 
Log Likelihood -25868.150 
Akaike Information Criterion 51754.300 
Bayesian Information Criterion 51809.480 
Note: *p < 0.05; **p < 0.01; ***p < 0.001 





Table C.3 Output from a linear mixed model of Bd load on infected animals across the two hibernation types 
(permanent pond vs. terrestrial) in the two fenced ponds. 
 Dependent variable: 
 Bd load in log (DNA copies + 1) 
Hibernation Type (pond vs. soil) -1.674* (-2.863, -0.485) 
 t = -2.760 
 p = 0.028 
Pond (Wood Lab vs. Sanctuary Lake) -0.368 (-0.908, 0.173) 
 t = -1.334 
 p = 0.185 
Hibernation Type : Pond 0.417 (-0.249, 1.083) 
 t = 1.228 
 p = 0.222 
Constant 4.245*** (3.373, 5.116) 
 t = 9.550 
 p < 0.001 
Observations 112 
Log Likelihood -201.944 
Akaike Information Criterion 415.888 
Bayesian Information Criterion 431.981 
Note: *p < 0.05; **p < 0.01; ***p < 0.001 









Table C.4 Output from a generalized linear mixed model with a binomial distribution of the probability of Bd 
infection (yes/no) across the two hibernation types in the two ponds. 
 Dependent variable: 
 Bd infection 
Hibernation Type (pond vs. soil) -3.522*** (-4.657, -2.388) 
 t = -6.084 
 p < 0.001 
Pond (Wood Lab vs. Sanctuary Lake) -0.949*** (-1.439, -0.459) 
 t = -3.794 
 p < 0.001 
Hibernation Type : Pond 1.132*** (0.555, 1.708) 
 t = 3.848 
 p < 0.001 
Constant 2.047*** (1.086, 3.008) 
 t = 4.176 
 p < 0.001 
Observations 338 
Log Likelihood -187.078 
Akaike Information Criterion 384.156 
Bayesian Information Criterion 403.256 
Note: *p < 0.05; **p < 0.01; ***p < 0.001 








Table C.5 Output from a linear mixed model comparing Bd infection load on leopard frogs (Rana pipiens) that 
metamorphosed in the Sanctuary Lake pond to all other amphibians captured leaving the pond. 
 Dependent variable: 
 Bd load in log (DNA copies + 1) 
 
Species (Rana pipiens vs. all other) -0.360 (-1.295, 0.574) 
 t = -0.755 
 p = 0.458 
Constant 2.569*** (2.111, 3.027) 
 t = 10.996 
 p < 0.001 
Observations 25 
R2 0.024 
Adjusted R2 -0.018 
Residual Standard Error 1.018 (df = 23) 
Note: *p < 0.05; **p < 0.01; ***p < 0.001 












Table C.6 Output from a generalized linear mixed model with a binomial distribution comparing the probability of 
Bd infection on leopard frogs (Rana pipiens) that metamorphosed in the Sanctuary Lake pond to all other 
amphibians captured leaving the pond. 
 Dependent variable: 
 Bd infection 
Species (Rana pipiens vs. all other) 18.148 (-3147.397, 3183.693) 
 t = 0.011 
 p = 0.991 
Constant -0.582* (-1.143, -0.021) 
 t = -2.032 
 p = 0.043 
Observations 59 
Log Likelihood -34.585 
Akaike Information Criterion 73.170 
Residual Deviance 69.170 (df = 57) 
Null Deviance 80.413 (df = 58) 
Note: *p < 0.05; **p < 0.01; ***p < 0.001 












Table C.7 Output from a linear mixed model comparing Bd infection load on the spotted salamanders (Ambystoma 
maculatum) that metamorphosed in the Wood Lab pond to all other amphibians captured leaving the pond. 
 Dependent variable: 
 Bd load in log (DNA copies + 1) 
Species (Ambystoma maculatum vs. all other) 1.655 (-0.195, 3.504) 
 t = 1.753 
 p = 0.097 
Constant 2.223* (0.468, 3.978) 
 t = 2.483 
 p = 0.024 
Observations 20 
R2 0.146 
Adjusted R2 0.098 
Residual Standard Error 1.266 (df = 18) 
Note: *p < 0.05; **p < 0.01; ***p < 0.001 














Table C.8 Generalized linear mixed model comparing the probability of Bd infection for the spotted salamanders 
(Ambystoma maculatum) that metamorphosed in the Wood Lab pond to all other amphibians captured leaving the 
pond. 
 Dependent variable: 
 Bd infection 
Metamorphosis 2.890** (1.000, 4.781) 
 t = 2.996 
 p = 0.003 
Constant -1.386 (-2.936, 0.163) 
 t = -1.754 
 p = 0.080 
Observations 32 
Log Likelihood -15.435 
Akaike Information Criterion 34.870 
Residual Deviance 30.870 (df = 30) 
Null Deviance 42.340 (df = 31) 
Note: *p < 0.05; **p < 0.01; ***p < 0.001 











Table C.9 Output from a linear mixed model comparing Bd infection load on the wood frogs (Rana sylvatica) that 
metamorphosed in the Wood Lab pond to all other amphibians captured leaving the pond. 
 Dependent variable: 
 Bd load in log (DNA copies + 1) 
Species (Rana sylvatica vs. all other) 1.404*** (0.690, 2.118) 
 t = 3.852 
 p < 0.001 
Constant 2.418*** (1.971, 2.865) 
 t = 10.606 
 p < 0.001 
Observations 46 
R2 0.252 
Adjusted R2 0.235 
Residual Standard Error 1.206 (df = 44) 
Note: *p < 0.05; **p < 0.01; ***p < 0.001 















Table C.10 Output from a generalized linear mixed model with a binomial distribution of the probability comparing 
Bd infection on the wood frogs (Rana sylvatica) that metamorphosed in the Wood Lab pond to all other amphibians 
captured leaving the pond. 
 Dependent variable: 
 Bd infection 
Species (Rana sylvatica vs. all other) 2.583*** (1.508, 3.659) 
 t = 4.709 
 p < 0.001 
Constant -1.303*** (-1.720, -0.885) 
 t = -6.112 
 p < 0.001 
Observations 154 
Log Likelihood -80.015 
Akaike Information Criterion 164.029 
Residual Deviance 160.029 (df = 152) 
Null Deviance 187.806 (df = 153) 
Note: *p < 0.05; **p < 0.01; ***p < 0.001 
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